{"title":"Oncology","description":"Books on the subject of Oncology","products":[{"product_id":"introduction-to-cancer-biology-paperback-9781107601482","title":"Introduction to Cancer Biology (Paperback \/ softback) 9781107601482","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eIntroduction to Cancer Biology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eA concise overview of the fundamental concepts of cancer biology for those with little or no background in the field.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eRobin Hesketh (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781107601482, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 13 December 2012\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e352 pages, 130 b\/w illus.  38 colour illus.\u003cbr\u003e24.6 x 18.9 x 1.8 cm, 0.8 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e'The structure of the book is clear and well organized. The author writes well, giving excellent explanations of concepts ranging from basic principles to cutting-edge research. The book is a valuable resource for introducing lower-level students to the biology of cancer. Highly recommended.' H. Zhou, Choice\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThis concise overview of the fundamental concepts of cancer biology is ideal for those with little or no background in the field. A summary of global cancer patterns introduces students to the general principles of how cancers arise and the risk factors involved. By focusing on fundamental examples of the signalling pathways within cells, the functional effects of DNA damage are explained. Later chapters then build on this foundation to provide a comprehensive summary of the major signalling pathways that affect tumour development. Current therapeutic strategies are reviewed, along with a discussion of methods for tumour detection and biomarker identification. Finally, the impact of whole genome sequencing is discussed, bringing students up to date with key recent developments in the field. From basic principles to insights into cutting-edge research, this book will enable the reader to move into the cancer field with confidence.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eIntroduction\u003cbr\u003e 1. Lessons from epidemiology\u003cbr\u003e 2. Causes of cancer\u003cbr\u003e 3. Signalling in normal cells\u003cbr\u003e 4. 'Cancer genes': mutations and cancer development\u003cbr\u003e 5. What is a tumour?\u003cbr\u003e 6. Cancer signalling networks\u003cbr\u003e 7. The future of cancer prevention, diagnosis and treatment\u003cbr\u003e 8. The future of cancer in the post-genomic era\u003cbr\u003e Ten major cancers at a glance\u003cbr\u003e Appendix. Targets of specific anti-cancer drugs\u003cbr\u003e Glossary\u003cbr\u003e Further reading\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Cellular biology [\u003ca title=\"See our other books on Cellular biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Cellular%20biology%20%5Bcytology%5D%20%5BPSF%5D%22\"\u003ecytology PSF\u003c\/a\u003e], Molecular biology [\u003ca title=\"See our other books on Molecular biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Molecular%20biology%20%5BPSD%5D%22\"\u003ePSD\u003c\/a\u003e], Developmental biology [\u003ca title=\"See our other books on Developmental biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Developmental%20biology%20%5BPSC%5D%22\"\u003ePSC\u003c\/a\u003e], Biochemistry [\u003ca title=\"See our other books on Biochemistry\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Biochemistry%20%5BPSB%5D%22\"\u003ePSB\u003c\/a\u003e], Biology, life sciences [\u003ca title=\"See our other books on Biology, life sciences\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Biology,%20life%20sciences%20%5BPS%5D%22\"\u003ePS\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46000293052696,"sku":"9781107601482","price":32.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781107601482i.jpg?v=1696766530"},{"product_id":"mastering-communication-with-seriously-ill-patients-balancing-honesty-with-empathy-and-hope-paperback-9780521706186","title":"Mastering Communication with Seriously Ill Patients; Balancing Honesty with Empathy and Hope (Paperback) 9780521706186","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eMastering Communication with Seriously Ill Patients\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eBalancing Honesty with Empathy and Hope\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eThis book guides the physician through the daunting communication challenges of explaining life-threatening illness to patients and families.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eAnthony Back (Author), Robert Arnold (Author), James Tulsky (Adapted by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521706186, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 2 March 2009\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e170 pages, 19 tables\u003cbr\u003e22.4 x 15 x 1.3 cm, 0.27 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e'This useful step-by-step guide tailors the message of developing good communication to some of the most difficult conversations a physician will ever have.' Doody's Notes\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003ePhysicians who care for patients with life-threatening illnesses face daunting communication challenges. Patients and family members can react to difficult news with sadness, distress, anger, or denial. This book defines the specific communication tasks involved in talking with patients with life-threatening illnesses and their families. Topics include delivering bad news, transition to palliative care, discussing goals of advance-care planning and do-not-resuscitate orders, existential and spiritual issues, family conferences, medical futility, and other conflicts at the end of life. Drs Anthony Back, Robert Arnold, and James Tulsky bring together empirical research as well as their own experience to provide a roadmap through difficult conversations about life-threatening issues. The book offers both a theoretical framework and practical conversational tools that the practising physician and clinician can use to improve communication skills, increase satisfaction, and protect themselves from burnout.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Taking your skills to the next level\u003cbr\u003e 2. Getting a good start\u003cbr\u003e 3. Talking about serious news\u003cbr\u003e 4. Making treatment decisions\u003cbr\u003e 5. Discussing prognosis\u003cbr\u003e 6. Between the big events\u003cbr\u003e 7. Conducting a family conference\u003cbr\u003e 8. Dealing with conflicts\u003cbr\u003e 9. Transitions to end of life care\u003cbr\u003e 10. Talking about dying\u003cbr\u003e 11. Cultivating your skills.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Palliative medicine [\u003ca title=\"See our other books on Palliative medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Palliative%20medicine%20%5BMMC%5D%22\"\u003eMMC\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Doctor\/patient relationship [\u003ca title=\"See our other books on Doctor\/patient relationship\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Doctor\/patient%20relationship%20%5BMBDP%5D%22\"\u003eMBDP\u003c\/a\u003e], Medicine: general issues [\u003ca title=\"See our other books on Medicine: general issues\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine:%20general%20issues%20%5BMB%5D%22\"\u003eMB\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46002509185304,"sku":"9780521706186","price":46.29,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521706186i_79d74001-0355-40ea-aeac-be8d016bd478.jpg?v=1691380223"},{"product_id":"handbook-of-breast-mri-paperback-9780521139663","title":"Handbook of Breast MRI (Paperback) 9780521139663","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eHandbook of Breast MRI\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eA practical guide to breast MRI providing core knowledge and clinical guidelines essential for any clinician involved in breast imaging.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJeremy Price (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521139663, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 17 November 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e230 pages, 240 b\/w illus.  10 colour illus.\u003cbr\u003e24.5 x 19 x 1.3 cm, 0.65 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\"...the book is engaging, easy to read, and contains a great deal of useful information, especially from a surgical perspective.\"    Doody's Review Services\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eBreast MRI is no longer the domain of specialised centres; it is now a mainstream diagnostic technique, and an understanding of its applications is essential for any clinician involved with breast imaging. The Handbook of Breast MRI provides core knowledge and clinical guidelines for performing breast MRI in everyday practice. Introductory chapters on breast MRI basics, anatomy and pathology are followed by detailed chapters on the use of MRI in screening, staging, problem-solving and MRI-guided interventions, each containing diagnostic algorithms, tables and lists for quick access to key diagnostic information. Each chapter also contains a selection of self testing questions, and numerous Appendices concisely summarise tumour classification and current breast cancer treatment options. The Handbook of Breast MRI is an invaluable practical diagnostic resource for radiologists, surgeons, oncologists and all clinicians involved in breast cancer management.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eForeword\u003cbr\u003e List of abbreviations\u003cbr\u003e Glossary of terms\u003cbr\u003e 1. Basics of breast MRI\u003cbr\u003e 2. Imaging-related anatomy and pathology\u003cbr\u003e 3. Interpreting breast MRI studies\u003cbr\u003e 4. MR-guided biopsy techniques\u003cbr\u003e 5. High risk screening using breast MRI\u003cbr\u003e 6. Pre-operative staging of breast cancer with MRI\u003cbr\u003e 7. Problem solving applications of breast MRI\u003cbr\u003e 8. MRI after breast augmentation\u003cbr\u003e Answers to multiple choice questions\u003cbr\u003e Appendices: i. Nephrogenic systemic fibrosis\u003cbr\u003e ii. Sensitivity and specificity\u003cbr\u003e iii. TNM classification\u003cbr\u003e iv. Overview of surgical procedures\u003cbr\u003e v. Overview of radiation therapy\u003cbr\u003e vi. Overview of systemic therapy\u003cbr\u003e vii. Breast cancer genes and genetic testing\u003cbr\u003e viii. Primary prevention strategies for high-risk women\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Surgical oncology [\u003ca title=\"See our other books on Surgical oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Surgical%20oncology%20%5BMNK%5D%22\"\u003eMNK\u003c\/a\u003e], Radiology [\u003ca title=\"See our other books on Radiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Radiology%20%5BMMPH%5D%22\"\u003eMMPH\u003c\/a\u003e], Medical imaging [\u003ca title=\"See our other books on Medical imaging\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20imaging%20%5BMMP%5D%22\"\u003eMMP\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46002704843032,"sku":"9780521139663","price":69.19,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521139663i_8e30c9f1-f282-4194-b7f6-b211f6813e64.jpg?v=1691372306"},{"product_id":"gynaecological-oncology-for-the-mrcog-and-beyond-paperback-9781906985219","title":"Gynaecological Oncology for the MRCOG and Beyond (Paperback \/ softback) 9781906985219","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eGynaecological Oncology for the MRCOG and Beyond\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis book is aimed at MRCOG candidates, covering all aspects of gynaecological oncology.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eNigel Acheson (Edited by), David Luesley (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781906985219, Royal College of Obstetricians and Gynaecologists (RCOG)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 1 January 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e273 pages\u003cbr\u003e21.5 x 13.7 x 1.3 cm, 0.38 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eA multidisciplinary approach to the care of women with gynaecological cancer - with treatment delivered in linked local or specialist centres - has been established in the UK. The second edition of this book therefore includes chapters which focus on the multidisciplinary approach. Chapters on pathology, radiology, chemotherapy and radiotherapy will increase understanding of these disciplines that are central to the care of women with gynaecological cancers. Chapters on laparoscopic surgery, basic surgical principles, palliative care, emergencies and treatment-related complications provide additional information. All content has been updated to reflect current practice and present the latest evidence on investigation, staging and management. The book is primarily designed to provide a comprehensive summary for candidates preparing for the Part 2 MRCOG examination, and as such covers the RCOG curriculum for gynaecological oncology. It is also a valuable guide for all healthcare professionals working in the field, including trainees, consultants and midwives.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Basic epidemiology Andrew Phillips and Nigel Acheson\u003cbr\u003e 2. Basic pathology of gynaecological cancer Raji Ganesan\u003cbr\u003e 3. Preinvasive disease of the lower genital tract Gabrielle Downey\u003cbr\u003e 4. Radiological assessment Sarah Higgins and Adrian Lim\u003cbr\u003e 5. Surgical principles Quentin Davies\u003cbr\u003e 6. Role of laparoscopic surgery Hans Nagar\u003cbr\u003e 7. Radiotherapy: principles and applications David Radstone\u003cbr\u003e 8. Chemotherapy: principles and applications Nigel Acheson\u003cbr\u003e 9. Ovarian cancer standards of care John Kirwan\u003cbr\u003e 10. Endometrial cancer standards of care Rob Gornall\u003cbr\u003e 11. Cervical cancer standards of care Jonathan Herod\u003cbr\u003e 12. Vulval cancer standards of care Michael Hannemann\u003cbr\u003e 13. Uncommon gynaecological cancers Susie Houghton\u003cbr\u003e 14. Palliative care Jo Sykes\u003cbr\u003e 15. Emergencies and treatment-related complications in gynaecological oncology Janos Balega and Kavita Singh\u003cbr\u003e Appendix 1. FIGO staging of gynaecological cancers\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Surgical oncology [\u003ca title=\"See our other books on Surgical oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Surgical%20oncology%20%5BMNK%5D%22\"\u003eMNK\u003c\/a\u003e], Gynaecology \u0026amp; obstetrics [\u003ca title=\"See our other books on Gynaecology \u0026amp; obstetrics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Gynaecology%20\u0026amp;%20obstetrics%20%5BMJT%5D%22\"\u003eMJT\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Medicine [\u003ca title=\"See our other books on Medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine%20%5BM%5D%22\"\u003eM\u003c\/a\u003e], Examinations \u0026amp; assessment [\u003ca title=\"See our other books on Examinations \u0026amp; assessment\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Examinations%20\u0026amp;%20assessment%20%5BJNKD%5D%22\"\u003eJNKD\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Royal College of Obstetricians and Gynaecologists","offers":[{"title":"Default Title","offer_id":46003256262936,"sku":"9781906985219","price":42.85,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781906985219i_dd84469b-828f-495d-9bdb-0211489e6cef.jpg?v=1696598757"},{"product_id":"gynaecological-oncology-paperback-9780521730242","title":"Gynaecological Oncology (Paperback) 9780521730242","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eGynaecological Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eA concise introduction providing a thorough and up-to-date overview of the full range of gynaecological cancers.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMahmood I. Shafi (Edited by), Helena M. Earl (Edited by), Li Tee Tan (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521730242, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 3 December 2009\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e248 pages, 40 b\/w illus.  14 tables\u003cbr\u003e23.3 x 15.7 x 1.5 cm, 0.53 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e'… comprehensive and easy to read … will be beneficial to trainees as an introduction to the management of gynaecological cancers.' The Obstetrician and Gynaecologist\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eProviding a thorough and up-to-date overview of the full range of gynaecological cancers, Gynaecological Oncology is a concise introduction, particularly useful for trainees working towards postgraduate examinations. The first section includes introductory chapters on epidemiology, screening and prevention, imaging, pathology, surgery, radiation therapy, chemotherapy, and palliation. The second part of the book covers the gynaecological cancer types in turn; each chapter following a similar format looking at clinical issues, staging, and principles of management. Where appropriate, flow-charts and diagrams are used to help the reader assimilate complex information. A chapter is devoted to decision-making, addressing those issues clinicians and women face when deciding on optimal management in given clinical scenarios. The book is practically based and is enhanced by highlighting learning points, management algorithms and clinical images. This is an invaluable resource for all doctors and allied health professionals dealing with women with gynaecological cancers.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Epidemiology of gynaecological cancers Anjum Memon\u003cbr\u003e 2. Screening and prevention of gynaecological cancers Ranjit Manchanda and Ian J. Jacobs\u003cbr\u003e 3. Pathology of gynaecological cancers Mark J. Arends\u003cbr\u003e 4. Imaging in gynaecological oncology Nyree Griffin and Evis Sala\u003cbr\u003e 5. Surgery for gynaecological cancers Alan Farthing\u003cbr\u003e 6. Radiation therapy for gynaecological cancers Charlotte Coles\u003cbr\u003e 7. Systemic therapies for gynaecological cancers Helena M. Earl\u003cbr\u003e 8. Palliative care for gynaecological oncology Sara Booth\u003cbr\u003e 9. Ovarian cancer Robin Crawford and Yin-Ling Woo\u003cbr\u003e 10. Endometrial cancer Cathrine Holland\u003cbr\u003e 11. Cervical and vaginal cancer Ahmed Ahmed, Li Tee Tan and Mahmood I. Shafi\u003cbr\u003e 12. Vulvar cancer Peter Baldwin\u003cbr\u003e 13. Gynaecological sarcomas John Latimer and Helena M. Earl\u003cbr\u003e 14. Gestational trophoblastic disease and ovarian germ cell tumours Neil J. Sebire and Michael J. Seckl\u003cbr\u003e 15. Decision-making in oncology Li Tee Tan and Helena M. Earl\u003cbr\u003e Appendix 1. WHO performance scale\/ASA grading\u003cbr\u003e Appendix 2. Incidence and mortality data\u003cbr\u003e Appendix 3. Staging – FIGO\u003cbr\u003e TNM\u003cbr\u003e Pictorial diagrams\u003cbr\u003e Appendix 4. Useful addresses\/websites\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Gynaecology \u0026amp; obstetrics [\u003ca title=\"See our other books on Gynaecology \u0026amp; obstetrics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Gynaecology%20\u0026amp;%20obstetrics%20%5BMJT%5D%22\"\u003eMJT\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46004814119192,"sku":"9780521730242","price":54.39,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521730242i_9e1733b0-6252-4db1-b55c-be25277a9bd5.jpg?v=1691380577"},{"product_id":"cancer-in-pregnancy-and-lactation-the-motherisk-guide-hardback-9781107006133","title":"Cancer in Pregnancy and Lactation; The Motherisk Guide (Hardback) 9781107006133","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer in Pregnancy and Lactation\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eThe Motherisk Guide\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eA comprehensive book that provides evidence-based information needed to address the complex issues of cancer in pregnancy.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eGideon Koren (Edited by), Michael Lishner (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781107006133, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 10 November 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e222 pages, 2 b\/w illus.\u003cbr\u003e24 x 15.9 x 1.5 cm, 0.51 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eCancer in pregnancy presents physicians with a serious and ethical challenge, yet the sources of concise data and guidance for the management of this disease are scarce. The Motherisk program, based at the Hospital for Sick Children, Toronto, is dedicated to addressing this problem. Cancer in Pregnancy and Lactation: The Motherisk Guide tackles this subject by providing evidence-based information needed to address the complex issues of maternal diagnosis, management, treatment, prognosis and long-term impact on the unborn child. Based on the research by members of the international Consortium of Cancer in Pregnancy Evidence (CCoPE) this book provides physicians with the core knowledge required to make sound clinical decisions in the face of sometimes conflicting interests. Co-edited by recognized experts in the field with over 25 years' experience, this comprehensive volume is essential reading for all maternal-fetal medicine physicians, obstetricians, neonatologists, oncologists and pharmacologists.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003e Part I. Specific Tumors During Pregnancy: 1. Bone malignancies in pregnancy Michael Lishner and Alla Osadchy\u003cbr\u003e 2. Breast cancer and pregnancy Liat Mlynarsky and Michael Lishner\u003cbr\u003e 3. Cervical cancer during pregnancy Asnat Walfisch\u003cbr\u003e 4. Hepatocellular carcinoma Parvaneh Yazdani-Brojeni and Michael Lishner\u003cbr\u003e 5. Hodgkin's lymphoma in pregnancy David Pereg and Michael Lishner\u003cbr\u003e 6. Intracranial tumours in pregnancy Michael Lishner and Geert W. 't Jong\u003cbr\u003e 7. The treatment of acute and chronic leukemia during pregnancy Tali Shapira-Rotenberg and Michael Lishner\u003cbr\u003e 8. Lung cancer and pregnancy Hisaki Fujii\u003cbr\u003e 9. Malignant melanoma and pregnancy Michael Lishner and Michael P. Tan\u003cbr\u003e 10. Non-Hodgkin's lymphoma during pregnancy David Pereg and Michael Lishner\u003cbr\u003e 11. Ovarian tumors and pregnancy Rinat Hackmon\u003cbr\u003e 12. Thyroid cancer and pregnancy Michael P. Tan\u003cbr\u003e Part II. Fetal Effects of Cancer Treatments and Interventions: 13. Pregnancy and radiation Eyal Fenig\u003cbr\u003e 14. Chemotherapy during pregnancy Israel Mazin, David Pereg and Michael Lishner\u003cbr\u003e 15. Non-obstetrical surgical interventions during pregnancy Bi Lan Wo, Angela Mazzolli and Alon Shrim\u003cbr\u003e Part III. Management of Maternal Complications During Treatment: 16. Management of complications associated with cancer or antineoplastic treatment during pregnancy Michael P. Tan\u003cbr\u003e 17. Management of nutritional problems in the pregnant cancer patient Deborah A. Kennedy\u003cbr\u003e 18. Pharmacological and non-pharmacological treatment of chemotherapy-induced nausea and vomiting Caroline Maltepe\u003cbr\u003e 19. Fertility considerations and methods of fertility preservation in patients undergoing treatment for cancer Avi Leader\u003cbr\u003e Part IV. Long Term Effects of In Utero Exposure on Children: 20. Long term neurodevelopment of children exposed in utero to treatment for maternal cancer Irena Nulman, Claire Tobias and Elizabeth Uleryk\u003cbr\u003e 21. Fertility of children exposed in utero to chemotherapy Tali Schechter and Ronen Loebstein\u003cbr\u003e 22. Lactation and cancer chemotherapy Taro Kamiya and Shinya Ito\u003cbr\u003e 23. Breast cancer and pregnancy: critical review of the effects of prior and subsequent pregnancy on the prognosis of young women with breast tumor Nava Siegelmann-Danieli and Ronen Loebstein\u003cbr\u003e 24. Effects of the placenta of metastatic breast cancer Shelly Tartakover-Matalon, Liat Drucker and Michael Lishner\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Materno-fetal medicine [\u003ca title=\"See our other books on Materno-fetal medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Materno-fetal%20medicine%20%5BMJTF%5D%22\"\u003eMJTF\u003c\/a\u003e], Gynaecology \u0026amp; obstetrics [\u003ca title=\"See our other books on Gynaecology \u0026amp; obstetrics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Gynaecology%20\u0026amp;%20obstetrics%20%5BMJT%5D%22\"\u003eMJT\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Reproductive medicine [\u003ca title=\"See our other books on Reproductive medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Reproductive%20medicine%20%5BMFKC%5D%22\"\u003eMFKC\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46005346730264,"sku":"9781107006133","price":73.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781107006133i_67751914-957c-42c1-88a8-495719a988a7.jpg?v=1691360879"},{"product_id":"extra-cranial-applications-of-diffusion-weighted-mri-hardback-9780521518697","title":"Extra-Cranial Applications of Diffusion-Weighted MRI (Hardback) 9780521518697","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eExtra-Cranial Applications of Diffusion-Weighted MRI\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eA practical clinical text on applications of extra-cranial diffusion-weighted MRI by world-renowned experts.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eBachir Taouli (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521518697, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 21 October 2010\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e226 pages, 150 b\/w illus.  46 colour illus.  26 tables\u003cbr\u003e25.4 x 19.4 x 1.5 cm, 0.78 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eContinuous improvement in MRI technology in recent years has led to the application of diffusion-weighted MR imaging in organ systems outside the brain. Extra-Cranial Applications of Diffusion-Weighted MRI provides an extensive review of current and future applications of this imaging modality by world-renowned experts. Organized by organ system, each chapter is highly illustrated, offering a balance of protocols, illustrations and principles of image interpretation. An initial chapter provides an overview of relevant physics and other technical details, followed by detailed chapters on all major body systems including liver, kidney, prostate, breast and spine. A final chapter discusses assessment of therapy response. Written and edited by leading DW-MRI experts worldwide, Extra-Cranial Applications of Diffusion-Weighted MRI is an invaluable resource for radiology trainees, practising radiologists and for researchers in a wide variety of disciplines.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003e 1. Basic physical principles of body diffusion-weighted imaging Eric E. Sigmund and Jens Jensen\u003cbr\u003e 2. Diffusion-weighted MR imaging of the liver Bachir Taouli and Dow-Mu Koh\u003cbr\u003e 3. Diffusion-weighted imaging of diffuse renal disease and kidney transplant Frederik De Keyzer and Harriet C. Thoeny\u003cbr\u003e 4. Diffusion-weighted imaging of focal renal masses Sooah Kim and Bachir Taouli\u003cbr\u003e 5. Diffusion-weighted imaging of the pancreas Tomoaki Ichikawa, Ali Muhi, Utaroh Motosugi and Katushiro Sano\u003cbr\u003e 6. Diffusion-weighted imaging of the prostate Sophie F. Riches and Nandita DeSouza\u003cbr\u003e 7. Breast applications of diffusion-weighted imaging Yong Guo\u003cbr\u003e 8. Diffusion-weighted MR imaging of lymph nodes Thomas C. Kwee and Taro Takahara\u003cbr\u003e 9. Diffusion-weighted MR imaging of female pelvic tumors Hela Sbano and Anwar R. Padhani\u003cbr\u003e 10. Diffusion-weighted MR imaging of the bone marrow and the spine Andrea Baur-Melnyk and Olaf Dietrich\u003cbr\u003e 11. Diffusion-weighted imaging of soft tissue tumors Masayuki Maeda\u003cbr\u003e 12. Evaluation of treatment response with DWI Andriy M. Babsky, Shenghong Ju and Navin Bansal\u003cbr\u003e 13. Diffusion-weighted MR imaging: future directions Dow-Mu Koh and David J. Collins\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Nuclear magnetic resonance [\u003ca title=\"See our other books on Nuclear magnetic resonance\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Nuclear%20magnetic%20resonance%20%5BNMR%20\/%20MRI%5D%20%5BMMPG%5D%22\"\u003eNMR \/ MRI MMPG\u003c\/a\u003e], Medical imaging [\u003ca title=\"See our other books on Medical imaging\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20imaging%20%5BMMP%5D%22\"\u003eMMP\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46005789786392,"sku":"9780521518697","price":57.29,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521518697i_074fa61a-3a5f-49e9-b556-f3a6e2bf09dd.jpg?v=1691383514"},{"product_id":"case-studies-in-urological-cancer-hardback-9781841101385","title":"Case Studies in Urological Cancer (Hardback) 9781841101385","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCase Studies in Urological Cancer\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eCase Studies in Urological Cancer  features over 30 detailed case studies, with comprehensive explanatory text.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eAdrian N. Harnett (Author), Robert N. Meddings (Author), Brian McGlynn (Author), Stephen Cooper (Contributions by), Bob Nairn (Contributions by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781841101385, Greenwich Medical Media\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 12 January 2002\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e160 pages, 60 colour illus.\u003cbr\u003e24.4 x 15.4 x 1.5 cm, 0.491 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eCase Studies in Urological Cancer builds in the success of Dr Harnett's previous Case Studies in Breast Cancer, which has established itself as a key title for anyone involved in diagnosis and care of the patient with breast cancer. Featuring over 30 detailed case studies, with comprehensive explanatory text and full colour illustrations, throughout, this book provides any healthcare professional involved in urological cancer with a selection of thought-provoking, practice-changing problems in this common malignant condition. To ensure a multidisciplinary perspective, and the most comprehensive coverage possible, Dr Harnett is assisted for this volume by two co-authors, one a urological surgeon and one a urology nurse specialist, both with many years' experience of front-line patient care.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Greenwich Medical Media","offers":[{"title":"Default Title","offer_id":46005894873368,"sku":"9781841101385","price":56.49,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781841101385i.jpg?v=1696708901"},{"product_id":"clinical-mr-spectroscopy-techniques-and-applications-hardback-9780521868983","title":"Clinical MR Spectroscopy; Techniques and Applications (Hardback) 9780521868983","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eClinical MR Spectroscopy\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eTechniques and Applications\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eCovers all MR spectroscopy techniques and their clinical applications in neurological disorders, malignancies and musculoskeletal diseases.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003ePeter B. Barker (Author), Alberto Bizzi (Author), Nicola De Stefano (Author), Rao Gullapalli (Author), Doris D. M.  Lin (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521868983, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 12 November 2009\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e274 pages, 84 b\/w illus.  60 colour illus.  7 tables\u003cbr\u003e25.3 x 19.3 x 2 cm, 0.93 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e'It is an excellent textbook for the initial foray into the topic and a great reference book … I would happily recommend [it] to anyone wanting to use MRS in clinical research and believe that it will encourage the use of this technology in mainstream practice.' The Lancet\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eIn vivo magnetic resonance spectrosopy (MRS) is increasingly being used in the clinical setting, particularly for neurological disorders. Clinical MR Spectroscopy – Techniques and Applications explains both the underlying physical principles of MRS and provides a perceptive review of clinical MRS applications. Topics covered include an introduction to MRS physics, information content of spectra from different organ systems, spectral analysis methods, recommended protocols and localization techniques, and normal age- and region-related spectral variations in the brain. Clinical applications in the brain are discussed for brain tumors, hypoxic and ischemic injury, infectious, inflammatory and demyelinating diseases, epilepsy, neurodegenerative disorders, trauma and metabolic diseases. Outside of the brain, techniques and applications are discussed for MRS in the musculosketal system, breast and prostate. Written by leading MRS experts, this is an invaluable guide for anyone interested in in vivo MRS, including radiologists, neurologists, neurosurgeons, oncologists and medical researchers.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003e Acknowledgements\u003cbr\u003e 1. Introduction to MR spectroscopy in vivo\u003cbr\u003e 2. Pulse sequences and protocol design\u003cbr\u003e 3. Spectral analysis methods, quantitation and common artifacts\u003cbr\u003e 4. Normal regional variations: brain development and aging\u003cbr\u003e 5. MRS in brain tumors\u003cbr\u003e 6. MRS in stroke and hypoxic-ischemic encephalopathy\u003cbr\u003e 7. MRS in infectious, inflammatory and demyelinating lesions\u003cbr\u003e 8. MRS in epilepsy\u003cbr\u003e 9. MRS in neurodegenerative disease\u003cbr\u003e 10. MRS in traumatic brain injury\u003cbr\u003e 11. Proton MR spectroscopy in brain metabolic disorders\u003cbr\u003e 12. MRS in prostate cancer\u003cbr\u003e 13. MRS in breast cancer\u003cbr\u003e 14. MRS in musculoskeletal disease\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Neurosurgery [\u003ca title=\"See our other books on Neurosurgery\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Neurosurgery%20%5BMNN%5D%22\"\u003eMNN\u003c\/a\u003e], Radiology [\u003ca title=\"See our other books on Radiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Radiology%20%5BMMPH%5D%22\"\u003eMMPH\u003c\/a\u003e], Medical imaging [\u003ca title=\"See our other books on Medical imaging\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20imaging%20%5BMMP%5D%22\"\u003eMMP\u003c\/a\u003e], Neurology \u0026amp; clinical neurophysiology [\u003ca title=\"See our other books on Neurology \u0026amp; clinical neurophysiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Neurology%20\u0026amp;%20clinical%20neurophysiology%20%5BMJN%5D%22\"\u003eMJN\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46005917909272,"sku":"9780521868983","price":102.59,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521868983i_59240a54-cc1c-4af3-98ea-bd6cf35fba76.jpg?v=1691358647"},{"product_id":"practical-geriatric-oncology-hardback-9780521513197","title":"Practical Geriatric Oncology (Hardback) 9780521513197","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePractical Geriatric Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis comprehensive text provides guidelines to the care of elderly cancer patients, which is different from that of younger adults.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eArti Hurria (Edited by), Harvey Jay Cohen (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521513197, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 13 September 2010\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e448 pages, 36 b\/w illus.  82 tables\u003cbr\u003e26.1 x 18.4 x 2.7 cm, 0.93 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThe risk of cancer increases with age, and the number of older adults seeking treatment is increasing dramatically in line with the aging population. The care of older patients differs from that of younger adults because of differences in the biology of the tumor, age-related differences in host physiology, comorbidity burden and psychosocial issues, which might impact the efficacy and side effects of cancer therapy. Practical Geriatric Oncology is a comprehensive, evidence-based text that synthesizes the growing literature in this field and provides practical guidelines to the care of older adults with cancer. Coverage includes patient assessment, management of solid tumors and hematologic malignancies, the impact of age on the pharmacology of cancer therapy, surgical oncology and radiation oncology in the older adult, symptom management and supportive care. In addition to serving as core reading for oncologists and hematologists, the book will also be a useful work for other healthcare professionals who provide oncology care, including surgeons, radiation oncologists, palliative care doctors, primary care providers, geriatricians and nurses.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePart I: 1. Geriatric assessment for the older adult with cancer Arti Hurria and Harvey Jay Cohen\u003cbr\u003e 2. Pharmacology and unique side-effects of chemotherapy in older adults Hans Wildier and Matti Aapro\u003cbr\u003e 3. Pharmacology and unique side-effects of hormonal therapy in older adults Leona Downey\u003cbr\u003e 4. Drug utilization, adherence, and unique side-effects of targeted therapy in older adults Tiffany A. Traina and Stuart M. Lichtman\u003cbr\u003e 5. Principles of surgical oncology in older adults Suzanne Gaskell, Siri R. Kristjansson and Riccardo A. Audisio\u003cbr\u003e 6. Principles of radiation oncology in older adults Benjamin D. Smith and Thomas A. Buccholz\u003cbr\u003e Part II. Management of Solid Tumors in Older Adults: 7. Management of breast cancer in older adults Michelle Shayne and Gretchen Kimmick\u003cbr\u003e 8. Management of lung cancer in older adults Suresh S. Ramalingam and Chandra P. Belani\u003cbr\u003e 9. Management of head and neck cancer in older adults Julie A. Kish\u003cbr\u003e 10. Management of esophagus and gastric cancer in older adults Shahzad Siddique and Jimmy Hwang\u003cbr\u003e 11. Management of colon and rectal cancer in older adults Supriya Gupta Mohile, Harman P. Kaur and Richard M. Goldberg\u003cbr\u003e 12. Management of renal and bladder cancer in older adults Matthew I. Milowsky and Dean F. Bajorin\u003cbr\u003e 13. Management of prostate cancer in older adults Andrew Liman and Gurkamal Chatta\u003cbr\u003e 14. Management of ovarian and endometrial cancer in older adults William P. Tew and Vivian von Gruenigan\u003cbr\u003e Part III. Management of Hematologic Malignancies in Older Adults: 15. Management of myelodysplasia in older adults Heidi D. Klepin and Bayard L. Powell\u003cbr\u003e 16. Management of chronic leukemia in older adults Martha Wadleigh and Richard Maury Stone\u003cbr\u003e 17. Management of acute myeloid leukemia in older adults Arati V. Rao and Joseph O. Moore\u003cbr\u003e 18. Hematopoietic cell transplantation in older adults Andrew S. Artz and William B. Ershler\u003cbr\u003e 19. Management of non-Hodgkin's lymphoma in older adults Anne H. Blaes and Vicki A. Morrison\u003cbr\u003e 20. Management of myeloma in older adults Amrita Y. Krishnan\u003cbr\u003e Part IV. Symptom Management and Supportive Care of Older Adults: 21. Optimizing quality of life in older adults with cancer Alice B. Kornblith and Mark T. Hegel\u003cbr\u003e 22. Optimizing functional status in older adults with cancer Gijsberta van Londen and Stephanie Studenski\u003cbr\u003e 23. The myeloid growth factors in older adults with cancer Gary H. Lyman\u003cbr\u003e 24. Erythropoiesis-stimulating agents in older adults with cancer Matthew S. McKinney and Jeffrey Crawford\u003cbr\u003e 25. Management of depression and anxiety in older adults with cancer Mark I. Weinberger, Christian J. Nelson and Andrew J. Roth\u003cbr\u003e 26. Management of pain in older adults with cancer Anthony Nicholas Galanos, Katya Elbert-Avila and Leslie J. Bryan\u003cbr\u003e 27. Management of fatigue in older adults with cancer Betty Ferrell and Tami Borneman\u003cbr\u003e 28. Management of dyspnea in older adults with cancer Amy P. Abernethy, Jane L. Wheeler and David C. Currow\u003cbr\u003e 29. Management of the gastrointestinal side-effects of therapy in older adults with cancer Laura Raftery, Stephen A. Bernard and Richard M. Goldberg.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Geriatric nursing [\u003ca title=\"See our other books on Geriatric nursing\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Geriatric%20nursing%20%5BMQCL4%5D%22\"\u003eMQCL4\u003c\/a\u003e], Surgical oncology [\u003ca title=\"See our other books on Surgical oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Surgical%20oncology%20%5BMNK%5D%22\"\u003eMNK\u003c\/a\u003e], Geriatric medicine [\u003ca title=\"See our other books on Geriatric medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Geriatric%20medicine%20%5BMJX%5D%22\"\u003eMJX\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46019724345624,"sku":"9780521513197","price":90.29,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521513197i_de630632-bbd0-4054-a453-b8c694f95762.jpg?v=1691383194"},{"product_id":"breast-cancer-hardback-9780521519502","title":"Breast Cancer (Hardback) 9780521519502","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eBreast Cancer\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eDiscusses key issues related to the screening, diagnosis and treatment of breast cancer by recognised international experts.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMichael J. Michell (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521519502, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 25 February 2010\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e282 pages, 143 b\/w illus.  17 colour illus.  20 tables\u003cbr\u003e25.4 x 18 x 2.1 cm, 0.89 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eWorldwide, breast cancer is by far the most common cancer amongst women, with an incidence rate more than twice that of colorectal cancer and cervical cancer and about three times that of lung cancer. Whilst screening programmes have improved detection, this disease still places a very high burden on healthcare services worldwide. Over the last two decades, improved public awareness, the implementation of population screening by mammography, and the development of new technology for diagnosis have transformed the care of patients with breast cancer. In this volume, recognised experts discuss key current issues in the diagnosis and management of breast disease. The development and application of new diagnostic techniques is described as well as the use of sophisticated drugs for more effective treatment. Complex contentious topics including risk factors, borderline lesions, professional performance and quality assurance are thoroughly explored by an expert multidisciplinary team.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSeries foreword\u003cbr\u003e Preface to Breast Cancer\u003cbr\u003e 1. Epidemiology of breast cancer Stephen W. Duffy\u003cbr\u003e 2. Quality assurance in breast cancer screening Roger G. Blanks and Rachel L. Bennett\u003cbr\u003e 3. Measuring radiology performance in breast screening Alistair Gale and Hazel Scott\u003cbr\u003e 4. Advances in X-ray mammography Kenneth C. Young and David R. Dance\u003cbr\u003e 5. Advanced applications of breast ultrasound William Svensson and Victoria Stewart\u003cbr\u003e 6. Mammographic signs of small invasive cancers Michael Michell and Rema Wasan\u003cbr\u003e 7. The radiology of DCIS – current issues Andy Evans\u003cbr\u003e 8. Pathology Sarah E. Pinder and Elena Provenzano\u003cbr\u003e 9. Advanced breast biopsy techniques Robin Wilson and David Evans\u003cbr\u003e 10. Radiological assessment of the axilla Eleanor Cornford and Jonathan James\u003cbr\u003e 11. Breast MRI Fiona Gilbert\u003cbr\u003e 12. Application of PET\/CT in breast cancer Iain D. Lyburn and Elizabeth F. Brown\u003cbr\u003e 13. Advances in treatment of breast cancer Muireann Kelleher and Paul Ellis\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Medical imaging [\u003ca title=\"See our other books on Medical imaging\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20imaging%20%5BMMP%5D%22\"\u003eMMP\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46019755245848,"sku":"9780521519502","price":50.29,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521519502i_77a3d284-724f-4f26-b19b-682597456adb.jpg?v=1691383548"},{"product_id":"primary-carcinomas-of-the-liver-hardback-9780521519519","title":"Primary Carcinomas of the Liver (Hardback) 9780521519519","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePrimary Carcinomas of the Liver\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eHighly illustrated review of diagnosis, staging and treatment of primary liver carcinomas by expert multidisciplinary author team for wide readership.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eHero K. Hussain (Edited by), Isaac R. Francis (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521519519, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 26 November 2009\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e254 pages, 137 b\/w illus.  4 colour illus.  9 tables\u003cbr\u003e25.4 x 18 x 2 cm, 0.81 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e'… an extensive subject that this book handles well … the book enables the reader to gain an in-depth appreciation of a complex subject matter.' Synergy-Imaging and Therapy Practice\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003ePrimary carcinomas of the liver are increasing in incidence in the developed world, probably due to dietary and environmental factors as well as the known role of infective agents such as Hepatitis C. They are usually diagnosed in the advanced stages and carry high morbidity and mortality. This volume summarises the latest developments in imaging of primary hepatic carcinomas, emphasising the multidisciplinary approach to the care of patients. In addition to extensive chapters on the radiological issues surrounding diagnosis and staging of the malignancies, individual chapters on epidemiology, pathology, and surgical and non-surgical treatment options are included. All treatment options are considered for both HCC and cholangiocarcinoma, including newer techniques such as TACE. Only by a well orchestrated multidisciplinary team approach including epidemiologists, diagnostic radiologists, hepatologists, oncologic surgeons, radiation oncologists, and pathologists can these complex malignancies be managed successfully.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSeries foreword\u003cbr\u003e Preface to Primary Carcinomas of the Liver\u003cbr\u003e 1. Epidemiology hepatocellular carcinoma (HCC) and cholangiocarcinoma Jorge A. Marrero\u003cbr\u003e 2. Surveillance\/screening for hepatocellular carcinoma Jorge A. Marrero and Hero K. Hussain\u003cbr\u003e 3. Pathology of hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma Barbara McKenna and Sharon Bihlmeyer\u003cbr\u003e 4. Radiological diagnosis of HCC Jonathon M. Willatt, Hero K. Hussain and Isaac R. Francis\u003cbr\u003e 5. Staging of hepatocellular carcinoma Jorge A. Marerro and Hero K. Hussain\u003cbr\u003e 6. Surgical treatment of HCC: resection and transplantation Sean Kumer and Shawn J. Pelletier\u003cbr\u003e 7. Non-surgical treatment of HCC: 7.1 Regional therapies for treatment of intermediate stage HCC: a. Trans-arterial chemoembolization (TACE) Venkat N. Krishnamurthy\u003cbr\u003e b. Ablation of hepatocellular carcinoma Elaine M. Caoili\u003cbr\u003e 7.2 Systemic therapies for advanced HCC: a. Review of current status of radiotherapy for the treatment of hepatocellular carcinoma Orit Gutfeld and Charlie Pan\u003cbr\u003e b. Review of current status of chemotherapy for the treatment of hepatocellular carcinoma Edward Kim and Mark Zalupski\u003cbr\u003e 8. Radiological identification of recurrent or residual hepatocellular carcinoma Peter S. Liu, Ajaykumar C. Morani and Hero K. Hussain\u003cbr\u003e 9. Radiological diagnosis of cholangiocarcinoma Hero K. Hussain and Isaac R. Francis\u003cbr\u003e 10. Staging of cholangiocarcinoma Hero K. Hussain and James A. Knol\u003cbr\u003e 11. Non-surgical treatment of cholangiocarcinoma: a. Radiotherapy Orit Gutfeld and Charlie Pan\u003cbr\u003e b. Systemic therapy of cholangiocarcinoma Gazala N. Khan and Mark M. Zalupski\u003cbr\u003e 12. Uncommon hepatic tumors Peter S. Liu and Hero K. Hussain\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Surgical oncology [\u003ca title=\"See our other books on Surgical oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Surgical%20oncology%20%5BMNK%5D%22\"\u003eMNK\u003c\/a\u003e], Radiology [\u003ca title=\"See our other books on Radiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Radiology%20%5BMMPH%5D%22\"\u003eMMPH\u003c\/a\u003e], Medical imaging [\u003ca title=\"See our other books on Medical imaging\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20imaging%20%5BMMP%5D%22\"\u003eMMP\u003c\/a\u003e], Pathology [\u003ca title=\"See our other books on Pathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pathology%20%5BMMF%5D%22\"\u003eMMF\u003c\/a\u003e], Hepatology [\u003ca title=\"See our other books on Hepatology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Hepatology%20%5BMJJ%5D%22\"\u003eMJJ\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Epidemiology \u0026amp; medical statistics [\u003ca title=\"See our other books on Epidemiology \u0026amp; medical statistics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Epidemiology%20\u0026amp;%20medical%20statistics%20%5BMBNS%5D%22\"\u003eMBNS\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46019756654872,"sku":"9780521519519","price":53.29,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521519519i_29df17ad-d224-45cc-bc77-dd2c0430595c.jpg?v=1691383540"},{"product_id":"manual-of-stem-cell-and-bone-marrow-transplantation-paperback-9781107661547","title":"Manual of Stem Cell and Bone Marrow Transplantation (Paperback \/ softback) 9781107661547","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eManual of Stem Cell and Bone Marrow Transplantation\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThe fully revised second edition is a practical manual for all members of the stem cell and bone marrow transplant team.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJoseph H. Antin (Author), Deborah Yolin Raley (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781107661547, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 17 October 2013\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e209 pages, 29 b\/w illus.  26 tables\u003cbr\u003e18.5 x 12.3 x 0.9 cm, 0.23 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eFully revised throughout, the second edition of Manual of Stem Cell and Bone Marrow Transplantation is based on the in-house handbook used at the world-renowned Dana-Farber Cancer Institute. It is a practical pocket manual for all members of the stem cell and bone marrow transplant team. Written by experts at Dana-Farber, the contents are handily arranged in outline format for maximum usefulness and convenience. This essential and user-friendly manual covers all aspects of the transplantation process, from stem cell processing through management of transplant-related complications. Topics discussed thoroughly include evaluation and counselling of patients and donors, preventative care, graft-versus-host disease and conditioning regimens. A new extensive chapter on oral health in stem cell transplantation has been added. These features make the Manual of Stem Cell and Bone Marrow Transplantation an ideal resource for the entire transplant team.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eAcknowledgements\u003cbr\u003e 1. Rationale for transplantation\u003cbr\u003e 2. Types of transplantation\u003cbr\u003e 3. HLA matching in allogeneic transplantation\u003cbr\u003e 4. Stem cell source\u003cbr\u003e 5. Pre-transplant evaluation and counselling of patient and donor\u003cbr\u003e 6. Conditioning regimens\u003cbr\u003e 7. Stem cell infusion\u003cbr\u003e 8. ABO compatibility\u003cbr\u003e 9. Engraftment\u003cbr\u003e 10. Preventative care\u003cbr\u003e 11. Transplant-related complications\u003cbr\u003e 12. Overview of acute and chronic graft-versus-host disease\u003cbr\u003e 13. Acute graft-versus-host disease and staging\u003cbr\u003e 14. Graft-versus-host prophylactic regimens\u003cbr\u003e 15. Treatment guidelines for acute graft-versus-host disease\u003cbr\u003e 16. Chronic graft-versus-host disease\u003cbr\u003e 17. Engraftment syndrome\u003cbr\u003e 18. Infectious disease\u003cbr\u003e 19. Graft rejection and failure\u003cbr\u003e 20. Gastrointestinal complications\u003cbr\u003e 21. Oral health in stem cell transplantation\u003cbr\u003e 22. Pulmonary complications\u003cbr\u003e 23. Veno-occlusive disease\u003cbr\u003e 24. Special transfusion-related situations\u003cbr\u003e 25. Cardiovascular complications\u003cbr\u003e 26. Neurologic complications\u003cbr\u003e 27. Cystitis\u003cbr\u003e 28. Donor lymphocyte infusion\u003cbr\u003e 29. Transplantation: regulation and accreditation\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Transplant surgery [\u003ca title=\"See our other books on Transplant surgery\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Transplant%20surgery%20%5BMNQ%5D%22\"\u003eMNQ\u003c\/a\u003e], Surgical oncology [\u003ca title=\"See our other books on Surgical oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Surgical%20oncology%20%5BMNK%5D%22\"\u003eMNK\u003c\/a\u003e], Haematology [\u003ca title=\"See our other books on Haematology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Haematology%20%5BMJF%5D%22\"\u003eMJF\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Medicine [\u003ca title=\"See our other books on Medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine%20%5BM%5D%22\"\u003eM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46265840861464,"sku":"9781107661547","price":62.27,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781107661547i.jpg?v=1694507223"},{"product_id":"cancer-and-reproductive-health-paperback-9781904752615","title":"Cancer and Reproductive Health (Paperback \/ softback) 9781904752615","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer and Reproductive Health\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThis book connects the complexity of cancer with fertility, conception and pregnancy.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eSean Kehoe (Edited by), Eric Jauniaux (Edited by), Pierre Martin-Hirsch (Edited by), Philip Savage (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781904752615, Royal College of Obstetricians and Gynaecologists (RCOG)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 1 November 2008\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e304 pages\u003cbr\u003e23.4 x 15.6 x 1.4 cm, 0.54 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eWhile cancer affects primarily the elderly, it also occurs in younger age groups, with different implications specifically relating to reproduction. Cancer can also occur during pregnancy itself. This brings together two diverse areas of medicine, encompassing the complexity of cancer and its varied biology and the equally challenging areas of fertility, conception and pregnancy. The 55th RCOG Study Group brought together a range of experts to examine these issues. This book presents the findings of the Study Group, with sections covering: • epidemiology, genetics and basic principles of chemotherapy and radiotherapy • fertility issues and paediatric cancers • gynaecological cancers and precancer • diagnostic dilemmas • the placenta • non-gynaecological cancers • multidisciplinary care and service provision.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSection I. Epidemiology, Genetics and Basic Principles of Chemotherapy and Radiotherapy: 1. Epidemiology of cancer in women during reproductive life Joanne Morrison and Sean Kehoe\u003cbr\u003e 2. Cancer genetics and reproduction Fiona Lalloo and Tara Clancy\u003cbr\u003e 3. Chemotherapy in the treatment of pregnant women with cancer Elyce Cardonick\u003cbr\u003e 4. Radiotherapy and cancer Mary McCormack\u003cbr\u003e Section 2. Fertility Issues and Paediatric Cancers: 5. Assisted reproductive technology for preserving fertility in women with cancer Shaun Fountain\u003cbr\u003e 6. Fertility after cancer therapy Melanie Davies\u003cbr\u003e 7. Fertility-preserving surgery in women with cancer of the cervix John Shepherd\u003cbr\u003e 8. Gonadal function and fertility issues in children and young people treated for cancer W. Hamish B. Wallace\u003cbr\u003e Section 3. Gynaecological Cancers and Precancer: 9. Management of cervical intraepithelial neoplasia during pregnancy Evangelos Paraskevaidis and George Koliopoulos\u003cbr\u003e 10. Impact of LLETZ on subsequent pregnancies Evangelos Paraskevaidis and Maria Kyrgiou\u003cbr\u003e 11. Ovarian masses and malignancies Sin Taylor and Pierre Martin-Hirsch\u003cbr\u003e 12. Cervical and endometrial cancer in relation to pregnancy Nigel Acheson\u003cbr\u003e Section 4. Diagnostic Dilemmas: 13. Imaging techniques Niall Moore and Anna Sharman\u003cbr\u003e 14. Serum markers for gynaecological cancer in the reproductive years Ranjit Manchanda and Usha Menon\u003cbr\u003e 15. Diagnostic dilemmas in cellular pathology Sanjiv Manek\u003cbr\u003e Section 5. The Placenta: 16. Placental and fetal malignancies Eric Jauniaux and Neil Sebire\u003cbr\u003e 17. Gestational trophoblastic neoplasia Philip Savage\u003cbr\u003e Section 6. Non-Gynaecological Cancers: 18. Pregnancy and breast cancer Martin Widschwendter, Paul Ellis and Michael Baum\u003cbr\u003e 19. The haematological malignancies Jane Apperley and Seonaid Pye\u003cbr\u003e 20. Melanoma and reproductive health Julia Newton-Bishop\u003cbr\u003e Section 7. Multidisciplinary Care and Service Provision\u003cbr\u003e 21. Multidisciplinary care Cathy Hughes and Nichola Kane\u003cbr\u003e Section 8. Consensus Views: 22. Consensus views arising from the 55th Study Group: Cancer and Reproductive Health\u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Women's health [\u003ca title=\"See our other books on Women's health\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Women's%20health%20%5BVFDW%5D%22\"\u003eVFDW\u003c\/a\u003e], Gynaecology \u0026amp; obstetrics [\u003ca title=\"See our other books on Gynaecology \u0026amp; obstetrics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Gynaecology%20\u0026amp;%20obstetrics%20%5BMJT%5D%22\"\u003eMJT\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Medicine [\u003ca title=\"See our other books on Medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine%20%5BM%5D%22\"\u003eM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Royal College of Obstetricians and Gynaecologists","offers":[{"title":"Default Title","offer_id":46281766043928,"sku":"9781904752615","price":65.39,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781904752615i.jpg?v=1696598750"},{"product_id":"dermoscopy-the-essentials-paperback-9780702068829","title":"Dermoscopy; The Essentials (Paperback) 9780702068829","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDermoscopy\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eThe Essentials\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eA portable guide to better diagnostic results through dermoscopy\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eH. Peter Soyer (Author), Giuseppe Argenziano (Author), Rainer Hofmann-Wellenhof (Author), Iris Zalaudek (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780702068829\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 13 March 2020\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e240 pages, Approx. 700 illustrations (700 in full color)\u003cbr\u003e24.6 x 18.9 x 1.6 cm, 0.41 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"This book presents hundreds of dermatoscopic color images of melanoma, nevi, and non-melanoma skin cancers. The objective is to teach readers how to recognize a skin malignancy by training the eye to scan for the major pertinent criteria. This is an essential skill for all dermatologists to master.\"\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003e-\u003c\/i\u003ePatricia Wong, MD (Private Practice) \u003cb\u003eDoody's Review Service\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eDermoscopy: The Essentials presents the practical guidance you need to master this highly effective, more economical, and less invasive alternative to biopsy. Drs. Peter Soyer, Giuseppe Argenziano, Rainer Hofmann-Wellenhof, and Iris Zalaudek explain all aspects of performing dermoscopy and interpreting results. With approximately 30% new clinical and dermoscopic images, valuable pearls and checklists, and online access to the fully searchable and downloadable text, you’ll have everything you need to diagnose earlier and more accurately\u003ci\u003e.\u003c\/i\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eAvoid diagnostic pitfalls\u003c\/li\u003e\u003c\/b\u003e through pearls that explain how to accurately use dermoscopy and highlight common mistakes.  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eMaster all aspects of performing dermoscopy and interpreting the results with \u003cb\u003eeasy-to-use \"traffic light\" systems and checklists\u003c\/b\u003e for quick and effective learning.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eGain a \u003cb\u003ebetter visual understanding\u003c\/b\u003e with approximately \u003cb\u003e30% new clinical and dermoscopic images\u003c\/b\u003e that depict the appearance of benign and malignant lesions and feature \u003cb\u003earrows and labels\u003c\/b\u003e to highlight important manifestations.\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eGet \u003cb\u003ebetter diagnostic results\u003c\/b\u003e for less by learning how to successfully perform dermoscopy with this portable, to-the-point resource.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eEnhanced\u003c\/li\u003e\u003c\/b\u003e \u003cb\u003eeBook version included with purchase. \u003c\/b\u003eYour enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eChapter 1 - Introduction: The 3-point checklist: The short, easy way to avoid missing a melanoma using dermoscopy\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eTechnique\u003c\/p\u003e \u003cp\u003eThe 3-point checklist\u003c\/p\u003e \u003cp\u003eTriage of suspicious pigmented skin lesions\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2 - Pattern analysis: Dermoscopic criteria for specific diagnoses\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFour global dermoscopic patterns for melanocytic nevi\u003c\/p\u003e \u003cp\u003eDiagnosis of melanoma using five melanoma-specific criteria\u003c\/p\u003e \u003cp\u003eDiagnosis of facial melanoma using four site-specific melanoma-specific criteria\u003c\/p\u003e \u003cp\u003eFour patterns for acral melanocytic lesions\u003c\/p\u003e \u003cp\u003eSix criteria for diagnosing non-melanocytic lesions\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3 - Common clinical scenarios: Side-by-side comparisons of similar-appearing lesions that are benign or malignant\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction\u003c\/p\u003e \u003cp\u003ePediatric scenario\u003c\/p\u003e \u003cp\u003eBlack lesions\u003c\/p\u003e \u003cp\u003eInkspot lentigo\u003c\/p\u003e \u003cp\u003eBlue lesions\u003c\/p\u003e \u003cp\u003eReticular lesions\u003c\/p\u003e \u003cp\u003eSpitzoid lesions\u003c\/p\u003e \u003cp\u003eSpecial nevi\u003c\/p\u003e \u003cp\u003eMultiple Clark (dysplastic) nevi\u003c\/p\u003e \u003cp\u003eFollow-up of melanocytic lesions\u003c\/p\u003e \u003cp\u003eLesions with regression\u003c\/p\u003e \u003cp\u003eFlat lesions on the face\u003c\/p\u003e \u003cp\u003eNodular lesions on the face\u003c\/p\u003e \u003cp\u003eAcral lesions\u003c\/p\u003e \u003cp\u003ePigmented lesions of the nails\u003c\/p\u003e \u003cp\u003eMucosal lesions\u003c\/p\u003e \u003cp\u003eDifferential diagnostic value of blood vessels\u003c\/p\u003e \u003cp\u003eAmelanotic and partially pigmented melanoma\u003c\/p\u003e \u003cp\u003eDermoscopy tests\u003c\/p\u003e \u003cp\u003eFurther reading\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Dermatology [\u003ca title=\"See our other books on Dermatology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Dermatology%20%5BMJK%5D%22\"\u003eMJK\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Medicine [\u003ca title=\"See our other books on Medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine%20%5BM%5D%22\"\u003eM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648100323608,"sku":"9780702068829","price":48.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780702068829.jpg?v=1694088288"},{"product_id":"epigenetic-cancer-therapy-paperback-9780323913676","title":"Epigenetic Cancer Therapy (Paperback \/ softback) 9780323913676","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eEpigenetic Cancer Therapy\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eOffers a deep examination of epigenetic cancer therapy, from fundamental biology and pathology to evolving treatment programs\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eSteven Gray (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323913676, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 3 May 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e772 pages\u003cbr\u003e23.5 x 19 x 4.7 cm, 1.61 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eEpigenetic Cancer Therapy, Second Edition\u003c\/i\u003e provides a comprehensive discussion of healthy and aberrant epigenetic biology, along with new discoveries to improve our understanding of cancer epigenetics and therapeutics. The book encompasses large-scale intergovernmental initiatives, as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer. Since the publication of the first edition of this book, the field of epigenetics has undergone significant change. New epigenetic therapies have been designed and approved for clinical use.\u003c\/p\u003e  \u003cp\u003eOur knowledge of the plasticity of the epigenome in cancer and disease has expanded dramatically, with increasing evidence linking pollution to epigenetic changes in cancer development. This second edition has been fully updated to address these changes, along with promising therapeutic programs such as CRISPR\/Cas9 mediated approaches, CAR-T based therapies, epigenetic priming, histone modifications, and similar, transformative advances across synthetic biology and cellular engineering.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. Introduction\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Introduction and Key Concepts\u003c\/b\u003e 2. DNA Methylation and Hydroxymethylation in Cancer  3. Writers, Readers, and Erasers of Epigenetic Marks  4. Oncohistones  5. MicroRNAs, epi-miRNAs and Cancer  6. Long Noncoding RNAs and Cancer  7. The Epitranscriptome  8. Mining the Epigenetic Landscape: Surface Mining or Deep Underground - Alecsandar Milosavljevic 9: Epigenetics Clocks: Concepts for Carcinogenesis10: Environmental Pollution Epigenetics and Cancer\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Epigenetics and Cancer\u003c\/b\u003e 11. Development of Epigenetic Targeted Therapies in Hematological Malignancies: From Serendipity to Synthetic Lethality  12. Epigenetic Therapy in Lung Cancer  13. Breast Cancer Epigenetics  14. Therapeutic Applications of the Prostate Cancer Epigenome  15. Neuroblastoma\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3: Targeting Aberrant Epigenetics\u003c\/b\u003e 16. Nutritional Epigenetic Regulators in the Field of Cancer: New Avenues for Chemopreventive Approaches - 17. Emerging Epigenetic Therapies- Lysine Methyltransferase\/PRC Complex Inhibitors  18. Inhibitors of Jumonji C-Domain Histone Demethylases  19. Emerging Epigenetic Therapies: Lysine Acetyltransferase Inhibitors 20: Histone Deacetylases  21. Emerging Epigenetic Therapies\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4: Issues to Overcome\/Areas of Concern\u003c\/b\u003e 22. Genetic Intratumoral Heterogeneity 23. Challenges for single cell epigenetic analysis 24. Epigenetics Underpinning DNA Damage Repair  25. Epigenetics of Cisplatin Resistance 26. Therapeutically Targeting Epigenetic Regulation of Cancer Stem Cells \u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 5: Future Directions: Translation to the Clinic\u003c\/b\u003e 27. Personalized Epigenetic Therapy-Chemosensitivity Testing 28. Personalized Therapy-Epigenetic Profiling as Predictors of Prognosis and Response 29. Epigenetic Priming - Fact or Fallacy  30. CRISPR and epigenetics  31. Epigenetics and CAR-T  \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Molecular biology [\u003ca title=\"See our other books on Molecular biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Molecular%20biology%20%5BPSD%5D%22\"\u003ePSD\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Cytology [\u003ca title=\"See our other books on Cytology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Cytology%20%5BMFCC%5D%22\"\u003eMFCC\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648108122392,"sku":"9780323913676","price":118.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323913676_5384c370-e86f-497f-a911-adbba59448a5.jpg?v=1694993435"},{"product_id":"walter-and-millers-textbook-of-radiotherapy-radiation-physics-therapy-and-oncology-hardback-9780702074851","title":"Walter and Miller's Textbook of Radiotherapy: Radiation Physics, Therapy and Oncology (Hardback) 9780702074851","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eWalter and Miller's Textbook of Radiotherapy: Radiation Physics, Therapy and Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003ePaul R Symonds (Edited by), John A Mills (Edited by), Angela Duxbury (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780702074851\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 21 August 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e640 pages, Approx. 705 illustrations (248 in full color)\u003cbr\u003e27.6 x 21.6 x 3.5 cm, 1.98 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eWalter and Miller’s Textbook of Radiotherapy is a key textbook for therapeutic radiography students as well as trainee clinical and medical oncologists, clinical physicists and technologists. The book is divided into 2 sections. The first section covers physics and provides a comprehensive review of radiotherapy physics. This section is designed to be non-physicist friendly, to simply and clearly explain the physical principles upon which radiotherapy and its technology are based. The second section is a systematic review by tumour site giving an up to date summary of radiotherapy practice. The title also covers the place of chemotherapy, surgery and non-radiotherapy treatments as well as the principles of cancer patient treatment including supportive care and palliative treatments. It is a comprehensive must-have resource for anyone studying therapeutic radiotherapy.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eHighly illustrated in full colour including 350 photographs.\u003c\/li\u003e \u003cli\u003eClearly and simply explains the fundamental physics for clinicians\u003c\/li\u003e \u003cli\u003eGives an up to date summary of radiotherapy practice organised by tumour site making it very easy to navigate.\u003c\/li\u003e \u003cli\u003eDescribes the wide range of devices and clearly explains the principles behind their operation.\u003c\/li\u003e \u003cli\u003eComprehensively explains the calculation models of dose predictions for treatment preparation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e \u003cli\u003eHeavy emphasis on how clinical trials have influenced current practice.\u003c\/li\u003e \u003cli\u003eShows how radiobiological knowledge has influenced current practice such as the fractionation regimens for breast and prostate cancer\u003c\/li\u003e \u003cli\u003eProton therapy; machines, dose measurement, covering the clinical advantages and pitfalls of this treatment modality.\u003c\/li\u003e \u003cli\u003eNew radiotherapy modalities such as stereotactic radiotherapy, types of intensity modulated radiotherapy and imaged guided radiotherapy are comprehensively covered as are recent advances in chemotherapy and molecular targeted therapy.\u003c\/li\u003e \u003cli\u003eIn depth coverage of dose measurement and new devices.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003eSECTION 1\u003c\/b\u003e\u003cbr\u003e1 Atoms, Nuclei and Radioactivity\u003cbr\u003e2 Interactions of Ionising Radiation With Matter\u003cbr\u003e3 Radiation Detection and Measurement\u003cbr\u003e4 Radiation Protection\u003cbr\u003e5 Imaging With X-Ray, Magnetic Resonance Imaging and Ultrasound\u003cbr\u003e6 Imaging With Radionuclides\u003cbr\u003e7 Therapy With Unsealed Radionuclides\u003cbr\u003e8 Radiotherapy Devices With Kilovoltage X-Rays and Radioisotopes\u003cbr\u003e9 Beam Production: Megavoltage Accelerators\u003cbr\u003e10 Radiation Treatment Planning: Immobilisation, Localisation and Verification Techniques\u003cbr\u003e11 Radiation Treatment Planning: Beam Models, Principles and Practice\u003cbr\u003e12 Networking, Data, Image Handling and Computing in Radiotherapy\u003cbr\u003e13 Quality Control\u003cbr\u003e14 Quality Management in Radiotherapy\u003cbr\u003e\u003cb\u003eSECTION 2\u003c\/b\u003e\u003cbr\u003e15 Epidemiology of Cancer and Screening\u003cbr\u003e16 Biological and Pathological Introduction\u003cbr\u003e17 Molecular, Cellular and Tissue Effects of Radiotherapy\u003cbr\u003e18 Principles of Management of Patients With Cancer\u003cbr\u003e19 Chemotherapy and Hormones\u003cbr\u003e20 Skin and Lip Cancer\u003cbr\u003e21 Head and Neck Cancer—General Principles\u003cbr\u003e22 Sino-Nasal, Oral, Larynx and Pharynx Cancers\u003cbr\u003e23 Thyroid Cancer\u003cbr\u003e24 Gastrointestinal Cancer\u003cbr\u003e25 Tumours of the Thorax\u003cbr\u003e26 Breast Cancer\u003cbr\u003e27 Gynaecological Cancer\u003cbr\u003e28 Cancer of Kidney, Bladder, Prostate, Testis, Urethra and Penis\u003cbr\u003e29 Lymphoma and Disease of Bone Marrow\u003cbr\u003e30 Tumours of the Central Nervous System\u003cbr\u003e31 Eye and Orbit\u003cbr\u003e32 Sarcomas\u003cbr\u003e33 Principles of Paediatric Oncology\u003cbr\u003e34 Care of Patients During Radiotherapy\u003cbr\u003e35 Medical Complications of Malignant Disease\u003cbr\u003e36 Proton Beam Therapy\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Radiography [\u003ca title=\"See our other books on Radiography\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Radiography%20%5BMQH%5D%22\"\u003eMQH\u003c\/a\u003e], Radiology [\u003ca title=\"See our other books on Radiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Radiology%20%5BMMPH%5D%22\"\u003eMMPH\u003c\/a\u003e], Medical imaging [\u003ca title=\"See our other books on Medical imaging\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20imaging%20%5BMMP%5D%22\"\u003eMMP\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648122376472,"sku":"9780702074851","price":65.29,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780702074851.jpg?v=1694088436"},{"product_id":"lifestyle-medicine-lifestyle-the-environment-and-preventive-medicine-in-health-and-disease-paperback-9780128104019","title":"Lifestyle Medicine; Lifestyle, the Environment and Preventive Medicine in Health and Disease (Paperback) 9780128104019","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eLifestyle Medicine\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eLifestyle, the Environment and Preventive Medicine in Health and Disease\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThis timely guide explores how lifestyle and related environmental factors drive modern chronic disease patterns on a worldwide basis\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMichael Sagner (Edited by), Garry Egger (Edited by), Andrew Binns (Edited by), Stephan Rossner (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128104019, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 6 April 2017\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e484 pages\u003cbr\u003e22.9 x 15.1 x 3 cm, 0.77 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eLifestyle Medicine: Lifestyle, the Environment and Preventive Medicine in Health and Disease, Third Edition,\u003c\/i\u003e is an adjunct approach to health practice that seeks to deal with the more complex modern determinants of chronic diseases—primarily lifestyle and the environments driving such lifestyles—in contrast to the microbial ‘causes’ of infectious disease. \u003c\/p\u003e  \u003cp\u003eOur lifestyle choices have a profound effect on our health. As we live longer, one thing is clear: many of us will spend time living with injury and chronic illness due to our own choices. Changes in health patterns typically follow shifts in living conditions. Disease patterns have changed worldwide, from infectious to chronic diseases such as obesity, diabetes, and heart disease. This change has been so emphatic—nearly 70% of all presentations to a doctor in modern western societies are now chronic disease related—that medical services are being forced to change to accommodate this.\u003c\/p\u003e  \u003cp\u003eNew chapters in this third edition explain the link between energy intake and expenditure; consider how modern technology are determinants of chronic disease; show how environmental influences, such as endocrine disruptors, influence our health; and summarize recent research on early childhood experiences and chronic disease.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eSection I. Background and Basis for the role of lifestyle factors In chronic disease Prevention and Treatment \u003c\/b\u003e1. Introduction to the Role of Lifestyle Factors in Medicine 2. The Epidemiology of Chronic Disease 3. A “Germ Theory? Equivalent Approach for Lifestyle Medicine 4. A Structure for Lifestyle Medicine 5. Everything You Wanted to Know About Motivation (But Weren’t Intrinsically Motivated Enough to Ask) 6. Self-Management in Lifestyle Medicine 7. Overweight and Obesity: The Epidemic’s Underbelly\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection II. Lifestyle and Environmental Determinants of Chronic disease \u003c\/b\u003e8. Nutrition for the Nondietitian 9. Fluids, Fitness, and Fatness 10. Behavioral Aspects of Nutrition 11. Physical Activity: Generic Prescription for Health 12. Physical Activity: Specific Prescription for Disease Management and Rehabilitation 13. Stress: Its Role in the S-AD Phenomenon 14. Dealing With Worry and Anxiety 15. Depression 16. Happiness and Mental Health: The Flip Side of S-AD 17. Technology-Induced Pathology: Watch (This) Space 18. To Sleep, Perchance to … Get Everything Else Right 19. Health and the Environment: Clinical Implications for Lifestyle Medicine 20. Meaninglessness, Alienation, and Loss of Culture\/Identity (MAL) as Determinants of Chronic Disease 21. Preventing and Managing Injury at the Clinical Level 22. Rethinking Chronic Pain in a Lifestyle Medicine Context 23. Understanding Addictions: Tackling Smoking and Hazardous Drinking 24. Medicines: The Good, The Not So Good, and The Sometimes Overused 25. Relationships, Social Inequity, and Distal Factors in Lifestyle Medicine: Tackling the Big Determinants\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection III. Other issues for Lifestyle medicine \u003c\/b\u003e26. Sex and Lifestyle: Not Being Able to Get Enough of a Good Thing Because of a Lifetime of Getting Too Much of a Good Thing 27. Lifestyle and Oral Health 28. Lifestyle and Environmental Influences on Skin 29. Lifestyle-Related Aspects of Gastrointestinal Health\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection IV. The Future of Health \u003c\/b\u003e30. The Next Chapter: The Future of Health Care and Lifestyle Interventions\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Popular medicine \u0026amp; health [\u003ca title=\"See our other books on Popular medicine \u0026amp; health\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Popular%20medicine%20\u0026amp;%20health%20%5BVFD%5D%22\"\u003eVFD\u003c\/a\u003e], Life sciences: general issues [\u003ca title=\"See our other books on Life sciences: general issues\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Life%20sciences:%20general%20issues%20%5BPSA%5D%22\"\u003ePSA\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Public health \u0026amp; preventive medicine [\u003ca title=\"See our other books on Public health \u0026amp; preventive medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Public%20health%20\u0026amp;%20preventive%20medicine%20%5BMBN%5D%22\"\u003eMBN\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648122867992,"sku":"9780128104019","price":57.19,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128104019.jpg?v=1694088441"},{"product_id":"neuro-oncology-blue-books-of-neurology-series-hardback-9780750675161","title":"Neuro-Oncology; Blue Books of Neurology Series (Hardback) 9780750675161","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNeuro-Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eBlue Books of Neurology Series\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eA comprehensive look at the latest advances in neuro-oncology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJeremy Rees (Author), Patrick Y Wen (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780750675161, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 20 May 2010\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e484 pages, Illustrated\u003cbr\u003e23.4 x 15.6 x 2.9 cm, 1.05 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"Contributors from neurology, from oncology, and especially from the overlap between the two, review the pathology, genetics, and radiological and clinical features of benign and malignant tumors of the nervous system. Their topics include the pathology and molecular genetics of common brain tumors, malignant gliomas in adults, low grade astrocytomas, pediatric neuro-oncology, the managing intramedullary spinal cord tumors, medical complications in the management of brain tumor, brain metastases, neoplastic meningitis, the neurotoxicity of chemotherapy, paraneoplastic disorders, and neurological complications of bone marrow and organ transplantation.\"\u003c\/p\u003e \u003cp\u003e- Book News, Inc.\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eNeuro-Oncology—a new title in the Blue Books of Practical Neurology series—is a concise and clinically applicable guide to this dynamic subspecialty. Jeremy Rees, PhD, MRCP and Patrick Y. Wen, MD present the most current information on the treatment and management of primary CNS tumors, secondary brain tumors, and the neurological complications of other cancers and their therapies in a format and scope appealing to both the general neurologist and the subspecialist.\u003c\/p\u003e\n\u003cp\u003eAccess comprehensive coverage of treatment for adult and pediatric conditions—including tumors of the spinal cord as well as the brain.\u003c\/p\u003e  \u003cp\u003eFind coverage of recent advances easily thanks to the emphasis on the latest clinical and laboratory findings and their implications for clinical management and treatment.\u003c\/p\u003e  \u003cp\u003eApply the possibilities and outcomes of neuro-oncologic surgery within the context of neurologic practice.\u003c\/p\u003e  \u003cp\u003eAddress the neurologic complications of cancer and its treatment as well as of primary and secondary tumors.\u003c\/p\u003e  \u003cp\u003eTap into the global perspectives of experts from all around the world for a multi-disciplinary approach to practice.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Neurology \u0026amp; clinical neurophysiology [\u003ca title=\"See our other books on Neurology \u0026amp; clinical neurophysiology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Neurology%20\u0026amp;%20clinical%20neurophysiology%20%5BMJN%5D%22\"\u003eMJN\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Saunders","offers":[{"title":"Default Title","offer_id":46648219730200,"sku":"9780750675161","price":109.19,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780750675161.jpg?v=1694089399"},{"product_id":"mosbys-oncology-nursing-advisor-a-comprehensive-guide-to-clinical-practice-hardback-9780323375634","title":"Mosby's Oncology Nursing Advisor; A Comprehensive Guide to Clinical Practice (Hardback) 9780323375634","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eMosby's Oncology Nursing Advisor\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eA Comprehensive Guide to Clinical Practice\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThe expert guidance you need to succeed on the job as an oncology nurse\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eSusan Maloney-Newton (Author), Margie Hickey (Author), Jeannine M. Brant (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323375634, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 23 November 2016\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e528 pages\u003cbr\u003e28.1 x 22.2 x 3.1 cm, 1.2 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eGet quick access to the most important information surrounding cancer and oncology nursing care with \u003cb\u003eMosby’s Oncology Nursing Advisor, 2nd Edition\u003c\/b\u003e. Covering everything from the various types of cancer and cancer treatment options to patient education and nursing best-practices, this indispensable nursing guide is like getting seven books in one! Plus, its user-friendly layout and straightforward coverage make it ideal for use in any clinical setting. With 17 new chapters, updated evidence-based content throughout, and proven patient teaching handouts, this new edition offers the authoritative guidance you need to provide the best possible oncology nursing care.\u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eDetailed descriptions of over 50 major cancer types\u003c\/li\u003e\u003c\/b\u003e provide essential information on incidence, etiology and risk factors, signs and symptoms, diagnostic workup, histology, staging, treatment, prognosis, and prevention. \u003cli\u003e\n\u003cb\u003eCoverage of cancer management principles\u003c\/b\u003e outlines a wide range of treatment and pharmacologic modalities, including surgery, chemotherapy, radiation therapy, hormonal therapy, immunotherapy, and complementary and alternative therapies.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eSymptom management guidelines\u003c\/b\u003e offer in-depth coverage of pathophysiology, signs and symptoms, assessment tools, lab and diagnostic tests, differential diagnoses, interventions, patient education, follow up care, and resources for over 30 common symptoms associated with cancer and cancer treatments.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eEssential information on many oncologic emergencies and emergent issues\u003c\/b\u003e prepares readers to respond quickly to structural, metabolic, and hematologic emergencies.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eSection on palliative care and end-of-life issues\u003c\/b\u003e offers helpful guidelines for dealing with topics related to survivorship, palliative care, the final hours of the cancer patient, and loss, grief, and bereavement.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eNEW! Updated evidence-based content \u003c\/li\u003e\u003c\/b\u003ereflects the latest national and international quality standards regarding various cancer types, major drug and non-drug treatments, treatment protocols, and approaches to symptom management. \u003cli\u003e\n\u003cb\u003eNEW! \u003ci\u003eNursing Practice Considerations\u003c\/i\u003e section\u003c\/b\u003e incorporates information on communication, cultural considerations, ethical considerations, safe and quality care, evidence-based practice, patient navigation, and patient education.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNEW! 17 new chapters \u003c\/b\u003ecover topics including myelofibrosis, neuroendocrine cancers, tumor treating fields, oral adherence, clinical trials, epistaxis, hypersensitivity reactions, hypertension, hyperglycemia, nail changes, ocular and visual changes, rashes, survivorship, quality and safety, evidence-based practice, nurse navigation, and patient education.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNEW! Expanded content on patient education \u003c\/b\u003ekeeps readers on top of best practices in this critical area.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eNEW! High-quality electronic patient teaching handouts \u003c\/b\u003eare evidence-based and have been vetted by practicing nurses.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eSection One: INTRODUCTION \u003c\/b\u003eCancer Epidemiology  Cancer Pathophysiology Cancer Genetics\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Two:  MAJOR CANCERS\u003c\/b\u003e Breast Cancer Central Nervous System Cancers Gastrointestinal System Cancers Genitourinary Cancers Gynecologic Cancers Head and Neck Cancers Leukemias Lymphomas Lung Cancers Multiple Myeloma Myelofibrosis \u003cb\u003eNEW! \u003c\/b\u003eNeuroendocrine Cancers \u003cb\u003eNEW!\u003c\/b\u003e Sarcomas Skin Cancers\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Three: PRINCIPLES OF CANCER MANAGEMENT\u003c\/b\u003e Surgical Therapy  Radiation Therapy Tumor Treating Fields \u003cb\u003eNEW!\u003c\/b\u003e Hematopoietic Stem Cell Transplantation Chemotherapy  Immunotherapy Targeted Therapy Hormonal Therapy Oral Adherence \u003cb\u003eNEW! \u003c\/b\u003eComplementary and Alternative Therapies Clinical Trials \u003cb\u003eNEW!\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Four: PRINCIPLES OF SYMPTOM MANAGEMENT\u003c\/b\u003e Alopecia Anorexia Anxiety Arthralgias and Myalgias Confusion  Constipation  Cough  Depressed Mood  Diarrhea  Dizziness and Vertigo  Dysphagia  Dyspnea  Epistaxis \u003cb\u003eNEW!\u003c\/b\u003e Esophagitis  Fatigue  Fever  Flu-like Symptoms  Hand-Foot Syndrome Headache  Hiccups  Hypersensitivity Reactions \u003cb\u003eNEW! \u003c\/b\u003eHypertension \u003cb\u003eNEW!\u003c\/b\u003e Hyperglycemia\u003cb\u003e NEW!\u003c\/b\u003e Lymphedema  Menopausal Symptoms  Mucositis  Nail Changes \u003cb\u003eNEW!\u003c\/b\u003e Nausea and Vomiting  Ocular\/Visual Changes \u003cb\u003eNEW! \u003c\/b\u003ePain  Peripheral Neuropathy  Pleural Effusion  Pruritus\/Xerosis  Rash \u003cb\u003eNEW!\u003c\/b\u003e Seizures  Sexuality Alterations Sleep Disturbances  Xerostomia\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Five: ONCOLOGIC EMERGENCIES\u003c\/b\u003e Structural Emergencies Urologic Emergencies Metabolic Emergencies Hematologic Emergencies\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Six: PALLIATIVE CARE AND END-OF-LIFE ISSUES\u003c\/b\u003e Survivorship \u003cb\u003eNEW! \u003c\/b\u003ePalliative Care Final Hours Loss, Grief, and Bereavement\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Seven. NURSING PRACTICE CONSIDERATIONS NEW!\u003c\/b\u003e Communication Cultural Considerations Ethical Considerations Quality and Safety \u003cb\u003eNEW! \u003c\/b\u003eEvidence-Based Practice \u003cb\u003eNEW!\u003c\/b\u003e Patient Navigation \u003cb\u003eNEW!\u003c\/b\u003e Patient Education \u003cb\u003eNEW!\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e Index \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Nursing [\u003ca title=\"See our other books on Nursing\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Nursing%20%5BMQC%5D%22\"\u003eMQC\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Mosby","offers":[{"title":"Default Title","offer_id":46648239751448,"sku":"9780323375634","price":67.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323375634.jpg?v=1694988958"},{"product_id":"integrating-conventional-and-chinese-medicine-in-cancer-care-a-clinical-guide-paperback-9780443100635","title":"Integrating Conventional and Chinese Medicine in Cancer Care; A Clinical Guide (Paperback \/ softback) 9780443100635","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eIntegrating Conventional and Chinese Medicine in Cancer Care\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eA Clinical Guide\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eA practical guide to using Chinese medicine as an adjunct to conventional cancer therapies.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eTai Lahans (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780443100635, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 14 June 2007\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e376 pages\u003cbr\u003e24.6 x 18.7 x 2.4 cm, 1.09 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThis new clinical resource clearly explains how to approach integrated care in a way that combines Chinese herbal medicine with Western medicine to enhance and improve medical care for patients with cancer - without undermining or negatively impacting patients' medical treatment. Each chapter covers a different type of cancer, first introducing the conventional medical understanding of that cancer including its etiology, diagnosis, and treatment according to staging and type. The chapter then covers that cancer from the perspective of Oriental medicine. Case studies illustrate the integration of treatment for each cancer type, raising important issues and considerations associated with specific cancers and treatments.\u003cul\u003e\n\u003cli\u003eFormulas are presented within the context of conventional treatment, intended to enhance the effectiveness of treatment and\/or treat side effects without undermining the treatment's function.\u003c\/li\u003e\n\u003cli\u003eEach formula is followed by a discussion of how and why the herbs are used, including classical Chinese theory and relevant pharmaceutical studies.\u003c\/li\u003e\n\u003cli\u003eStaging and the age and performance status of various patients is used as a means by which to explain how formulas are changed.\u003c\/li\u003e\n\u003cli\u003eCase studies explore issues related to the integration of treatment for each type of cancer.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003eIntroduction\u003cbr\u003eDisclaimer\u003cbr\u003e1.General pathophysiology and treatment:    conventional and Chinese medicine\u003cbr\u003e2.\tLung cancer\u003cbr\u003e3.\tColorectal cancer\u003cbr\u003e4.      Breast cancer\u003cbr\u003e5.\tProstate cancer\u003cbr\u003e6.\tCervical and uterine cancers\u003cbr\u003e7.      Ovarian cancer\u003cbr\u003e8.      Bladder and renal cancer\u003cbr\u003e9.      Pancreatic and hepatic cancers\u003cbr\u003e10.\tLymphomas\u003cbr\u003e11.\tLeukemia\u003cbr\u003e12.\tConcurrent issues \u003cbr\u003e13.\tDeath and dying \u003cbr\u003e14.     Prevention\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Chinese medicine \u0026amp; acupuncture [\u003ca title=\"See our other books on Chinese medicine \u0026amp; acupuncture\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Chinese%20medicine%20\u0026amp;%20acupuncture%20%5BVXHT1%5D%22\"\u003eVXHT1\u003c\/a\u003e], Complementary medicine [\u003ca title=\"See our other books on Complementary medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Complementary%20medicine%20%5BMX%5D%22\"\u003eMX\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Churchill Livingstone","offers":[{"title":"Default Title","offer_id":46648327766296,"sku":"9780443100635","price":37.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780443100635.jpg?v=1694979746"},{"product_id":"clinical-immuno-oncology-hardback-9780323877633","title":"Clinical Immuno-Oncology (Hardback) 9780323877633","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eClinical Immuno-Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eUnderstand and apply recent advances in immunology to oncology therapeutics\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJohn E. Niederhuber (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323877633, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 9 June 2023\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e336 pages\u003cbr\u003e23.4 x 15.6 x 2.4 cm, 0.48 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eOffering focused, practical, and up-to-date content on immunotherapies used to treat a wide variety of cancer types, Clinical Immuno-Oncology covers the basic cellular and molecular mechanisms involved in cancer initiation and progression. The text reviews the development of tumor specific antigens and the challenges of developing cancer immunotherapies. Every effort is made to relate the fundamental aspects of host immunity to the efficacy of current immunotherapies and how they work in conjunction with the immune system to combat cancer. This foundational resource explains the basics of cancer immunotherapy, discusses best practices, and provides recommendations from experienced clinicians in the field. Dr. John E. Niederhuber and a team of expert contributing authors provide clinically focused information essential for integrating these new therapies into practice—making this an ideal resource for fellows, practitioners, and other cancer team members in medical oncology, radiation oncology, cancer surgery, immunology, and cancer research.\u003cul\u003e \u003cli\u003e  \u003cp\u003eOffers balanced and synthesized content on clinical science, clinical and translational research, and evidence-based practice for cutting-edge immunotherapies. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eDiscusses clinical applications of immunotherapies in common types of cancer including melanoma, breast cancer, pancreatic cancer, colon and rectum cancer, prostate cancer, leukemias, and hematologic malignancies. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eIncludes dedicated chapters on immune responses, innate immunity, active immunization against cancer, and cell-based therapies by leading experts. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eCovers key topics such as cancer immunotherapy in the presence of COVID-19, immunotherapeutics, new findings concerning the role of the microbiome in immunotherapy, advances in engineered cell-based therapies, and active immunization against cancer. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eAn eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e   Tentative TOC:\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003eIntroduction:\u003c\/p\u003e \u003cp\u003eChapter 1.0 Development and Structure of the Lymphoid System\u003c\/p\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eembryologic development\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003egross anatomy of the human immune system\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003elymphatic endothelial cells, heterogeneity of, and lymph node microscopic structure\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003elymph node function; afferent lymph cellular components\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003erole of the gut microbiome in immune system development\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003especific functions related to the spread of cancer\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ecancer-induced lymphangiogeneis; sentinel LNs\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003cp\u003eChapter 2.0 The Chemistry, Structure, and Function of Immunoglobulins\u003c\/p\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eimmunoglobulin isotypes\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ethe structure of immunoglobulins\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ethe genetics of immunoglobulin diversity\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eantibody-dependent cellular cytotoxicity\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eheavy-chain C domain and role of glycosylation\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ethe development of humanized monoclonals\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003cp\u003eChapter 3.0 The Role of the Complement System in Cancer\u003c\/p\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003e\u003cb\u003ecomplement system activation pathways (classical, alternative and lectin)\u003c\/b\u003e\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ethe role of complement activation in cancer progression\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ecomplement regulatory proteins (CRPs) and cancer\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ethe role of compliment activation in the tumor microenvironment enhances tumor growth\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ecomplement-dependent cytotoxicity in immune therapy of cancer\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eformation of the membrane attack complex (MAC)\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003epotential application of anti-complement cancer therapies (C3aR\/C5aR\/IL-10 pathway)\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003cp\u003eChapter 4.0 Cancer as Non-Self\u003c\/p\u003e \u003cp\u003e4.1 primary generator of tumor-specific transplantation type antigens \u003c\/p\u003e \u003cp\u003e4.2 character of non-self, tumor associated antigens\u003c\/p\u003e \u003cp\u003e4.3 immune surveillance – innate immunity\u003c\/p\u003e \u003cp\u003e4.4 distinguishing between self and non-self\u003c\/p\u003e \u003cp\u003e4.5 toll-like receptors (TLRs); soluble bioactive proteins such as cytokines and C’ proteins\u003c\/p\u003e \u003cp\u003e4.6 NK cells\u003c\/p\u003e \u003cp\u003eChapter 5.0 The Adaptive Immune Response in Cancer\u003c\/p\u003e \u003col\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ethe diversity of active tumor antigen receptors\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003etarget specificity without limits in cancer-receptor variability\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003etumor antigen presentation; dendritic cells\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eimmune response stimulation against the cancer\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCytotoxic T-cells and T-regulatory cells\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eB-cells and antibodies\u003c\/li\u003e \u003c\/ol\u003e\n\u003c\/ol\u003e \u003cp\u003eChapter 6.0 The Science of Innate Immunity\u003c\/p\u003e \u003cp\u003e6.1 critical regulator of human inflammatory disease\u003c\/p\u003e \u003cp\u003e6.2 anatomic and physiologic barriers to pathogens – cancer causing viruses\u003c\/p\u003e \u003cp\u003e6.3 centrally a limited number of critical receptors\u003c\/p\u003e \u003cp\u003e6.4 the character of the inflammatory response\u003c\/p\u003e \u003cp\u003e6.5 lack of ability to form memory\u003c\/p\u003e \u003cp\u003e6.5 role in activating subsequent adaptive immune response\u003c\/p\u003e \u003cp\u003eChapter 7.0 Immune Surveillance\u003c\/p\u003e \u003cp\u003e7.1 history of concept (Ilya Mechnikov 1908 Nobel Prize)\u003c\/p\u003e \u003cp\u003e7.2 evidence for immune surveillance today\u003c\/p\u003e \u003cp\u003e7.3 cancer in the immunocompromised host\u003c\/p\u003e \u003cp\u003eChapter 8.0 Cancer – Avoiding Immune Detection\u003c\/p\u003e \u003cp\u003e8.1 cancer and the presence of immune resistance\u003c\/p\u003e \u003cp\u003e8.2 concept for the development of tumor cell tolerance\u003c\/p\u003e \u003cp\u003eChapter 9.0 Active Immunization Against Cancer and Cell-based Therapies\u003c\/p\u003e \u003cp\u003e9.1 infusing in-vitro expanded Tumor Infiltrating Lymphocytes (TILs)\u003c\/p\u003e \u003cp\u003e9.2 infusing dendritic cells pre-loaded with tumor specific oligopeptide antigens\u003c\/p\u003e \u003cp\u003e9.3 B7 co-activating receptor\u003c\/p\u003e \u003cp\u003e9.4 vaccines\u003c\/p\u003e \u003cp\u003eChapter 10.0 The Three Major Clinical Components of Cancer Immunotherapy \u003c\/p\u003e \u003cp\u003e(modulating cell-mediated immune mechanisms)\u003c\/p\u003e \u003cp\u003e10.1 the role of and application of check point blockade\u003c\/p\u003e \u003cp\u003e10.2 the role and application of cell-based therapies including CAR-T cell therapies\u003c\/p\u003e \u003cp\u003e10.3 antibodies (and vaccines); monoclonal antibodies and novel application of bi- or tri-specifics\u003c\/p\u003e \u003cp\u003eChapter 11.0 The Clinical Application of Immunotherapeutics\u003c\/p\u003e \u003cp\u003e11.1 in melanoma cancer\u003c\/p\u003e \u003cp\u003e11.2 in breast cancer\u003c\/p\u003e \u003cp\u003e11.3 in pancreatic cancer\u003c\/p\u003e \u003cp\u003e11.4 in colon and rectum cancer\u003c\/p\u003e \u003cp\u003e11.5 in prostate cancer\u003c\/p\u003e \u003cp\u003e11.6 in leukemias and hematologic malignancies\u003c\/p\u003e \u003cp\u003e11.7 in other malignancies \u003c\/p\u003e \u003cp\u003eChapter 12.0 Cancer Immunotherapy in the Presence of COVID-19\u003c\/p\u003e \u003cp\u003e12.1 immune response to coronavirus-2 infection\u003c\/p\u003e \u003cp\u003e12.2 CD8\u003csup\u003e+ \u003c\/sup\u003eT cell depression during chronic viral infection and cancer\u003c\/p\u003e \u003cp\u003e12.3 checkpoint inhibitors in cancer patients with coronavirus infection\u003c\/p\u003e \u003cp\u003e12.4 coronavirus depletion of CD4\u003csup\u003e+\u003c\/sup\u003e T cells\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648348737816,"sku":"9780323877633","price":89.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323877633.jpg?v=1694992341"},{"product_id":"new-techniques-for-management-of-inoperable-gliomas-hardback-9780128136331","title":"New Techniques for Management of ‘Inoperable’ Gliomas (Hardback) 9780128136331","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNew Techniques for Management of ‘Inoperable’ Gliomas\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eDescribes techniques for removing gliomas that are traditionally deemed inoperable\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMichael E. Sughrue (Edited by), Isaac Yang (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128136331, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 7 October 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e256 pages\u003cbr\u003e22.9 x 15.1 x 2.1 cm, 0.54 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eNew Techniques for Management of 'Inoperable' Gliomas\u003c\/i\u003e radically challenges the assumption that certain gliomas cannot be removed with modern techniques, contesting stereotypical thinking and establishing new paradigms in the field. Gliomas are primary brain tumors which are often fatal. Recent data has demonstrated that despite the fact that surgery cannot cure gliomas, patient survival is substantially improved by removing as much of the tumor as possible. This fact has raised the imperative that neurologists try to improve techniques to bring surgical resection to as many patients as possible. This book brings new insights and technologies to the forefront, giving hope to patients. \u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Introduction to “inoperable? gliomas\u003cbr\u003eIsaac Yang, Carlito Lagman, Giyarpuram N. Prashant, Thien Phuc Nguyen and John Patrick Sheppard\u003cbr\u003e2. The ethics of brain tumor “inoperability?\u003cbr\u003eMichael E. Sughrue\u003cbr\u003e3. Connectomic imaging for neurosurgeons\u003cbr\u003eMichael E. Sughrue\u003cbr\u003e4. Network anatomy of the brain\u003cbr\u003eMichael E. Sughrue\u003cbr\u003e5. Techniques for tackling difficult gliomas\u003cbr\u003eMichael E. Sughrue\u003cbr\u003e6. Advances in the surgical treatment of speech-eloquent gliomas\u003cbr\u003eNathan Kong and Matthew Tate\u003cbr\u003e7. Insular gliomas\u003cbr\u003eMichael E. Sughrue\u003cbr\u003e8. Advances in the surgical resection of temporoparietal-occipital junction gliomas\u003cbr\u003eIsaac Yang and Giyarpuram N. Prashant\u003cbr\u003e9. Surgical techniques for motor eloquent gliomas\u003cbr\u003eMichael E. Sughrue\u003cbr\u003e10. Butterfly glioma resection: Surgery around the initiation axis\u003cbr\u003eMichael E. Sughrue\u003cbr\u003e11. Thalamic gliomas: Advances in the surgical management\u003cbr\u003eMichael Lim and Alice Hung\u003cbr\u003e12. Essentials to planning a brainstem case\u003cbr\u003eChad A. Glenn, Michael E. Sughrue and Charles Teo\u003cbr\u003e13. The role of adjuvant therapies in “inoperable? gliomas\u003cbr\u003eGordon Li, David Dadey and Kevin Chow\u003cbr\u003e14. The role of adjuvant therapies in “inoperable? gliomas\u003cbr\u003eMichelle A. Wedemeyer and Gabriel Zada\u003cbr\u003e15. Laser interstitial thermal therapy for “inoperable? gliomas\u003cbr\u003eDaniel Eichberg, Ashish Shah and Michael E. Ivan\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Neurosciences [\u003ca title=\"See our other books on Neurosciences\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Neurosciences%20%5BPSAN%5D%22\"\u003ePSAN\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648355488024,"sku":"9780128136331","price":114.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128136331.jpg?v=1694090802"},{"product_id":"diagnostic-pathology-soft-tissue-tumors-hardback-9780323661102","title":"Diagnostic Pathology: Soft Tissue Tumors (Hardback) 9780323661102","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDiagnostic Pathology: Soft Tissue Tumors\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eStay up to date with recent changes in soft tissue pathology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMatthew R. Lindberg (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323661102, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 25 June 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e920 pages, \u003cp\u003eApprox. 2000 full-color illustrations\u003c\/p\u003e\n\u003cbr\u003e27.9 x 21.6 x 4.4 cm, 2.65 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eCovering all aspects of soft tissue pathology, this highly regarded volume in the \u003ci\u003eDiagnostic Pathology\u003c\/i\u003e series is an\u003cb\u003e excellent point-of-care resource for pathologists at all levels of experience and training\u003c\/b\u003e—both as a quick reference and as an efficient review to improve knowledge and skills. Specifically designed as a point-of-care resource, the updated third edition uses a templated, highly formatted design; concise, bulleted text; and superior color images throughout that demonstrate the variety of differentiating factors in soft tissue tumors.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eIncludes \u003cb\u003enew chapters\u003c\/b\u003e on recently described entities such as superficial CD34-positive fibroblastic tumor and atypical spindle cell lipomatous tumor, with numerous images detailing characteristic histology for ease of recognition\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers \u003cb\u003erecent advances and discoveries in immunohistochemistry and molecular pathology\u003c\/b\u003e of soft tissue tumors, including new IHC antibodies FOSB and H3k27me3, ALK-1 expression in angiomatoid fibrous histiocytoma, and entries on BCOR-CCNB2 fusion-defined sarcoma, novel PDGFD rearrangements in dermatofibrosarcoma protuberans, and RB gene loss in acral fibromyxoma\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003eextensive new 8th edition AJCC staging information\u003c\/b\u003e for soft tissue sarcomas in convenient table format\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003emore than 2,000 annotated images throughout\u003c\/b\u003e, including gross pathology, a wide range of stains, and detailed medical illustrations, with coverage of key diagnostic features for each tumor as well as morphologic variants\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003eeasy-to-reference chapters\u003c\/b\u003e that begin with Key Facts, followed by terminology, clinical issues, macro- and microscopic features, ancillary tests and a list of differential diagnoses with bulleted characteristics\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides \u003cb\u003ean organized framework\u003c\/b\u003e that includes \"Approach to Diagnosis\" chapters designed to help you successfully recognize and diagnose challenging soft tissue tumors with the availability of common patterns and histologic features\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eEnhanced eBook version included with purchase, which allows you to access all of the text, figures, and references from the book on a variety of devices\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eSoft Tissue Introduction\u003c\/p\u003e \u003cp\u003eIntroduction and Overview\u003c\/p\u003e \u003cp\u003eGross Examination\u003c\/p\u003e \u003cp\u003eGrading and Staging\u003c\/p\u003e \u003cp\u003eAncillary Techniques\u003c\/p\u003e \u003cp\u003eSoft Tissue Immunohistochemistry\u003c\/p\u003e \u003cp\u003eMolecular Features of Soft Tissue Tumors\u003c\/p\u003e \u003cp\u003eDiagnostic Approach to Soft Tissue Tumors\u003c\/p\u003e \u003cp\u003eOverview\u003c\/p\u003e \u003cp\u003eBiopsy and Resection of Soft Tissue Tumors\u003c\/p\u003e \u003cp\u003eClinical Approach\u003c\/p\u003e \u003cp\u003eAge- and Location-Based Approach to Diagnosis\u003c\/p\u003e \u003cp\u003eHistologic Approach\u003c\/p\u003e \u003cp\u003ePattern-Based Approach to Diagnosis\u003c\/p\u003e \u003cp\u003eFeature-Based Approach to Diagnosis\u003c\/p\u003e \u003cp\u003eTumors of Adipose Tissue\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eLipoma\u003c\/p\u003e \u003cp\u003eLipomatosis of Nerve\u003c\/p\u003e \u003cp\u003eSynovial Lipomatosis\u003c\/p\u003e \u003cp\u003eAngiolipoma\u003c\/p\u003e \u003cp\u003eSpindle Cell\/Pleomorphic Lipoma\u003c\/p\u003e \u003cp\u003eChondroid Lipoma\u003c\/p\u003e \u003cp\u003eMyolipoma\u003c\/p\u003e \u003cp\u003eHibernoma\u003c\/p\u003e \u003cp\u003eMyelolipoma\u003c\/p\u003e \u003cp\u003eLipoblastoma\u003c\/p\u003e \u003cp\u003eIntermediate, Locally Aggressive\u003c\/p\u003e \u003cp\u003eAtypical Lipomatous Tumor\/Well-Differentiated Liposarcoma\u003c\/p\u003e \u003cp\u003eAtypical Spindle Cell Lipomatous Tumor\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eDedifferentiated Liposarcoma\u003c\/p\u003e \u003cp\u003eMyxoid Liposarcoma\u003c\/p\u003e \u003cp\u003ePleomorphic Liposarcoma\u003c\/p\u003e \u003cp\u003eFibroblastic\/Myofibroblastic Lesions\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eNodular Fasciitis\u003c\/p\u003e \u003cp\u003eProliferative Fasciitis\/Myositis\u003c\/p\u003e \u003cp\u003eIschemic Fasciitis\u003c\/p\u003e \u003cp\u003eMyositis Ossificans\u003c\/p\u003e \u003cp\u003eFibroosseous Pseudotumor of the Digit\u003c\/p\u003e \u003cp\u003eFibroma of Tendon Sheath\u003c\/p\u003e \u003cp\u003eDesmoplastic Fibroblastoma\u003c\/p\u003e \u003cp\u003eElastofibroma\u003c\/p\u003e \u003cp\u003eAngiofibroma of Soft Tissue\u003c\/p\u003e \u003cp\u003eMammary-Type Myofibroblastoma\u003c\/p\u003e \u003cp\u003eIntranodal Palisaded Myofibroblastoma\u003c\/p\u003e \u003cp\u003eSuperficial CD34(+) Fibroblastic Tumor\u003c\/p\u003e \u003cp\u003ePleomorphic Fibroma\u003c\/p\u003e \u003cp\u003eDermatomyofibroma\u003c\/p\u003e \u003cp\u003eStoriform Collagenoma\u003c\/p\u003e \u003cp\u003eKeloid\u003c\/p\u003e \u003cp\u003eNuchal-Type Fibroma\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003ePalmar\/Plantar Fibromatosis\u003c\/p\u003e \u003cp\u003eDesmoid-Type Fibromatosis\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003eDermatofibrosarcoma Protuberans\u003c\/p\u003e \u003cp\u003eSolitary Fibrous Tumor\u003c\/p\u003e \u003cp\u003eLow-Grade Myofibroblastic Sarcoma\u003c\/p\u003e \u003cp\u003eInflammatory Myofibroblastic Tumor\u003c\/p\u003e \u003cp\u003eMyxoinflammatory Fibroblastic Sarcoma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eAdult-Type Fibrosarcoma\u003c\/p\u003e \u003cp\u003eMyxofibrosarcoma\u003c\/p\u003e \u003cp\u003eLow-Grade Fibromyxoid Sarcoma\u003c\/p\u003e \u003cp\u003eSclerosing Epithelioid Fibrosarcoma\u003c\/p\u003e \u003cp\u003ePediatric Fibroblastic\/Myofibroblastic Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eFibrous Hamartoma of Infancy\u003c\/p\u003e \u003cp\u003eCalcifying Aponeurotic Fibroma\u003c\/p\u003e \u003cp\u003eCalcifying Fibrous Tumor\u003c\/p\u003e \u003cp\u003eInclusion Body Fibromatosis\u003c\/p\u003e \u003cp\u003eHyaline Fibromatosis Syndrome\u003c\/p\u003e \u003cp\u003eFibromatosis Colli\u003c\/p\u003e \u003cp\u003eGardner Fibroma\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003eLipofibromatosis\u003c\/p\u003e \u003cp\u003eGiant Cell Fibroblastoma\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003eInfantile Fibrosarcoma\u003c\/p\u003e \u003cp\u003eFibrohistiocytic, Histiocytic, and Dendritic Cell Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eDermatofibroma and Fibrous Histiocytoma\u003c\/p\u003e \u003cp\u003eDeep Benign Fibrous Histiocytoma\u003c\/p\u003e \u003cp\u003eLocalized-Type Tenosynovial Giant Cell Tumor\u003c\/p\u003e \u003cp\u003eDiffuse-Type Tenosynovial Giant Cell Tumor\u003c\/p\u003e \u003cp\u003eCellular Neurothekeoma\u003c\/p\u003e \u003cp\u003eXanthomas\u003c\/p\u003e \u003cp\u003eSolitary (Juvenile) Xanthogranuloma\u003c\/p\u003e \u003cp\u003eReticulohistiocytoma\u003c\/p\u003e \u003cp\u003eDeep Granuloma Annulare\u003c\/p\u003e \u003cp\u003eRheumatoid Nodule\u003c\/p\u003e \u003cp\u003eLangerhans Cell Histiocytosis\u003c\/p\u003e \u003cp\u003eExtranodal Rosai-Dorfman Disease\u003c\/p\u003e \u003cp\u003eCrystal-Storing Histiocytosis\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003ePlexiform Fibrohistiocytic Tumor\u003c\/p\u003e \u003cp\u003eGiant Cell Tumor of Soft Tissue\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eHistiocytic Sarcoma\u003c\/p\u003e \u003cp\u003eFollicular Dendritic Cell Sarcoma\u003c\/p\u003e \u003cp\u003eInterdigitating Dendritic Cell Sarcoma\u003c\/p\u003e \u003cp\u003eSmooth Muscle Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eSmooth Muscle Hamartoma\u003c\/p\u003e \u003cp\u003eSuperficial Leiomyoma\u003c\/p\u003e \u003cp\u003eDeep Leiomyoma\u003c\/p\u003e \u003cp\u003eIntermediate\u003c\/p\u003e \u003cp\u003eEpstein-Barr Virus-Associated Smooth Muscle Tumor\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eLeiomyosarcoma\u003c\/p\u003e \u003cp\u003ePericytic (Perivascular) Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eGlomus Tumors (and Variants)\u003c\/p\u003e \u003cp\u003eMyopericytoma\u003c\/p\u003e \u003cp\u003eMyofibroma and Myofibromatosis\u003c\/p\u003e \u003cp\u003eAngioleiomyoma\u003c\/p\u003e \u003cp\u003eTumors of Skeletal Muscle\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eFocal Myositis\u003c\/p\u003e \u003cp\u003eAdult Rhabdomyoma\u003c\/p\u003e \u003cp\u003eFetal Rhabdomyoma\u003c\/p\u003e \u003cp\u003eGenital Rhabdomyoma\u003c\/p\u003e \u003cp\u003eCardiac Rhabdomyoma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eEmbryonal Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eAlveolar Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eSpindle Cell Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eSclerosing Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003ePleomorphic Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eEpithelioid Rhabdomyosarcoma\u003c\/p\u003e \u003cp\u003eVascular Tumors (Including Lymphatics)\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003ePapillary Endothelial Hyperplasia\u003c\/p\u003e \u003cp\u003eBacillary Angiomatosis\u003c\/p\u003e \u003cp\u003eCongenital Hemangioma\u003c\/p\u003e \u003cp\u003eInfantile Hemangioma\u003c\/p\u003e \u003cp\u003eLobular Capillary Hemangioma\u003c\/p\u003e \u003cp\u003eEpithelioid Hemangioma\u003c\/p\u003e \u003cp\u003eSpindle Cell Hemangioma\u003c\/p\u003e \u003cp\u003eIntramuscular Hemangioma\u003c\/p\u003e \u003cp\u003eHobnail Hemangioma\u003c\/p\u003e \u003cp\u003eAcquired Tufted Angioma\u003c\/p\u003e \u003cp\u003eMicrovenular Hemangioma\u003c\/p\u003e \u003cp\u003eSinusoidal Hemangioma\u003c\/p\u003e \u003cp\u003eGlomeruloid Hemangioma\u003c\/p\u003e \u003cp\u003eAngiomatosis\u003c\/p\u003e \u003cp\u003eLymphangioma\u003c\/p\u003e \u003cp\u003eMassive Localized Lymphedema\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003eKaposiform Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003ePapillary Intralymphatic Angioendothelioma\u003c\/p\u003e \u003cp\u003eRetiform Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eComposite Hemangioendothelioma\u003c\/p\u003e \u003cp\u003ePseudomyogenic Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eAtypical Vascular Lesion\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eEpithelioid Hemangioendothelioma\u003c\/p\u003e \u003cp\u003eAngiosarcoma\u003c\/p\u003e \u003cp\u003eKaposi Sarcoma\u003c\/p\u003e \u003cp\u003eChondro-Osseous Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eSoft Tissue Chondroma\u003c\/p\u003e \u003cp\u003eSynovial Chondromatosis\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eExtraskeletal Osteosarcoma\u003c\/p\u003e \u003cp\u003eExtraskeletal Mesenchymal Chondrosarcoma\u003c\/p\u003e \u003cp\u003ePeripheral Nerve Sheath Tumors\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eSolitary Circumscribed Neuroma\u003c\/p\u003e \u003cp\u003eSchwannoma\u003c\/p\u003e \u003cp\u003eNeurofibroma\u003c\/p\u003e \u003cp\u003ePerineurioma\u003c\/p\u003e \u003cp\u003eHybrid Nerve Sheath Tumor\u003c\/p\u003e \u003cp\u003eGranular Cell Tumor\u003c\/p\u003e \u003cp\u003eDermal Nerve Sheath Myxoma\u003c\/p\u003e \u003cp\u003eGanglioneuroma\u003c\/p\u003e \u003cp\u003eNeuromuscular Choristoma\u003c\/p\u003e \u003cp\u003eIntermediate\u003c\/p\u003e \u003cp\u003eMelanotic Schwannoma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eMalignant Peripheral Nerve Sheath Tumor\u003c\/p\u003e \u003cp\u003eEpithelioid Malignant Peripheral Nerve Sheath Tumor\u003c\/p\u003e \u003cp\u003eEctomesenchymoma\u003c\/p\u003e \u003cp\u003eGenital Stromal Tumors\u003c\/p\u003e \u003cp\u003eFibroepithelial Stromal Polyp\u003c\/p\u003e \u003cp\u003eAngiomyofibroblastoma\u003c\/p\u003e \u003cp\u003eCellular Angiofibroma\u003c\/p\u003e \u003cp\u003eDeep (Aggressive) Angiomyxoma\u003c\/p\u003e \u003cp\u003eTumors of Mesothelial Cells\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eAdenomatoid Tumor\u003c\/p\u003e \u003cp\u003eMulticystic Peritoneal Mesothelioma\u003c\/p\u003e \u003cp\u003eWell-Differentiated Papillary Mesothelioma\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eMalignant Mesothelioma\u003c\/p\u003e \u003cp\u003eHematopoietic Tumors in Soft Tissue\u003c\/p\u003e \u003cp\u003eSolitary Extramedullary Plasmacytoma\u003c\/p\u003e \u003cp\u003eMyeloid Sarcoma\u003c\/p\u003e \u003cp\u003eLymphoma of Soft Tissue\u003c\/p\u003e \u003cp\u003eTumors of Uncertain Differentiation\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eIntramuscular Myxoma\u003c\/p\u003e \u003cp\u003eJuxtaarticular Myxoma\u003c\/p\u003e \u003cp\u003eSuperficial Angiomyxoma\u003c\/p\u003e \u003cp\u003eAcral Fibromyxoma\u003c\/p\u003e \u003cp\u003ePleomorphic Hyalinizing Angiectatic Tumor\u003c\/p\u003e \u003cp\u003eAneurysmal Bone Cyst of Soft Tissue\u003c\/p\u003e \u003cp\u003eEctopic Hamartomatous Thymoma\u003c\/p\u003e \u003cp\u003eIntermediate (Locally Aggressive)\u003c\/p\u003e \u003cp\u003eHemosiderotic Fibrolipomatous Tumor\u003c\/p\u003e \u003cp\u003eIntermediate (Rarely Metastasizing)\u003c\/p\u003e \u003cp\u003eAtypical Fibroxanthoma\u003c\/p\u003e \u003cp\u003eAngiomatoid Fibrous Histiocytoma\u003c\/p\u003e \u003cp\u003eOssifying Fibromyxoid Tumor\u003c\/p\u003e \u003cp\u003eMyoepithelioma of Soft Tissue\u003c\/p\u003e \u003cp\u003ePhosphaturic Mesenchymal Tumor\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eSynovial Sarcoma\u003c\/p\u003e \u003cp\u003eEpithelioid Sarcoma\u003c\/p\u003e \u003cp\u003eAlveolar Soft Part Sarcoma\u003c\/p\u003e \u003cp\u003eClear Cell Sarcoma\u003c\/p\u003e \u003cp\u003ePerivascular Epithelioid Cell Tumor (PEComa)\u003c\/p\u003e \u003cp\u003eDesmoplastic Small Round Cell Tumor\u003c\/p\u003e \u003cp\u003eExtraskeletal Ewing Sarcoma\u003c\/p\u003e \u003cp\u003eExtraskeletal Myxoid Chondrosarcoma\u003c\/p\u003e \u003cp\u003eExtrarenal Rhabdoid Tumor\u003c\/p\u003e \u003cp\u003eIntimal Sarcoma\u003c\/p\u003e \u003cp\u003eUndifferentiated\/Unclassified Sarcomas\u003c\/p\u003e \u003cp\u003eUndifferentiated Pleomorphic Sarcoma\u003c\/p\u003e \u003cp\u003eUndifferentiated Round Cell Sarcoma With *CIC-DUX4* Translocation\u003c\/p\u003e \u003cp\u003eBCOR-CCNB3 (Ewing-Like) Sarcoma\u003c\/p\u003e \u003cp\u003eMesenchymal Tumors of the Gastrointestinal Tract\u003c\/p\u003e \u003cp\u003eBenign Neural Gastrointestinal Polyps\u003c\/p\u003e \u003cp\u003eGastrointestinal Stromal Tumor\u003c\/p\u003e \u003cp\u003eGastrointestinal Schwannoma\u003c\/p\u003e \u003cp\u003eGastrointestinal Smooth Muscle Neoplasms\u003c\/p\u003e \u003cp\u003eInflammatory Fibroid Polyp\u003c\/p\u003e \u003cp\u003eGangliocytic Paraganglioma\u003c\/p\u003e \u003cp\u003ePlexiform Fibromyxoma\u003c\/p\u003e \u003cp\u003eMalignant Gastrointestinal Neuroectodermal Tumor\u003c\/p\u003e \u003cp\u003eOther Entities\u003c\/p\u003e \u003cp\u003eBenign\u003c\/p\u003e \u003cp\u003eAmyloidoma\u003c\/p\u003e \u003cp\u003eGanglion Cyst\u003c\/p\u003e \u003cp\u003eTumoral Calcinosis\u003c\/p\u003e \u003cp\u003eIdiopathic Tumefactive Fibroinflammatory Lesions\u003c\/p\u003e \u003cp\u003eCardiac Myxoma\u003c\/p\u003e \u003cp\u003eCardiac Fibroma\u003c\/p\u003e \u003cp\u003eCongenital Granular Cell Epulis\u003c\/p\u003e \u003cp\u003eNasopharyngeal Angiofibroma\u003c\/p\u003e \u003cp\u003eSinonasal Glomangiopericytoma\u003c\/p\u003e \u003cp\u003eEctopic Meningioma\u003c\/p\u003e \u003cp\u003eGlial Heterotopia\u003c\/p\u003e \u003cp\u003eIntermediate\u003c\/p\u003e \u003cp\u003eParaganglioma\u003c\/p\u003e \u003cp\u003ePeripheral Hemangioblastoma\u003c\/p\u003e \u003cp\u003eMelanotic Neuroectodermal Tumor of Infancy\u003c\/p\u003e \u003cp\u003eEpendymoma of Soft Tissue\u003c\/p\u003e \u003cp\u003eMalignant\u003c\/p\u003e \u003cp\u003eMetastatic Tumors to Soft Tissue Sites\u003c\/p\u003e \u003cp\u003eNeuroblastoma and Ganglioneuroblastoma\u003c\/p\u003e \u003cp\u003eExtraaxial Soft Tissue Chordoma\u003c\/p\u003e \u003cp\u003eUndifferentiated Embryonal Sarcoma of the Liver\u003c\/p\u003e \u003cp\u003ePrimary Pulmonary Myxoid Sarcoma\u003c\/p\u003e \u003cp\u003eBiphenotypic Sinonasal Sarcoma\u003c\/p\u003e \u003cp\u003eSpindle Epithelial Tumor With Thymus-Like Differentiation\u003c\/p\u003e \u003cp\u003eLow-Grade Endometrial Stromal Sarcoma\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pathology [\u003ca title=\"See our other books on Pathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pathology%20%5BMMF%5D%22\"\u003eMMF\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648356143384,"sku":"9780323661102","price":245.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323661102_b5153fbb-d205-48cd-b164-5ae070604312.jpg?v=1694990072"},{"product_id":"the-molecular-basis-of-cancer-hardback-9781455740666","title":"The Molecular Basis of Cancer (Hardback) 9781455740666","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eThe Molecular Basis of Cancer\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eBetter understand the biological basis of the malignancies you face in everyday practice\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJohn Mendelsohn (Author), Peter M. Howley (Author), Mark A. Israel (Author), Joe W. Gray (Author), Craig B. Thompson (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781455740666, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 21 February 2014\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e888 pages, Approx. 500 illustrations (500 in full color)\u003cbr\u003e27.6 x 21.5 x 4.3 cm, 1.95 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"This is a well-organized and well-written book that improves readers' understanding of the diverse mechanisms involved in cancer risk, growth, and treatments. The book provides a unique experience, uniting basic science with clinical applications to provide an integrated appreciation of the diverse molecular biology of cancer. It should be in the library of anyone interested in cancer research and treatment.\"-Karen L Reckamp, MD, MS(City of Hope) \u003cb\u003eDoody Review: 4 stars\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2015 BMA Medical Book Awards: Highly Commended in Oncology\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003e2015 BMA Medical Book Awards Highly Commended in Oncology Category!\u003c\/b\u003e\u003ci\u003eThe Molecular Basis of Cancer\u003c\/i\u003e arms you with the \u003cb\u003elatest knowledge\u003c\/b\u003e and \u003cb\u003ecutting-edge advances\u003c\/b\u003e in the battle against cancer. This thoroughly revised, comprehensive oncology reference explores the \u003cb\u003escientific basis\u003c\/b\u003e for our current understanding of malignant transformation and the pathogenesis and treatment of this disease. A team of \u003cb\u003eleading experts\u003c\/b\u003e thoroughly explains the \u003cb\u003emolecular biologic principles\u003c\/b\u003e that underlie the diagnostic tests and therapeutic interventions now being used in clinical trials and practice. Detailed descriptions of topics from\u003cb\u003e molecular abnormalities\u003c\/b\u003e in common cancers to \u003cb\u003enew approaches for cancer therapy\u003c\/b\u003e equip you to understand and apply the complexities of ongoing research in everyday clinical application. \u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eEffectively determine\u003c\/li\u003e\u003c\/b\u003e the\u003cb\u003e course of malignancy \u003c\/b\u003eand design\u003cb\u003e appropriate treatment protocols \u003c\/b\u003eby\u003cb\u003e \u003c\/b\u003eunderstanding the scientific underpinnings of cancer. \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eVisually grasp and retain difficult concepts easily thanks to a user-friendly format with abundant full-color figures.\u003cb\u003e \u003c\/b\u003e\n\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFind critical information quickly with chapters following a logical sequence that moves from pathogenesis to therapy.\u003c\/li\u003e \u003c\/ul\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eStay current with the latest discoveries in molecular and genomic research. \u003c\/li\u003e\u003c\/b\u003eSweeping revisions throughout include eight brand-new chapters on: Tumor Suppressor Genes; Inflammation and Cancer; Cancer Systems Biology: The Future; Biomarkers Assessing Risk of Cancer; Understanding and Using Information About Cancer Genomes; The Technology of Analyzing Nucleic Acids in Cancer; Molecular Abnormalities in Kidney Cancer; and Molecular Pathology.\u003cb\u003e   \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eAccess the entire text and illustrations online, fully searchable, at \u003cb\u003eExpert Consult\u003c\/b\u003e. \u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eThe Molecular Basis of Cancer, 4e\u003c\/p\u003e \u003cp\u003eMendelsohn, Howley, Israel, Gray, Thompson\u003c\/p\u003e  \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart I: Carcinogenesis and Cancer Genetics \u003c\/p\u003e \u003cp\u003e1. Cancer, A Genetic Disorder\u003c\/p\u003e \u003cp\u003e2. Oncogenes and Signal Transduction\u003c\/p\u003e \u003cp\u003e3. Tumor Suppressor Genes\u003c\/p\u003e \u003cp\u003e4. Genomic Instability and DNA Repair\u003c\/p\u003e \u003cp\u003e5. Epigenetics and Cancer\u003c\/p\u003e \u003cp\u003e6. Infectious Agents and Cancer\u003c\/p\u003e \u003cp\u003e7. Environmental Carcinogenesis\u003c\/p\u003e \u003cp\u003e8. Animal Models: Flies, Fish and Yeast\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9. Genetic Mouse Models of Cancer\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart II: Cancer Biology \u003c\/p\u003e \u003cp\u003e10. Cancer Stem Cells\u003c\/p\u003e \u003cp\u003e11. Regulation of the Cell Cycle \u003c\/p\u003e \u003cp\u003e12. Cell Growth\u003c\/p\u003e \u003cp\u003e13. Cancer Cell Metabolism \u003c\/p\u003e \u003cp\u003e14. Apoptosis, Autophagy and Necrosis\u003c\/p\u003e \u003cp\u003e15. Cell Growth Arrest and Senescence\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e  16. Stromal-Cancer Interactions in the Microenvironment\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e  17. Hypoxia and Angiogenesis\u003c\/p\u003e \u003cp\u003e18. Invasion and Metastasis\u003c\/p\u003e \u003cp\u003e19. Inflammation and Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e  20. Molecular Pathways and Systems Biology\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart III: Molecular Pathology and Diagnostics\u003c\/p\u003e \u003cp\u003e21. Biomarkers Assessing Risk of Cancer\u003c\/p\u003e \u003cp\u003e22. Biomarkers for Detecting Cancer: Molecular Screening\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e  23. Biomarkers for Predicting Response to Specific Therapy\u003c\/p\u003e \u003cp\u003e24. The Technology of Analyzing Nucleic Acids\u003c\/p\u003e \u003cp\u003e25. Imaging Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Saunders","offers":[{"title":"Default Title","offer_id":46648504516888,"sku":"9781455740666","price":135.45,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9781455740666.jpg?v=1694809269"},{"product_id":"abeloffs-clinical-oncology-hardback-9780323476744","title":"Abeloff's Clinical Oncology (Hardback) 9780323476744","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eAbeloff's Clinical Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eEasily accessible, authoritative information for the cancer team\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJohn E. Niederhuber (Author), James O. Armitage (Author), James H Doroshow (Author), Michael B. Kastan (Author), Joel E. Tepper (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323476744, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 28 March 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e2072 pages, 1352 illustrations (955 in full color)\u003cbr\u003e28.1 x 22.2 x 8.4 cm, 3.92 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eEasily accessible and clinically focused, \u003ci\u003eAbeloff's Clinical Oncology, 6th Edition\u003c\/i\u003e, covers recent advances in our understanding of the pathophysiology of cancer, cellular and molecular causes of cancer initiation and progression, new and emerging therapies, current trials, and much more. Masterfully authored by an international team of leading cancer experts, it offers \u003cb\u003eclear, practical coverage\u003c\/b\u003e of everything from basic science to multidisciplinary collaboration on diagnosis, staging, treatment and follow up.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eIncludes \u003cb\u003enew chapters\u003c\/b\u003e on Cancer Metabolism and Clinical Trial Designs in Oncology and a standalone chapter on lifestyles and cancer prevention.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003eextensive updates\u003c\/b\u003e including the latest clinical practice guidelines, decision-making algorithms, and clinical trial implications, as well as new content on precision medicine, genetics, and PET\/CT imaging.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003erevised diagnostic and treatment protocols\u003c\/b\u003e for medical management, surgical considerations, and radiation oncology therapies, stressing a \u003cb\u003emultispecialty, integrated approach\u003c\/b\u003e to care.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eHelps you \u003cb\u003efind information quickly\u003c\/b\u003e with updated indexing related to management recommendations, focused fact summaries, updated key points at the beginning of each chapter \u003cb\u003eideal for quick reference and board review\u003c\/b\u003e, and algorithms for patient evaluation, diagnosis, and treatment options.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eOffers \u003cb\u003emore patient care coverage\u003c\/b\u003e in disease chapters, plus new information on cancer as a chronic illness and cancer survivorship.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDiscusses \u003cb\u003etoday’s key topics\u003c\/b\u003e such as immuno-oncology, functional imaging, precision medicine, the application of genetics in pathologic diagnosis and sub-categorization of tumors as well as the association of chronic infectious diseases such as HIV and cancer.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eEnhanced eBook version included with purchase. \u003c\/li\u003e\u003c\/b\u003eYour enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eAbeloff’s Clinical Oncology Sixth Edition\u003c\/p\u003e   \u003cp\u003ePART I: SCIENCE AND CLINCIAL ONCOLOGY\u003c\/p\u003e \u003cp\u003eSECTION A: BIOLOGY AND CANCER\u003c\/p\u003e \u003cp\u003e1. Molecular Tools in Cancer Research\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e2. Intracellular Signaling\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e3. The Cellular Microenvironment and Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e4. Control of the Cell Cycle\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e5. The Pathophysiology of Cancer Cell Death\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e6. Cancer Immunology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e7. Stem Cells, Cell Differentiation, and Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e8. Vascular and Interstitial Biology of Tumors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e9. Cancer Metabolism\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION B: GENESIS OF CANCER\u003c\/p\u003e \u003cp\u003e10. Environmental Factors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e11. DNA Damage Response Pathways and Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e12. Viruses and Human Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e13. Genetic Factors: Hereditary Cancer Predisposition Syndromes\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e14. Genetic and Epigenetic Changes in Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION C: DIAGNOSIS OF CANCER\u003c\/p\u003e \u003cp\u003e15. Pathology, Biomarkers, and Molecular Diagnostics\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e16. Imaging\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION D: CLINICAL TRIALS\u003c\/p\u003e \u003cp\u003e17. Biostatistics and Bioinformatics in Clinical Trials\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e18. Trial Design\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e19. Structures Supporting Cancer Clinical Trials\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e20. Oncology and Health Care Policy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION E: PREVENTION AND EARLY DETECTION\u003c\/p\u003e \u003cp\u003e21. Discovery and Characterization of Cancer Genetic Susceptibility Alleles\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e22. Lifestyle and Cancer Prevention\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e23. Cancer Screening and Early Detection\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e24. Nicotine Dependence: Current Treatments and Future Directions\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION F: TREATMENT\u003c\/p\u003e \u003cp\u003e25. Cancer Pharmacology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e26. Therapeutic Targeting of Cancer Cells: Era of Molecularly Targeted Agents\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e27. Basics of Radiation Therapy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e28. Hematopoietic Stem Cell Transplantation\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e29. Gene Therapy in Oncology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e30. Therapeutic Antibodies and Immunologic Conjugates\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e31. Complementary and Alternative Medicine\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003ePART II: PROBLEMS COMMON TO CANCER AND THERAPY\u003c\/p\u003e \u003cp\u003eSECTION A: HEMATOLOGIC PROBLEMS AND INFACTIONS\u003c\/p\u003e \u003cp\u003e32. Disorders of Blood Cell Production in Clinical Oncology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e33. Diagnosis, Treatment, and Prevention of Cancer-Related Venous Thrombosis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e34. Infection in the Patient with Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION B: SYMPTOM MANAGEMENT\u003c\/p\u003e \u003cp\u003e35. Hypercalcemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e36. Tumor Lysis Syndrome\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e37. Cancer-Related Pain\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e38. Cancer Cachexia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e39. Nausea and Vomiting\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION C: TREATMENT COMPLICATIONS\u003c\/p\u003e \u003cp\u003e40. Oral Complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e41. Dermatologic Toxicities of Anticancer Therapy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e42. Cardiovascular Effects of Cancer Therapy \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e43. Reproductive Complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e44. Paraneoplastic Neurologic Syndromes \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e45. Neurologic complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e46. Endocrine Complications\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e47. Pulmonary Complications of Anticancer Treatment\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION D: POST TREATMENT CONSIDERATIONS\u003c\/p\u003e \u003cp\u003e48. Rehabilitation of Individuals with Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e49. Survivorship\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e50. Second Malignant Neoplasms\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e51. Caring for Patients at the End of Life\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION E: LOCAL EFFECTS OF CANCER AND ITS METASTASIS\u003c\/p\u003e \u003cp\u003e52. Acute Abdomen, Bowel Obstruction, and Fistula\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e53. Superior Vena Cava Syndrome\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e54. Spinal Cord Compression\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e55. Brain Metastases and Neoplastic Meningitis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e56. Bone Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e57. Lung Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e58. Liver Metastases\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e59. Malignancy-Related Effusions\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION F: SPECIAL POPULATIONS\u003c\/p\u003e \u003cp\u003e60. Cancer in the Elderly: Biology, Prevention, and Treatment\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e61. Special Issues in Pregnancy\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e62. Human Immunodeficiency Virus (HIV) Infection and Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003ePART III: SPECIFIC MALIGNANCIES\u003c\/p\u003e \u003cp\u003eSECTION A\u003c\/p\u003e \u003cp\u003e63. Cancer of the Central Nervous System\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION B\u003c\/p\u003e \u003cp\u003e64. Ocular Tumors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e65. Cancer of the Head and Neck\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION C: SKIN\u003c\/p\u003e \u003cp\u003e66. Melanoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e67. Nonmelanoma Skin Cancers: Basal Cell and Squamous Cell Carcinomas\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION D: ENDOCRINE\u003c\/p\u003e \u003cp\u003e68. Cancer of the Endocrine System\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION E: THORACIC\u003c\/p\u003e \u003cp\u003e69. Cancer of the Lung: Non-Small Cell Lung Cancer and Small Cell Lung Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e70. Diseases of the Pleura and Mediastinum \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e71. Cancer of the Esophagus and Gastroesophageal Junction\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION F: GASTROINTESTINAL\u003c\/p\u003e \u003cp\u003e72. Cancer of the Stomach and Gastroesophageal Junction\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e73. Cancer of the Small Bowel\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e74. Colon Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e75. Cancer of the Rectum\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e76. Cancer of the Anal Canal\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e77. Liver and Bile Duct Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e78. Carcinoma of the Pancreas\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION G: GENITOURINARY\u003c\/p\u003e \u003cp\u003e79. Cancer of the Kidney\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e80. Carcinoma of the Bladder\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e81. Prostate Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e82. Cancer of the Penis\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e83. Testicular Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION H: GYNECOLOGICAL\u003c\/p\u003e \u003cp\u003e84. Cancers of the Cervix, Vulva, and Vagina\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e85. Cancer of the Endometrium\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e86. Ovaries and Fallopian Tubes\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e87. Gestational Trophoblastic Disease\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e88. Cancer of the Breast\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION I: SARCOMAS\u003c\/p\u003e \u003cp\u003e89. Sarcomas of Bone\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e90. Sarcomas of Soft Tissue\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION J\u003c\/p\u003e \u003cp\u003e91. Carcinoma of Unknown Primary\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION K: PEDIATRICS\u003c\/p\u003e \u003cp\u003e92. Pediatric Solid Tumors\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e93. Childhood Leukemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e94. Childhood Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003eSECTION L: HEMATOLOGICAL\u003c\/p\u003e \u003cp\u003e95. Acute Leukemias in Adults \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e96. Myelodysplastic Syndromes\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e97. Myeloproliferative Disorders\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e98. Chronic Myeloid Leukemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e99. Chronic Lymphoid Leukemias\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e100. Hairy Cell Leukemia\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e101. Multiple Myeloma and Related Disorders\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e102. Hodgkin’s Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e103. Non-Hodgkin Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e104. Cutaneous T-Cell Lymphoma and Cutaneous B-Cell Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e105. Adult T-Cell Leukemia-Lymphoma\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648513200408,"sku":"9780323476744","price":223.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323476744_087eb592-8345-4079-adf6-e75aeccbbfe1.jpg?v=1694989834"},{"product_id":"novel-designs-of-early-phase-trials-for-cancer-therapeutics-paperback-9780128125120","title":"Novel Designs of Early Phase Trials for Cancer Therapeutics (Paperback) 9780128125120","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eNovel Designs of Early Phase Trials for Cancer Therapeutics\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eProvides discussions on early phase cancer trial designs, the process of drug development, and the integration of molecular profiling \u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eShivaani Kummar (Edited by), Chris Takimoto (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128125120, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 26 May 2018\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e234 pages\u003cbr\u003e23.4 x 19 x 1.6 cm, 0.48 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eNovel Designs of Early Phase Trials for Cancer Therapeutics\u003c\/i\u003e provides a comprehensive review by leaders in the field of the process of drug development, the integration of molecular profiling, the changes in early phase trial designs, and endpoints to optimally develop a new generation of cancer therapeutics. The book discusses topics such as statistical perspectives on cohort expansions, the role and application of molecular profiling and how to integrate biomarkers in early phase trials. Additionally, it discusses how to incorporate patient reported outcomes in phase one trials.\u003c\/p\u003e  \u003cp\u003eThis book is a valuable resource for medical oncologists, basic and translational biomedical scientists, and trainees in oncology and pharmacology who are interested in learning how to improve their research by using early phase trials.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eIntroduction: Changing landscape of phase I trials1. Phase I trial designs: Past, Present, and Future2. Statistical perspectives on cohort expansions in early phase trials3. Determining the optimal dose and schedule4. Conducting large phase I trials with multiple expansion cohorts5. Role and application of molecular profiling in early phase trials6. Novel trial designs for immunotherapies7. Designing trials for cell based therapies8. Evaluating novel drug combinations in early phase trials9. Integrating biomarkers in early phase trials: developing the evidence base for ‘actionable’ biomarkers10. Novel imaging endpoints in early phase trials11. Developing a novel agent: the regulatory process perspective12. Conducting proof of concept phase I trials-Regulatory Implications13. Efficacy endpoints in early phase trials14. Incorporation of Patient Reported Outcomes in early phase trials\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Biomedical engineering [\u003ca title=\"See our other books on Biomedical engineering\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Biomedical%20engineering%20%5BMQW%5D%22\"\u003eMQW\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648515232024,"sku":"9780128125120","price":98.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128125120.jpg?v=1694092009"},{"product_id":"chimeric-antigen-receptor-t-cell-therapies-for-cancer-a-practical-guide-paperback-9780323661812","title":"Chimeric Antigen Receptor T-Cell Therapies for Cancer; A Practical Guide (Paperback \/ softback) 9780323661812","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eChimeric Antigen Receptor T-Cell Therapies for Cancer\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eA Practical Guide\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eTimely guidance on this fast-changing area in cancer therapy\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eDaniel W. Lee (Edited by), Nirali N. Shah (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323661812, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 2 December 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e244 pages\u003cbr\u003e23.4 x 19 x 1.6 cm, 0.5 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eFrom patient referral to post-therapy management, \u003ci\u003eChimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide\u003c\/i\u003e presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eCovers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care. \u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003ePresents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon.\u003c\/li\u003e \u003cli\u003eEditors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eIntroduction 1. When to Refer a Patient for CAR-T Cell Therapy 2. Optimizing the Apheresis Product 3. CAR T Cells: Cell Processing Laboratory Considerations 4. Peri-CAR-T Cell Management 5. Management of Cytokine Release Syndrome 6. Special Considerations for ICU Management of Patients Receiving CAR Therapy 7. Neurotoxicities After CAR-T Cell Immunotherapy 8. Hematologic and Non-CRS Toxicities 9. Response Assessment and PosteCAR-T Cell Therapy Management 10. Relapse Management and Role for Consolidative Hematopoietic Stem Cell Transplantation Following CAR-T Cell Therapy 11. Promising Chimeric Antigen Receptors for Non-B Cell Hematological Malignancies, Pediatric Solid Tumors, and Carcinomas 12. CAR T Cell Therapy for CNS Malignancies 13. CAR 2.0: The Next Generation of Synthetic ReceptoreBased Cellular Therapy for Cancer\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648534958360,"sku":"9780323661812","price":52.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323661812_430427c2-a912-4bfc-b09f-bb9a85ede0b5.jpg?v=1694990042"},{"product_id":"lanzkowskys-manual-of-pediatric-hematology-and-oncology-hardback-9780128216712","title":"Lanzkowsky's Manual of Pediatric Hematology and Oncology (Hardback) 9780128216712","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eLanzkowsky's Manual of Pediatric Hematology and Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eFully updated seventh edition is a concise, systematic approach to all pediatric cancers and blood disorders in one authoritative manual\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJonathan D. Fish (Edited by), Jeffrey M. Lipton (Edited by), Philip Lanzkowsky (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128216712, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 25 November 2021\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e834 pages, 75 illustrations (65 in full color)\u003cbr\u003e27.6 x 21.6 x 4.1 cm, 2.36 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePraise for the 7th Edition: \u003c\/b\u003e\"Even in this digital age, \u003ci\u003eLanzkowsky’s Manual of Pediatric Hematology and Oncology\u003c\/i\u003e remains the essential manual for pediatric hematology\/oncology trainees, junior faculty and even senior investigators. The manual serves as a concise yet comprehensive guide that can steer physicians at any stage of their careers to best practices in areas both common and rare. The Manual is an authoritative and well-illustrated compendium that should be on the must have list of every pediatric hematologist and oncologist.\" --\u003cb\u003eJohn M. Maris, MD, D'Angio Professor of Pediatrics, Children's Hospital of Philadelphia, Philadephia, Pennsylvania, USA\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"\u003ci\u003eLanzkowsky’s Manual of Pediatric Hematology and Oncology\u003c\/i\u003e, now in its 7th edition, has long had a fundamental place in the training of paediatric haematologists and oncologists, and provided subsequent support during their career due to its authoritative, concise and clear presentation of the speciality. It now constitutes a canonical work in haematology and as such acts as a reference tool to support the work of paediatric haematology departments and the personal development of senior clinicians and scientists. I very much welcome this new edition.\" --\u003cb\u003eProfessor Josu de la Fuente PhD FRCP FRCPI FRCPCH FRCPath, Consultant Haematologist and Director Paediatric Blood and Marrow Transplant Programme, St Mary’s Hospital and Imperial College London, London, UK\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"I have been using \u003ci\u003eLanzkowsky’s Manual of Pediatric Hematology Oncology\u003c\/i\u003e since it was first published in 1980. The Manual is a very valuable ready reference, written in a didactic way, filled with excellent algorithms and up-to-date treatment regimens, which are extremely useful to the clinician. I highly recommend it to all students and practitioners of pediatric hematology and oncology as an essential reference book.\" --\u003cb\u003eCyril Karabus MB, ChB, MMed Paed (UCT), DCH, FRCP (London), FRCP (Edin), Emeritus Associate Professor of Pediatrics, University of Cape Town, Cape Town, South Africa\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"\u003ci\u003eLanzkowsky’s Manual of Pediatric Hematology and Oncology\u003c\/i\u003e was the first book I bought when I started my fellowship at the NIH in 1993 and I am thrilled to see the seventh edition. I recently read the sixth edition, cover to cover, in preparation for becoming the Director of a large Pediatric Hematology Oncology Division. Amazingly, Dr. Lanzkowsky and his colleagues managed to incorporate in a reasonable-sized book, both the practical “recipes? for diagnosis and management of common as well as serious and rare oncologic and hematologic disorders. The new scientific revolution has been translated into precision medicine and brings us closer to curing every child with cancer and to the precise diagnosis and management of patients with serious hematologic disorders. These new advances and therapies are covered in the new edition in a clear and authoritative way. I recommend this book without hesitation to students, residents, fellows, attending physicians, nurses, diagnostic hematological laboratories, and yes, to Directors of Hematology Oncology services like myself.\" --\u003cb\u003eShai Izraeli, Prof of Hematological Malignancies at Tel Aviv University, Head of the Rina Zaizov Division of Pediatric Hematology Oncology at Schneider Children’s Medical Center of Israel, Treasurer and Head of Research the European Hematology Association.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The Lanzkowsky Manual was the first manual I consulted when I was a resident interested in pediatric hematology and oncology; over the years the Manual has remained close at hand as it has grown, keeping pace with the field. I continue to consult it often and recommend it highly to international colleagues for its practical and up-to-date guidance.\" --\u003cb\u003eCarlos Rodriguez-Galindo, MD, Executive Vice-President, Director, St. Jude Global, Chair, Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The 7th edition \u003ci\u003eLanzkowsky’s Manual of Pediatric Hematology and Oncology\u003c\/i\u003e provides an excellent up-to-date reference for teaching and practicing pediatric hematology and oncology (PHO).  Written by leaders in the field, it can be used as a comprehensive reference while at the same time, it is a concise, well-organized manual that you can access for a fast look while on-call, addressing common and rare PHO conditions with an algorithmic approach.  I recommend this book without hesitation.\" --\u003cb\u003eTheodosia A. Kalfa, MD, PhD, Professor of Pediatrics, Co-Director of the Erythrocyte Diagnostic Laboratory, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eLanzkowsky’s Manual of Pediatric Hematology and Oncology\u003c\/i\u003e, Seventh Edition remains the go-to clinical manual for the treatment and management of childhood cancers and blood disorders. It is a comprehensive book on patient management, replete with algorithms and flow diagrams, and includes a new section on vascular anomalies. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the seventh edition of this successful clinical manual is entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format, again, enables readers to make accurate diagnoses and treatment decisions without having to reference larger medical textbooks.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Molecular and genomic methodologies for clinicians\u003cbr\u003e2. Hematologic manifestations of systemic illness\u003cbr\u003e3. Classification and diagnosis of anemia in children and neonates\u003cbr\u003e4. Nutritional anemias\u003cbr\u003e5. Lymphadenopathy and diseases of the spleen\u003cbr\u003e6. Bone marrow failure\u003cbr\u003e7. General considerations of hemolytic diseases, red cell membrane, and enzyme defects\u003cbr\u003e8. Extracorpuscular hemolytic anemia\u003cbr\u003e9. Hemoglobinopathies\u003cbr\u003e10. Primary and secondary erythrocytosis\u003cbr\u003e11. Disorders of white blood cells\u003cbr\u003e12. Disorders of platelets\u003cbr\u003e13. Disorders of coagulation\u003cbr\u003e14. Vascular anomalies\u003cbr\u003e15. Histiocytic disorders\u003cbr\u003e16. Lymphoproliferative disorders\u003cbr\u003e17. Myelodysplastic syndromes and myeloproliferative disorders\u003cbr\u003e18. Acute lymphoblastic leukemia\u003cbr\u003e19. Acute myeloid leukemia\u003cbr\u003e20. Hodgkin lymphoma\u003cbr\u003e21. Non-Hodgkin lymphoma\u003cbr\u003e22. Central nervous system tumors\u003cbr\u003e23. Neuroblastoma\u003cbr\u003e24. Renal tumors\u003cbr\u003e25. Rhabdomyosarcoma and other soft-tissue sarcomas\u003cbr\u003e26. Malignant bone tumors\u003cbr\u003e27. Retinoblastoma\u003cbr\u003e28. Extracranial germ cell tumors\u003cbr\u003e29. Hepatic tumors\u003cbr\u003e30. Hematopoietic stem cell transplant and cellular therapy\u003cbr\u003e31. Management of oncologic emergencies\u003cbr\u003e32. Supportive care of patients with cancer\u003cbr\u003e33. Evaluation, investigations, and management of late effects of childhood cancer\u003cbr\u003e34. Psychosocial factors impacting children with cancer and their families\u003cbr\u003e35. Pediatric blood banking principles and transfusion medicine practices\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648551899416,"sku":"9780128216712","price":175.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128216712.jpg?v=1694092256"},{"product_id":"gunderson-and-tepper-s-clinical-radiation-oncology-hardback-9780323672467","title":"Gunderson and Tepper’s Clinical Radiation Oncology (Hardback) 9780323672467","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eGunderson and Tepper’s Clinical Radiation Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eComplete coverage of this fast-moving field, ideal for today’s multidisciplinary radiation oncology team\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJoel E. Tepper (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323672467, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 15 February 2020\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1656 pages, 1000 illustrations (1000 in full color)\u003cbr\u003e28.4 x 22.4 x 7 cm, 3.26 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eA comprehensive, multidisciplinary resource for the entire radiation oncology team\u003ci\u003e, Gunderson \u0026amp; Tepper’s Clinical Radiation Oncology, 5th Edition\u003c\/i\u003e, thoroughly covers all aspects of this complex and dynamic field. \u003cb\u003eConcise, templated chapters\u003c\/b\u003e cover the basic biology of oncologic disease processes as well as updated treatment algorithms, the latest clinical guidelines, and state-of-the-art techniques and modalities. \u003cb\u003eMore than 1,000 images\u003c\/b\u003e—detailed anatomy drawings, radiographic images, and more—provide outstanding visual support for every area of the text.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eDivides content into three distinct sections for \u003cb\u003equick access to information\u003c\/b\u003e: Scientific Foundations, Techniques and Modalities, and Disease Sites. Disease Site chapters include overviews summarizing the most important issues and concluding discussions on controversies and problems.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003enew and expanded content\u003c\/b\u003e on molecular and cellular biology and its relevance in individualized treatment approaches, stereotactic radiation therapy, radiosurgery, proton therapy, biologic therapy, precision radiation therapy, targeted radiation, dosing guidelines for better quality of life and improved patient outcomes, and more.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003enew chapters\u003c\/b\u003e on Radiation Physics: Particle Therapy, Interventional Radiology, Radiation Therapy in the Elderly, Palliative Care, Quality and Safety, and Immunotherapy with Radiotherapy.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides guidance on \u003cb\u003esingle-modality and combined-modality approaches\u003c\/b\u003e, as well as \u003cb\u003eoutcome data\u003c\/b\u003e including disease control, survival, and treatment tolerance.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes access to \u003cb\u003evideos\u003c\/b\u003e on Intraoperative Irradiation, Prostate Brachytherapy, Penile Brachytherapy, and Ocular Melanoma.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eExpert Consult™ eBook version included with purchase.\u003c\/li\u003e\u003c\/b\u003e This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, and references from the book on a variety of devices. \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSECTION I SCIENTIFIC FOUNDATIONS OF RADIATION ONCOLOGY\u003c\/p\u003e \u003cp\u003ePart A. Radiobiology\u003c\/p\u003e \u003cp\u003e1. The Biological Basis of Radiation Oncology\u003c\/p\u003e \u003cp\u003e2. Molecular and Cellular Biology\u003c\/p\u003e \u003cp\u003e3. Dose-Response Modifiers in Radiation Therapy\u003c\/p\u003e \u003cp\u003e4. Interaction of Chemotherapy and Radiation\u003c\/p\u003e \u003cp\u003e5. Biologics and Their Interactions with Radiation\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart B. Physics\u003c\/p\u003e \u003cp\u003e6. Radiation Oncology Physics\u003c\/p\u003e \u003cp\u003e7. Radiation Physics - Stereotactic\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart C. Related Cancer Disciplines\u003c\/p\u003e \u003cp\u003e8. Surgical Principles\u003c\/p\u003e \u003cp\u003e9. Principles of Chemotherapy\u003c\/p\u003e \u003cp\u003e10. Imaging in Oncology\u003c\/p\u003e \u003cp\u003e11. Nuclear Medicine\u003c\/p\u003e \u003cp\u003e12. Health Services Research in Radiation Oncology\u003c\/p\u003e \u003cp\u003e13. Statistics and Clinical Trials\u003c\/p\u003e \u003cp\u003e14. Late Effects after Radiation\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSECTION II TECHNIQUES AND MODALITIES\u003c\/p\u003e \u003cp\u003e15. Brachytherapy\u003c\/p\u003e \u003cp\u003e16. Intensity-Modulated and Image-Guided Radiation Therapy\u003c\/p\u003e \u003cp\u003e17. Intraoperative Irradiation\u003c\/p\u003e \u003cp\u003e18. Total Body Irradiation\u003c\/p\u003e \u003cp\u003e19. Charged Particle Radiotherapy\u003c\/p\u003e \u003cp\u003e20. Neutron Radiotherapy\u003c\/p\u003e \u003cp\u003e21. Hyperthermia\u003c\/p\u003e \u003cp\u003e22. Targeted Radionuclide Therapy\u003c\/p\u003e \u003cp\u003e23. Stereotactic Irradiation: CNS Tumors\u003c\/p\u003e \u003cp\u003e24. Stereotactic Body Irradiation: Extracranial Tumors\u003c\/p\u003e \u003cp\u003e25. Metastatic Disease: Bone, Spinal Cord, Brain, Liver, and Lung\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSECTION III DISEASE SITES\u003c\/p\u003e \u003cp\u003ePart A. Central Nervous System Tumors\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e26. Low-Grade Gliomas\u003c\/p\u003e \u003cp\u003e27. High-Grade Gliomas\u003c\/p\u003e \u003cp\u003e28. Benign Brain Tumors: Meningiomas and Vestibular Schwannomas\u003c\/p\u003e \u003cp\u003e29. Pituitary Tumors and Craniopharyngiomas\u003c\/p\u003e \u003cp\u003e30. Spinal Cord Tumors\u003c\/p\u003e \u003cp\u003e31. Orbital, Ocular, and Optic Nerve Tumors\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart B. Head and Neck Tumors\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e32. Oral Cavity \u003c\/p\u003e \u003cp\u003e33. Oropharyngeal Cancer\u003c\/p\u003e \u003cp\u003e34. Nasopharyngeal Carcinoma\u003c\/p\u003e \u003cp\u003e35. Larynx and Hypopharynx Cancer\u003c\/p\u003e \u003cp\u003e36. Sinonasal Cancer\u003c\/p\u003e \u003cp\u003e37. Salivary Gland Malignancies\u003c\/p\u003e \u003cp\u003e38. Thyroid Cancer\u003c\/p\u003e \u003cp\u003e39. Unknown Head and Neck Primary Site\u003c\/p\u003e \u003cp\u003e40. Management of the Neck\u003c\/p\u003e \u003cp\u003e41. Cutaneous Carcinoma\u003c\/p\u003e \u003cp\u003e42. Malignant Melanoma\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart C. Thoracic Neoplasms\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e43. Small Cell Lung Cancer\u003c\/p\u003e \u003cp\u003e44. Non-Small Cell Lung Cancer\u003c\/p\u003e \u003cp\u003e45. Cancer of the Esophagus\u003c\/p\u003e \u003cp\u003e46. Uncommon Thoracic Tumors\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart D. Gastrointestinal Tumors\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e47. Gastric\/GE Junction Cancer\u003c\/p\u003e \u003cp\u003e48. Pancreatic Cancer\u003c\/p\u003e \u003cp\u003e49. Hepatobiliary Cancer\u003c\/p\u003e \u003cp\u003e50. Colon Cancer\u003c\/p\u003e \u003cp\u003e51. Rectal Cancer\u003c\/p\u003e \u003cp\u003e52. Anal Carcinoma\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart E. Genitourinary Tumors\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e53. Prostate Cancer\u003c\/p\u003e \u003cp\u003e54. Bladder Cancer\u003c\/p\u003e \u003cp\u003e55. Testicular Cancer\u003c\/p\u003e \u003cp\u003e56. Kidney and Ureteral Carcinoma\u003c\/p\u003e \u003cp\u003e57. Penile Cancer\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart F. Gynecologic Tumors\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e58. Cervical Cancer\u003c\/p\u003e \u003cp\u003e59. Endometrial Cancer\u003c\/p\u003e \u003cp\u003e60. Cancers of the Vulva and Vagina\u003c\/p\u003e \u003cp\u003e61. Ovarian Cancer\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart G. Breast Cancer\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e62. Noninvasive Breast Cancer\u003c\/p\u003e \u003cp\u003e63. Breast Cancer: Stages I-II\u003c\/p\u003e \u003cp\u003e64. Breast Cancer: Postmastectomy Radiation, Locally Advanced Disease, and Inflammatory Breast Cancer\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart H. Sarcoma and Benign Disease\u003c\/p\u003e \u003cp\u003e65. Soft Tissue Sarcoma\u003c\/p\u003e \u003cp\u003e66. Benign Diseases\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart I. Childhood Cancers\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e67. Central Nervous System Tumors \u003c\/p\u003e \u003cp\u003e68. Pediatric Soft Tissue Sarcomas\u003c\/p\u003e \u003cp\u003e69. Pediatric Sarcomas of Bone\u003c\/p\u003e \u003cp\u003e70. Wilms' Tumor\u003c\/p\u003e \u003cp\u003e71. Retinoblastoma\u003c\/p\u003e \u003cp\u003e72. Neuroblastoma\u003c\/p\u003e \u003cp\u003e73. Pediatric Leukemias and Lymphomas\u003c\/p\u003e \u003cp\u003e74. Pediatric Hodgkin's Lymphoma\u003c\/p\u003e \u003cp\u003e75. Rare Pediatric Tumors\u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePart J. Lymphoma and Hematologic Malignancies\u003c\/p\u003e \u003cp\u003eOverview \u003c\/p\u003e \u003cp\u003e76. Hodgkin's Lymphoma\u003c\/p\u003e \u003cp\u003e77. Non-Hodgkin's Lymphoma\u003c\/p\u003e \u003cp\u003e78. Multiple Myeloma and Other Plasma Cell Neoplasms\u003c\/p\u003e \u003cp\u003e79. Mycosis Fungoides\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648659247384,"sku":"9780323672467","price":159.49,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323672467.jpg?v=1694093147"},{"product_id":"lanzkowskys-manual-of-pediatric-hematology-and-oncology-hardback-9780128013687","title":"Lanzkowsky's Manual of Pediatric Hematology and Oncology (Hardback) 9780128013687","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eLanzkowsky's Manual of Pediatric Hematology and Oncology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThis comprehensive clinical manual provides a concise, systematic approach to the diagnosis and treatment of hematologic and oncologic cancers and disorders in children, and is based on the new standards of genetic classification and prognostic information that have emerged in the past five years\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eJonathan D. Fish (Edited by), Jeffrey M. Lipton (Edited by), Philip Lanzkowsky (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128013687\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 18 May 2016\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e788 pages\u003cbr\u003e27.6 x 21.5 x 4 cm, 2.38 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"I would like to applaud Professor Philip Lanzkowsky and his colleagues for the publication of the sixth edition of \u003ci\u003eLanzkowsky’s Manual of Pediatric Hematology and Oncology. \u003c\/i\u003eAs with the previous editions, the manual is a most practical tool for students, residents, and physicians in the field of hematology and oncology. It should automatically be on the list of required study for trainees and on the shelf on practicing clinicians. It provides valuable diagnostic algorithms, including state of the art diagnostic approaches and up-to-date therapeutic regimens, which influence decisions for management at the bedside. Dr. Lanzkowsky’s didactic approach, the product of over five decades of academic clinical practice, permeates the book, which is distinguished by its clarity and clinical relevance.\" \u003cb\u003e--Isaac Yaniv, MD, Associate Professor of Pediatrics, Tel Aviv University, Chairman The Rina Zaizov Pediatric Hematology-Oncology division, Schneider Children’s Medical Center of Israel, Tel Aviv, Israel\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The Lanzkowsky Manual was the first book I bought when I started my fellowship and to this day, I buy every new edition that comes out. It is my first choice ‘go-to’ for all subjects in pediatric hematology-oncology. The book is characterized by a clarity of style, packed with useful information which is easily accessible.\" \u003cb\u003e--Kenan Onel, MD, PhD, Associate Professor of Pediatrics, Section of Hematology-Oncology, University of Chicago, Chicago, IL, USA\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"Lanzkowsky’s Manual of Pediatric Hematology and Oncology has deservedly earned a worldwide reputation as the standard authoritative text on the subject. Now in its sixth edition, with an expansion of contributing authors commensurate with the major developments in the field, Professor Lanzkowsky’s clarity of style and clinical relevance have remained the hallmarks of this book. It is an essential practical companion for clinicians in the field of pediatric hematology and oncology.\" \u003cb\u003e--Victor Dubowitz, MB, ChB, MD, PhD, FRCP, FRCPH, Emeritus Professor of Pediatrics, University of London, London, UK\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The Lanzkowsky Manual was the first manual I consulted when I was a resident interested in pediatric hematology and oncology; I loved its comprehensive and yet clear approach to so many topics. The manual has kept its unique place on my shelf over the years and the many editions since it was first published. I continue to consult it often for its practical guidance, and it remains a book of reference for me.\" \u003cb\u003e--Carlos Rodriquez-Galindo, MD, Professor of Pediatrics, Harvard Medical School, Director Solid Tumor Program and Medical Director Pediatric Oncology Clinical Trials, Dana-Farber Cancer Institute, Boston, MA, USA\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The sixth edition of the Manual of Pediatric Hematology and Oncology has now been retitled Lanzkowsky’s Manual of Pediatric Hematology and Oncology in recognition of the contribution of the original editor and guiding author for over 35 years. Like all the previous editions, this edition is a highly valuable resource providing the most up-to-date information in an accessible form focusing on practical clinical information. It is a \"must consult\" book for all clinicians in the field. The new chapters on transfusion medicine and diagnostic, molecular, and genomic methodologies are excellent additions reflecting recent progress in these areas. This edition has been enhanced by 51 highly regarded contributing authors who are leaders in their respective fields.\" \u003cb\u003e--Kanti Rai MD, Past President, American Society of Hematology, Professor of Medicine and Professor of Molecular Medicine, Hofstra Northwell School of Medicine, Hempstead, NY, USA\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"I have been using Lanzkowsky’s Manual of Pediatric Hematology Oncology since it was first published in 1980. The Manual is a very valuable ready reference, written in a didactic way, filled with excellent algorithms and up-to-date treatment regimens, which are extremely useful to the clinician. I highly recommend it to all students and practitioners of pediatric hematology and oncology as an essential reference book.\" \u003cb\u003e--Cyril Karabus MB, ChB, MMed Paed (UCT), DCH, FRCP (London), FRCP (Edin), Emeritus Associate Professor of Pediatrics, University of Cape Town, Cape Town, South Africa\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003ci\u003e \u003c\/i\u003e\u003cp\u003eLanzkowsky’s Manual of Pediatric Hematology and Oncology, Sixth Edition, is a comprehensive book on patient management, replete with algorithms and flow diagrams on diagnosis and management. Reflecting the considerable advances in the treatment and management of hematologic and oncologic diseases in children, the sixth edition of this successful clinical manual has been entirely updated to incorporate all current treatment protocols, new drugs, and management approaches. Its concise and easy-to-read format will enable readers to make accurate diagnoses and permit them to treat patients without having to reference larger medical textbooks. \u003c\/p\u003e  \u003cp\u003eBased on the new standards of genetic classification and prognostic information that have arisen in the past five years, the sixth edition includes two new chapters (Diagnostic, Molecular, and Genomic Methodologies for the Hematologist, Transfusion Medicine) and several new expanded chapters that were previously sections in consolidated chapters (Myelodysplasia, Myeloid Leukemias, Lymphoid Leukemias, Hemolytic Anemia, and Disorders of Coagulation).\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1. Diagnostic, Molecular and Genomic Methodologies for the Hematologist \/ Oncologist \u003cbr\u003eVijay G. Sankaran\u003cbr\u003e2. Hematologic Manifestations of Systemic Illness\u003cbr\u003eLawrence C. Wolfe\u003cbr\u003e3. Classification and Diagnosis of Anemia in Children\u003cbr\u003eLanzkowsky Philip\u003cbr\u003e4. Lymphadenopathy and Splenomegaly\u003cbr\u003eLanzkowsky Philip\u003cbr\u003e5. Anemia During the Neonatal Period\u003cbr\u003eLanzkowsky Philip\u003cbr\u003e6. Iron-Deficiency Anemia\u003cbr\u003eLanzkowsky Philip\u003cbr\u003e7. Megaloblastic Anemia\u003cbr\u003eLanzkowsky Philip\u003cbr\u003e8. Bone Marrow Failure\u003cbr\u003eJeffrey M. Lipton and Adrianna Vlachos \u003cbr\u003e9. Hemolytic Anemia\u003cbr\u003eLawrence C. Wolfe\u003cbr\u003e10. Red Cell Membrane and Enzyme Defects\u003cbr\u003eLionel Blanc and Lawrence C. Wolfe \u003cbr\u003e11. Hemoglobinopathies\u003cbr\u003eJanet L. Kwiatkowski\u003cbr\u003e12. Polycythemia\u003cbr\u003eJosef T. Prchal and Tsewang Tashi \u003cbr\u003e13. Disorders of White Blood Cells\u003cbr\u003eMary Ann Bonilla and Jill S. Menell \u003cbr\u003e14. Disorders of Platelets\u003cbr\u003eJames B. Bussel\u003cbr\u003e15. Disorders of Coagulation \u003cbr\u003eSuchitra S. Acharya\u003cbr\u003e16. Lymphoproliferative Disorders \u003cbr\u003eDavid T. Teachey\u003cbr\u003e17. Myelodysplasia\u003cbr\u003eCharlotte Niemeyer and M. Tarek Elghetany \u003cbr\u003e18. Lymphoid leukemias\u003cbr\u003eWilliam L. Carroll and Teena Bhatla \u003cbr\u003e19. Myeloid leukemias\u003cbr\u003eArlene Sara Redner and Rachel Markowitz Kessel \u003cbr\u003e20. Histiocytosis Syndromes\u003cbr\u003eRobert J. Arceci\u003cbr\u003e21. Hodgkin Lymphoma\u003cbr\u003eDebra L. Friedman\u003cbr\u003e22. Non-Hodgkin Lymphoma\u003cbr\u003eHoward Weinstein and Mary S. Huang \u003cbr\u003e23. Central Nervous System Malignancies\u003cbr\u003eMark P. Atlas\u003cbr\u003e24. Neuroblastoma\u003cbr\u003eBagatell Rochelle and Julie R. Park \u003cbr\u003e25. Renal Tumors\u003cbr\u003eJeffrey Dome\u003cbr\u003e26. Rhabdomyosarcoma and Other Soft-Tissue Sarcomas\u003cbr\u003eCarolyn Fein Levy and Leonard H. Wexler \u003cbr\u003e27. Malignant Bone Tumors\u003cbr\u003eNoah Federman\u003cbr\u003e28. Retinoblastoma\u003cbr\u003eAnn-Marie Leahey\u003cbr\u003e29. Germ Cell Tumors\u003cbr\u003eThomas A. Olson\u003cbr\u003e30. Hepatic Tumors\u003cbr\u003eThomas A. Olson\u003cbr\u003e31. Hematopoietic Stem Cell Transplantation\u003cbr\u003eIndira Sahdev and Hisham Abdel-Azim \u003cbr\u003e32. Management of Oncological Emergencies\u003cbr\u003eSusan R. Rheingold\u003cbr\u003e33. Supportive Care of Patients with Cancer\u003cbr\u003eJames H. Feusner and Anurag K. Agrawal \u003cbr\u003e34. Evaluation, Investigation and Management of Late Effects\u003cbr\u003eJonathan D. Fish\u003cbr\u003e35. Psychosocial Aspects of Cancer for Children and Their Families\u003cbr\u003eMeg Tippy\u003cbr\u003e36. Transfusion Medicine \u003cbr\u003eNaomi L. C. Luban\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Molecular biology [\u003ca title=\"See our other books on Molecular biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Molecular%20biology%20%5BPSD%5D%22\"\u003ePSD\u003c\/a\u003e], Pharmacology [\u003ca title=\"See our other books on Pharmacology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pharmacology%20%5BMMG%5D%22\"\u003eMMG\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648666980632,"sku":"9780128013687","price":103.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128013687_9cafa026-e82c-4ba4-83d2-141bca7a76ae.jpg?v=1694353051"},{"product_id":"oral-head-and-neck-oncology-and-reconstructive-surgery-hardback-9780323265683","title":"Oral, Head and Neck Oncology and Reconstructive Surgery (Hardback) 9780323265683","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eOral, Head and Neck Oncology and Reconstructive Surgery\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThe only OMS text of its kind on the market!\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eR. Bryan Bell (Author), Peter A. Andersen (Author), Rui P. Fernandes (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323265683, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 25 September 2017\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e968 pages, Approx. 900 illustrations (900 in full color)\u003cbr\u003e27.6 x 21.5 x 4.6 cm, 2.85 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eOral, Head and Neck Oncology and Reconstructive Surgery\u003c\/b\u003e is the first multidisciplinary text to provide readers with a system for managing adult head and neck cancers based upon stage. Using an evidence-based approach to the management and treatment of a wide variety of clinical conditions, the extensive experience of the author and contributors in head and neck surgery and oncology are highlighted throughout the text. This includes computer aided surgical simulation, intraoperative navigation, robotic surgery, endoscopic surgery, microvascular reconstructive surgery, molecular science, and tumor immunology. In addition, high quality photos and illustrations are included, which are easily accessible on mobile devices.\u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eManagement protocols and outcomes assessment\u003c\/li\u003e\u003c\/b\u003e provide clear guidelines for managing problems related to adult head and neck oncology and reconstructive surgery. \u003cli\u003e\n\u003cb\u003eState-of-the art guidance by recognized experts\u003c\/b\u003e details current techniques as well as technological advances in head and neck\/cranio-maxillofacial surgery and oncology.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eEvidence-based content\u003c\/b\u003e details the latest diagnostic and therapeutic options for treating a wide-variety of clinical problems with an emphasis on surgical technique and outcomes.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eMultidisciplinary approach\u003c\/b\u003e reflects best practices in managing head and neck oncology and cranio-maxillofacial surgery.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003e900 highly detailed images \u003c\/b\u003eclearly demonstrate pathologies and procedures.\u003c\/li\u003e \u003cli\u003e\n\u003cb\u003eDesigned for the modern classroom\u003c\/b\u003e which lets you access important information anywhere through mobile tablets and smart phones.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePart 1: Principles\u003c\/b\u003e  1. Epidemiology  2. Cellular and Molecular Pathology 3. Molecular Biology 4. Oncoviruses 5. Diagnostic Imaging 6. Endoscopic Evaluation of the Upper Aerodigestive Tract  7. Virtual Surgical Planning 8. Intraoperative Navigation 9. Management of the Neck 10. Microvascular Surgery 11. Tissue Engineering 12. Maxillofacial Reconstruction and Prosthetic Rehabilitation 13. Radiation Therapy 14. Chemotherapy 15. Immunotherapy 16. Oral\/Dental Oncology 17. Speech Pathology and Rehabilitation\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Site-Specific Multidisciplinary Treatment\u003c\/b\u003e  \u003cb\u003eSection A: Oral Cavity \u003c\/b\u003e18. Early Tongue Cancer 19. Advanced Tongue Cancer 20. Advanced Tongue Cancer (special considerations requiring total glossectomy) 21. Early Floor of Mouth Cancer 22. Advanced Floor of Mouth Cancer 23. Early Oro-mandibular Cancer 24. Advanced Oro-mandibular Cancer 25. Early Buccal Mucosa Cancer 26. Advanced Buccal Mucosa Cancer 27. Early Palatomaxillary Cancer  28. Advanced Palatomaxillary Cancer 29. Advanced Palatomaxillary Cancer (special considerations related to reconstruction) 30. Advanced Palato-Maxillary Cancer (special considerations related to nasal involvement) 31. Lip Cancer\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection B: Pharynx \u003c\/b\u003e32. Early HPV-Related Tonsil Cancer 33. Early HPV-Related Base of Tongue Cancer 34. Advanced HPV-Related Oropharynx Cancer 35. Advanced HPV-Unrelated Pharynx Cancer  36. Soft Palate Cancer\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection C: Larynx\u003c\/b\u003e 37. Early Supraglottic Larynx Cancer 38. Advanced Supraglottic Larynx Cancer 39. Early Glottic Larynx Cancer 40. Advanced Larynx Cancer 41. Subglottic Larynx Cancer\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection D: Other \u003c\/b\u003e42. Major Salivary Gland Cancer 43. Melanoma 44. Aggressive Non-melanoma Skin Cancer  45. Osteoradionecrosis\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Plastic \u0026amp; reconstructive surgery [\u003ca title=\"See our other books on Plastic \u0026amp; reconstructive surgery\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Plastic%20\u0026amp;%20reconstructive%20surgery%20%5BMNP%5D%22\"\u003eMNP\u003c\/a\u003e], Dentistry [\u003ca title=\"See our other books on Dentistry\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Dentistry%20%5BMMD%5D%22\"\u003eMMD\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648681431320,"sku":"9780323265683","price":223.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323265683.jpg?v=1694988899"},{"product_id":"cancer-genomics-from-bench-to-personalized-medicine-hardback-9780123969675","title":"Cancer Genomics; From Bench to Personalized Medicine (Hardback) 9780123969675","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer Genomics\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eFrom Bench to Personalized Medicine\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eGain insight into the technological advances shaping studies, diagnosis and treatment of cancer.\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eGraham Dellaire (Edited by), Jason N Berman (Edited by), Robert J. Arceci (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780123969675, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 15 January 2014\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e510 pages\u003cbr\u003e27.6 x 21.5 x 3 cm, 1.61 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"…provides a snapshot of the current issues and state-of-the-art technologies used in cancer genomics. Subsequent chapters highlight how these approaches have informed our understanding of hereditary cancer syndromes and the diagnosis, treatment and outcome in a variety of adult and pediatric solid tumors and hematologic malignancies.\" --\u003cb\u003eAnticancer Research 34, 2014\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eCancer Genomics\u003c\/i\u003e addresses how recent technological advances in genomics are shaping how we diagnose and treat cancer. Built on the historical context of cancer genetics over the past 30 years, the book provides a snapshot of the current issues and state-of-the-art technologies used in cancer genomics. Subsequent chapters highlight how these approaches have informed our understanding of hereditary cancer syndromes and the diagnosis, treatment and outcome in a variety of adult and pediatric solid tumors and hematologic malignancies. The dramatic increase in cancer genomics research and ever-increasing availability of genomic testing are not without significant ethical issues, which are addressed in the context of the return of research results and the legal considerations underlying the commercialization of genomic discoveries. Finally, the book concludes with \"Future Directions\", examining the next great challenges to face the field of cancer genomics, namely the contribution of non-coding RNAs to disease pathogenesis and the interaction of the human genome with the environment. \u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eIntroduction 1. Historical Overview\u003c\/p\u003e \u003cp\u003eMethodological Approaches and Background 2. Expression Arrays (SNPs, etc.) 3. Tissue micro-arrays (breast, ovarian)  4. Next generation sequencing (DNAseq)  5. RNAseq (breast cancer, sarcomas) 6. Epigenetic Analyses 7. Pharmcogenomics 8. Biomarker discovery through genomics  9. Preclinical models for genomics (cell culture, transgenic animals, xenografts)  10. Bioinformatics and computational methods for data analysis 11. Genomic Resource Projects – The Cancer Genome Atlas (TCGA) International Cancer Genome Consortium (ICGC)\u003c\/p\u003e \u003cp\u003eEthics of Genomics Research   12. Ethics of Genomics Research  \u003c\/p\u003e \u003cp\u003eThe Genomics, Epigenomics and Transcriptomics of Cancer 13. Somatic mutations, Transcription and Epigenetics Overview\u003c\/p\u003e \u003cp\u003eAdult Solid Tumors 14. Lung Cancer 15. Breast Cancer 16. Prostate Cancer 17. Colon Cancer 18. Thyroid Cancer\u003c\/p\u003e \u003cp\u003eAge Non-specific Tumors and Hematopoietic Malignancies 19. ALL  20. AML 21. NHL 22. Multiple Myeloma 23. Brain Tumors\u003c\/p\u003e \u003cp\u003ePediatric Cancers 24. Neuroblastoma 25. Soft tissue sarcomas 26. Osteosarcoma 27. Wilms Tumors\u003c\/p\u003e \u003cp\u003eGermline Mutations and Hereditary Cancer Syndromes  28. Germline Mutations and Hereditary Cancer Syndromes\u003c\/p\u003e \u003cp\u003eFuture Directions 29. The role of microRNAs and ultraconserved non-coding RNAs in cancer 30. Environmental impact on cancer genomics \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: DNA \u0026amp; Genome [\u003ca title=\"See our other books on DNA \u0026amp; Genome\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22DNA%20\u0026amp;%20Genome%20%5BPSAK1%5D%22\"\u003ePSAK1\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Medical genetics [\u003ca title=\"See our other books on Medical genetics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medical%20genetics%20%5BMFN%5D%22\"\u003eMFN\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648683069720,"sku":"9780123969675","price":100.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780123969675.jpg?v=1694093308"},{"product_id":"diagnostic-pathology-familial-cancer-syndromes-hardback-9780323712040","title":"Diagnostic Pathology: Familial Cancer Syndromes (Hardback) 9780323712040","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDiagnostic Pathology: Familial Cancer Syndromes\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThe latest findings in recognizing and treating genetic cancer syndromes\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eVania Nosé (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323712040, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 26 March 2020\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e896 pages, \u003cp\u003eApprox. 2200 full-color illustrations\u003c\/p\u003e\n\u003cbr\u003e27.6 x 21.6 x 4.4 cm, 2.72 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"This book, written by world renowned experts in the field, is user-friendly in its well-organized presentation of cancer syndromes grouped by organ systems and serves as a rapid and efficient assistant in the recognition, diagnosis, reporting, and management of these diseases. I highly recommend this book to anyone who diagnoses or treats patients with familial cancer syndromes.\"\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e-Laura Baugh, D.O., Ph.D. (University of Michigan Medical School) \u003cb\u003eDoody's Review Score: 95-4 Stars!\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eThis expert volume in the \u003ci\u003eDiagnostic Pathology \u003c\/i\u003eseries is an \u003cb\u003eexcellent point-of-care resource for practitioners at all levels of experience and training\u003c\/b\u003e. Physicians should have the knowledge derived from morphological findings to identify the likelihood of a cancer patient having an additional underlying familial syndrome— and to decide if that patient should undergo molecular genetic evaluation. This volume is specifically designed to help pathologists, oncologists, and other physicians who diagnose and treat cancer to recognize syndromes and syndrome- associated neoplasms and advise patients and their families on the possibility of a familial syndrome and their risk of developing other tumors. \u003ci\u003eDiagnostic Pathology: Familial Cancer Syndromes\u003c\/i\u003e, second edition, is \u003cb\u003ean easy-to-use, one-stop reference for information on hereditary cancer syndromes\u003c\/b\u003e, including differential diagnosis and management, that offers a \u003cb\u003etemplated, highly formatted design; concise, bulleted text; and\u003c\/b\u003e \u003cb\u003esuperior color images throughout.\u003c\/b\u003e\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eContains \u003cb\u003eall the information necessary \u003c\/b\u003eto determine whether a neoplasm typically encountered in daily practice is sporadic or related to a familial cancer syndrome\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures a revised structure to keep you up to date: Part I includes more than \u003cb\u003e80 detailed chapters describing diagnoses \u003c\/b\u003eassociated with familial cancer syndromes; Part II contains more than \u003cb\u003e70 chapters with detailed descriptions of major syndromes \u003c\/b\u003e(cross-referenced with diagnoses); and Part III features a \u003cb\u003emolecular factors index \u003c\/b\u003ethat includes a complete description of each known gene associated with a familial cancer syndrome\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eContains \u003cb\u003eupdated chapters \u003c\/b\u003ewith newly classified GI, neurology, multiple organ, eye, endocrine, GYN, and kidney tumors, as well as \u003cb\u003emore than 20 entirely new chapters \u003c\/b\u003ecovering recently recognized syndromes\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncorporates up-to-date \u003cb\u003emolecular findings \u003c\/b\u003eand their significance for familial cancer syndromes; \u003cb\u003enew techniques and technologies \u003c\/b\u003ebeing used to discover gene mutations and other alterations; and details on \u003cb\u003epersonalized medicine \u003c\/b\u003etargeted to specific genes\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003emore than 2,200 images throughout\u003c\/b\u003e, including clinical and radiological images, algorithms, graphics, gross pathology, histology, and a wide range of special and immunohistochemical stains—all carefully annotated to highlight the most diagnostically significant factors\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003etime-saving bulleted text\u003c\/b\u003e, \u003cb\u003ekey facts \u003c\/b\u003ein each chapter, an \u003cb\u003eextensive \u003c\/b\u003eindex, and \u003cb\u003enumerous tables \u003c\/b\u003efor quick reference and thorough understanding\u003c\/li\u003e \u003cb\u003e \u003cli\u003eIncludes the enhanced eBook version\u003c\/li\u003e\u003c\/b\u003e, which allows you to search all text, figures, and references on a variety of devices\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eI. Diagnosis Associated With Syndromes by Organ \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eBreast \u003c\/p\u003e \u003cp\u003eBreast Carcinoma, Female \u003c\/p\u003e \u003cp\u003eBreast Carcinoma, Male \u003c\/p\u003e \u003cp\u003eBreast Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eBlood and Bone Marrow \u003c\/p\u003e \u003cp\u003eAcute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma \u003c\/p\u003e \u003cp\u003eAcute Myeloid Leukemia and Myelodysplastic Syndrome \u003c\/p\u003e \u003cp\u003eBlood and Bone Marrow Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eBone and Soft Tissue \u003c\/p\u003e \u003cp\u003eChondrosarcoma \u003c\/p\u003e \u003cp\u003eChordoma \u003c\/p\u003e \u003cp\u003eMalignant Peripheral Nerve Sheath Tumor \u003c\/p\u003e \u003cp\u003eOsteosarcoma \u003c\/p\u003e \u003cp\u003eRhabdomyosarcoma \u003c\/p\u003e \u003cp\u003eSchwannoma \u003c\/p\u003e \u003cp\u003eBone and Soft Tissue Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eHead and Neck \u003c\/p\u003e \u003cp\u003eEndolymphatic Sac Tumor \u003c\/p\u003e \u003cp\u003eSquamous Cell Carcinoma \u003c\/p\u003e \u003cp\u003eHead and Neck Table \u003c\/p\u003e \u003cp\u003eSalivary Glands Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eEndocrine \u003c\/p\u003e \u003cp\u003eAdrenal Cortex \u003c\/p\u003e \u003cp\u003eAdrenal Cortical Adenoma \u003c\/p\u003e \u003cp\u003eAdrenal Cortical Carcinoma \u003c\/p\u003e \u003cp\u003eAdrenal Cortical Neoplasms in Children \u003c\/p\u003e \u003cp\u003ePrimary Pigmented Nodular Adrenocortical Disease \u003c\/p\u003e \u003cp\u003eAdrenal Cortex Table \u003c\/p\u003e \u003cp\u003eAdrenal Medulla and Paraganglia \u003c\/p\u003e \u003cp\u003eAdrenal Medullary Hyperplasia \u003c\/p\u003e \u003cp\u003eNeuroblastoma \u003c\/p\u003e \u003cp\u003ePheochromocytoma and Paraganglioma \u003c\/p\u003e \u003cp\u003eAdrenal Medulla and Paraganglia Table \u003c\/p\u003e \u003cp\u003ePancreas \u003c\/p\u003e \u003cp\u003ePancreatic Neuroendocrine Neoplasms \u003c\/p\u003e \u003cp\u003ePancreas Table \u003c\/p\u003e \u003cp\u003eParathyroid \u003c\/p\u003e \u003cp\u003eParathyroid Adenoma \u003c\/p\u003e \u003cp\u003eParathyroid Carcinoma \u003c\/p\u003e \u003cp\u003eParathyroid Hyperplasia \u003c\/p\u003e \u003cp\u003eParathyroid Table \u003c\/p\u003e \u003cp\u003ePituitary \u003c\/p\u003e \u003cp\u003ePituitary Adenoma \u003c\/p\u003e \u003cp\u003ePituitary Hyperplasia \u003c\/p\u003e \u003cp\u003ePituitary Table \u003c\/p\u003e \u003cp\u003eThyroid, Medullary \u003c\/p\u003e \u003cp\u003eC-Cell Hyperplasia \u003c\/p\u003e \u003cp\u003eMedullary Thyroid Carcinoma \u003c\/p\u003e \u003cp\u003eThyroid, Medullary Table \u003c\/p\u003e \u003cp\u003eThyroid, Nonmedullary \u003c\/p\u003e \u003cp\u003eFamilial Thyroid Carcinoma \u003c\/p\u003e \u003cp\u003eFollicular Thyroid Carcinoma \u003c\/p\u003e \u003cp\u003eThyroid, Nonmedullary Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eGastrointestinal \u003c\/p\u003e \u003cp\u003eTubular Gut \u003c\/p\u003e \u003cp\u003eColon Adenoma \u003c\/p\u003e \u003cp\u003eEsophageal Adenocarcinoma \u003c\/p\u003e \u003cp\u003eEsophageal Squamous Cell Carcinoma \u003c\/p\u003e \u003cp\u003eGastric Adenocarcinoma \u003c\/p\u003e \u003cp\u003eGastrointestinal Stromal Tumor \u003c\/p\u003e \u003cp\u003eHamartomatous Polyps of GI Tract \u003c\/p\u003e \u003cp\u003eSmall Bowel Adenocarcinoma \u003c\/p\u003e \u003cp\u003eColon\/Rectum Table \u003c\/p\u003e \u003cp\u003eEsophagus\/Stomach\/Small Bowel Table \u003c\/p\u003e \u003cp\u003eTubular Gut Table \u003c\/p\u003e \u003cp\u003eHepatobiliary and Pancreas \u003c\/p\u003e \u003cp\u003eBiliary Tract Neoplasia \u003c\/p\u003e \u003cp\u003eHepatoblastoma \u003c\/p\u003e \u003cp\u003eHepatocellular Carcinoma \u003c\/p\u003e \u003cp\u003ePancreatic Adenocarcinoma \u003c\/p\u003e \u003cp\u003eBiliary Tract\/Liver\/Pancreas Table \u003c\/p\u003e \u003cp\u003eHepatobiliary and Pancreas Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eGenitourinary \u003c\/p\u003e \u003cp\u003eBladder \u003c\/p\u003e \u003cp\u003eBladder Table \u003c\/p\u003e \u003cp\u003eKidney \u003c\/p\u003e \u003cp\u003eAngiomyolipoma \u003c\/p\u003e \u003cp\u003eClear Cell Renal Cell Carcinoma \u003c\/p\u003e \u003cp\u003eHLRCC Syndrome-Associated Renal Cell Carcinoma \u003c\/p\u003e \u003cp\u003ePapillary Renal Cell Carcinoma \u003c\/p\u003e \u003cp\u003eRenal Oncocytoma, Chromophobe, and Hybrid Tumors \u003c\/p\u003e \u003cp\u003eWilms Tumor \u003c\/p\u003e \u003cp\u003eKidney Table \u003c\/p\u003e \u003cp\u003eProstate \u003c\/p\u003e \u003cp\u003eProstate Table \u003c\/p\u003e \u003cp\u003eRenal Pelvis and Ureter \u003c\/p\u003e \u003cp\u003eRenal Pelvis and Ureter Table \u003c\/p\u003e \u003cp\u003eTesticle \u003c\/p\u003e \u003cp\u003eGerm Cell Tumor \u003c\/p\u003e \u003cp\u003eSertoli Cell Neoplasms \u003c\/p\u003e \u003cp\u003eTesticle Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eGynecology \u003c\/p\u003e \u003cp\u003eCervical Tumors \u003c\/p\u003e \u003cp\u003eFallopian Tube Tumors \u003c\/p\u003e \u003cp\u003eOvarian Tumors \u003c\/p\u003e \u003cp\u003eUterine Tumors \u003c\/p\u003e \u003cp\u003eCervix \u003c\/p\u003e \u003cp\u003eEndometrium \u003c\/p\u003e \u003cp\u003eFallopian Tube \u003c\/p\u003e \u003cp\u003eOvary \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eNervous System \u003c\/p\u003e \u003cp\u003eCentral Nervous System \u003c\/p\u003e \u003cp\u003eEye \u003c\/p\u003e \u003cp\u003ePeripheral Nervous System \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003ePulmonary \u003c\/p\u003e \u003cp\u003eAdenocarcinoma, Lung \u003c\/p\u003e \u003cp\u003eAdenocarcinoma With Lepidic (Bronchioloalveolar) Predominant Pattern \u003c\/p\u003e \u003cp\u003eLymphangioleiomyomatosis \u003c\/p\u003e \u003cp\u003eNeuroendocrine Carcinoma, Lung \u003c\/p\u003e \u003cp\u003ePleuropulmonary Blastoma \u003c\/p\u003e \u003cp\u003eLung Table \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSkin \u003c\/p\u003e \u003cp\u003eBAP1-Inactivated Melanocytic Tumor \u003c\/p\u003e \u003cp\u003eBasal Cell Carcinoma \u003c\/p\u003e \u003cp\u003eCutaneous Melanoma \u003c\/p\u003e \u003cp\u003eCutaneous Squamous Cell Carcinoma \u003c\/p\u003e \u003cp\u003eSebaceous Carcinoma \u003c\/p\u003e \u003cp\u003eSkin Table\u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003eII. Overview of Syndromes \u003c\/p\u003e \u003cp\u003eIntroduction \u003c\/p\u003e \u003cp\u003ePathology of Familial Tumor Syndromes \u003c\/p\u003e \u003cp\u003eClinical Diagnosis and Management of Familial\/Hereditary Tumor Syndromes \u003c\/p\u003e \u003cp\u003eMolecular Aspects of Familial\/Hereditary Tumor Syndromes \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eSyndromes \u003c\/p\u003e \u003cp\u003eAtaxia Telangiectasia \u003c\/p\u003e \u003cp\u003eBAP1 Tumor Predisposition Syndrome \u003c\/p\u003e \u003cp\u003eBasal Cell Nevus Syndrome\/Gorlin Syndrome \u003c\/p\u003e \u003cp\u003eBeckwith-Wiedemann Syndrome \u003c\/p\u003e \u003cp\u003eBirt-Hogg-Dubé Syndrome \u003c\/p\u003e \u003cp\u003eBloom Syndrome \u003c\/p\u003e \u003cp\u003eBrooke-Spiegler Syndrome \u003c\/p\u003e \u003cp\u003eCarney Complex \u003c\/p\u003e \u003cp\u003eCostello Syndrome \u003c\/p\u003e \u003cp\u003eCystic Nephroma Syndrome \u003c\/p\u003e \u003cp\u003eDenys-Drash Syndrome \u003c\/p\u003e \u003cp\u003eDiamond-Blackfan Anemia \u003c\/p\u003e \u003cp\u003eDICER1 Syndrome \u003c\/p\u003e \u003cp\u003eDown Syndrome \u003c\/p\u003e \u003cp\u003eDyskeratosis Congenita \u003c\/p\u003e \u003cp\u003eFamilial Acute Myeloid Leukemia and Myelodysplastic Syndrome \u003c\/p\u003e \u003cp\u003eFamilial Adenomatous Polyposis \u003c\/p\u003e \u003cp\u003eFamilial Chordoma \u003c\/p\u003e \u003cp\u003eFamilial Gastrointestinal Stromal Tumor \u003c\/p\u003e \u003cp\u003eFamilial Infantile Myofibromatosis \u003c\/p\u003e \u003cp\u003eFamilial Isolated Hyperparathyroidism \u003c\/p\u003e \u003cp\u003eFamilial Medullary Thyroid Carcinoma \u003c\/p\u003e \u003cp\u003eFamilial Nonmedullary Thyroid Carcinoma \u003c\/p\u003e \u003cp\u003eFamilial Paraganglioma-Pheochromocytoma Syndrome \u003c\/p\u003e \u003cp\u003eFamilial Testicular Tumor \u003c\/p\u003e \u003cp\u003eFamilial Uveal Melanoma \u003c\/p\u003e \u003cp\u003eFamilial Wilms Tumor \u003c\/p\u003e \u003cp\u003eFanconi Anemia \u003c\/p\u003e \u003cp\u003eGATA2 Spectrum Disorders \u003c\/p\u003e \u003cp\u003eGlucagon Cell Hyperplasia and Neoplasia \u003c\/p\u003e \u003cp\u003eHereditary Breast\/Ovarian Cancer Syndrome: BRCA1 \u003c\/p\u003e \u003cp\u003eHereditary Breast\/Ovarian Cancer Syndrome: BRCA2 \u003c\/p\u003e \u003cp\u003eHereditary Diffuse Gastric Cancer \u003c\/p\u003e \u003cp\u003eHereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC) \u003c\/p\u003e \u003cp\u003eHereditary Multiple Exostosis \u003c\/p\u003e \u003cp\u003eHereditary Neuroblastoma \u003c\/p\u003e \u003cp\u003eHereditary Pancreatic Cancer Syndrome \u003c\/p\u003e \u003cp\u003eHereditary Papillary Renal Cell Carcinoma \u003c\/p\u003e \u003cp\u003eHereditary Paraganglioma\/Pheochromocytoma Syndromes \u003c\/p\u003e \u003cp\u003eHereditary Prostate Cancer \u003c\/p\u003e \u003cp\u003eHereditary Renal Epithelial Tumors, Others \u003c\/p\u003e \u003cp\u003eHereditary Retinoblastoma \u003c\/p\u003e \u003cp\u003eHereditary SWI\/SNF Complex Deficiency Syndromes \u003c\/p\u003e \u003cp\u003eHeritable Gastrointestinal Stromal Tumors Syndromes \u003c\/p\u003e \u003cp\u003eHowel-Evans Syndrome\/Keratosis Palmares and Plantares With Esophageal Cancer \u003c\/p\u003e \u003cp\u003eHyperparathyroidism-Jaw Tumor Syndrome \u003c\/p\u003e \u003cp\u003eJuvenile Polyposis Syndrome \u003c\/p\u003e \u003cp\u003eLi-Fraumeni Syndrome\/Li-Fraumeni-Like Syndrome \u003c\/p\u003e \u003cp\u003eLynch Syndrome \u003c\/p\u003e \u003cp\u003eMcCune-Albright Syndrome \u003c\/p\u003e \u003cp\u003eMelanoma\/Pancreatic Carcinoma Syndrome \u003c\/p\u003e \u003cp\u003eMultiple Endocrine Neoplasia Type 1 (MEN1) \u003c\/p\u003e \u003cp\u003eMultiple Endocrine Neoplasia Type 2 (MEN2) \u003c\/p\u003e \u003cp\u003eMultiple Endocrine Neoplasia Type 4 (MEN4) \u003c\/p\u003e \u003cp\u003eMYH-Associated Polyposis \u003c\/p\u003e \u003cp\u003eNeurofibromatosis Type 1 \u003c\/p\u003e \u003cp\u003eNeurofibromatosis Type 2 \u003c\/p\u003e \u003cp\u003eNijmegen Breakage Syndrome \u003c\/p\u003e \u003cp\u003ePancreatic Neuroendocrine Tumor Syndromes \u003c\/p\u003e \u003cp\u003e*PDGFRA*-Mutant Syndrome \u003c\/p\u003e \u003cp\u003ePeutz-Jeghers Syndrome \u003c\/p\u003e \u003cp\u003ePTEN Hamartoma Tumor Syndromes \u003c\/p\u003e \u003cp\u003eRASopathies: Noonan Syndrome \u003c\/p\u003e \u003cp\u003eRhabdoid Predisposition Syndrome \u003c\/p\u003e \u003cp\u003eSchwannomatosis \u003c\/p\u003e \u003cp\u003eShwachman-Diamond Syndrome \u003c\/p\u003e \u003cp\u003eSteatocystoma Multiplex \u003c\/p\u003e \u003cp\u003eSuccinate Dehydrogenase (SDH)-Deficient Renal Cell Carcinoma \u003c\/p\u003e \u003cp\u003eTuberous Sclerosis Complex \u003c\/p\u003e \u003cp\u003eTumor Syndromes Predisposing to Osteosarcoma \u003c\/p\u003e \u003cp\u003evon Hippel-Lindau Syndrome \u003c\/p\u003e \u003cp\u003eWerner Syndrome\/Progeria \u003c\/p\u003e \u003cp\u003eWilms Tumor-Associated Syndrome \u003c\/p\u003e \u003cp\u003eWiskott-Aldrich Syndrome \u003c\/p\u003e \u003cp\u003eXeroderma Pigmentosum \u003c\/p\u003e\n\u003cb\u003e \u003c\/b\u003e\u003cp\u003eReference \u003c\/p\u003e \u003cp\u003eMolecular Factors \u003c\/p\u003e \u003cp\u003eMolecular Factors Index \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Histopathology [\u003ca title=\"See our other books on Histopathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Histopathology%20%5BMMFH%5D%22\"\u003eMMFH\u003c\/a\u003e], Pathology [\u003ca title=\"See our other books on Pathology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pathology%20%5BMMF%5D%22\"\u003eMMF\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648684216600,"sku":"9780323712040","price":175.27,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323712040_92495844-32db-4006-946e-f5c7b8798609.jpg?v=1694990140"},{"product_id":"oncologic-imaging-a-multidisciplinary-approach-hardback-9780323695381","title":"Oncologic Imaging: A Multidisciplinary Approach (Hardback) 9780323695381","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eOncologic Imaging: A Multidisciplinary Approach\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eConsult with more than 100 experts from MD Anderson Cancer Center on every aspect of cancer imaging\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003ePaul M. Silverman (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323695381, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 9 March 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e760 pages, Approx. 1000 illustrations\u003cbr\u003e27.6 x 21.6 x 3.9 cm, 2.27 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eComprehensive, authoritative, and up to date, Oncologic Imaging: A Multidisciplinary Approach, 2nd Edition, covers every aspect of radiographic imaging for the diagnosis, treatment, and management of the cancer patient. Dr. Paul M. Silverman and an expert author team from MD Anderson Cancer Center provide all the current, practical information available, while incorporating their unique experience based upon extensive, daily clinical care of patients with cancer. In one convenient volume, this definitive, one-of-a-kind text discusses new diagnostic imaging and surgical approaches as well as therapeutic cutting-edge treatments from radiation and medical oncology, focusing on best practices and the newest standards for personalized medicine.\u003cul\u003e \u003cli\u003e  \u003cp\u003eBrings together a unique multidisciplinary team of authors including clinical radiologists, medical oncologists, radiation oncologists, and surgical oncologists who reflect team-based practice. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eFeatures an all-new chapter on head and neck imaging, authored by world experts in this complex area. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eContains extensive updates throughout, including transformational state-of-the-art imaging modalities such as PET\/CT, and the full range of traditional modalities, including multidetector CT (MDCT), ultrasound, and MR in conjunction with the latest advances in genetics, molecular oncology, and targeted therapies. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eDistills practical, up-to-date information into a concise and consistent format with key point summaries, algorithms, clear drawings, and full-color staging diagrams. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eIncludes emerging options for care based on practice recommendations and evidence in the literature. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eProvides updated tumor staging information based on the AJCC Classification of Malignant Tumors, 8th edition. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eHighlights the text with 1,000 high-quality radiographic images: CT, MR, hybrid imaging (PET\/CT, PET\/MR), mammography, and ultrasound, as well as clear line anatomic drawings, graphs, and algorithms. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1       A Multidisciplinary Approach to Cancer: A Radiologist's View\u003cbr\u003e2       A Multidisciplinary Approach to Cancer: A Surgeon's View\u003cbr\u003e3       A Multidisciplinary Approach to Cancer: A Medical Oncologist's View\u003cbr\u003e4       A Multidisciplinary Approach to Cancer: A Radiation Oncologist's View\u003cbr\u003e5       Assessing Response to Therapy\u003cbr\u003e6       Head and Neck Cancer\u003cbr\u003e7       Lung Cancer\u003cbr\u003e8       Primary Mediastinal Neoplasms\u003cbr\u003e9       Pleural Tumors\u003cbr\u003e10     Liver Cancer: Hepatocellular and Fibrolamellar Carcinoma\u003cbr\u003e11     Cholangiocarcinoma\u003cbr\u003e12     Pancreatic Ductal Adenocarcinoma\u003cbr\u003e13     Cystic Pancreatic Lesions\u003cbr\u003e14     Pancreatic Neuroendocrine Tumors\u003cbr\u003e15     Esophageal Cancer\u003cbr\u003e16     Gastric Carcinoma\u003cbr\u003e17     Small Bowel Malignant Tumors\u003cbr\u003e18     Colorectal Cancer\u003cbr\u003e19     Renal Tumors\u003cbr\u003e20     Urothelial Carcinoma (Bladder Cancer and Upper Tracts)\u003cbr\u003e21     Testicular Germ Cell Tumors\u003cbr\u003e22     Primary Adrenal Malignancy\u003cbr\u003e23     Prostate Cancer\u003cbr\u003e24     Primary Retroperitoneal Tumors\u003cbr\u003e25     Tumors of the Uterine Corpus\u003cbr\u003e26     Cervical Cancer\u003cbr\u003e27     Ovarian Cancer\u003cbr\u003e28     Breast Cancer\u003cbr\u003e29     Myeloma and Leukemia\u003cbr\u003e30     Hematologic Malignancy: The Lymphomas\u003cbr\u003e31     Thoracic Metastatic Disease\u003cbr\u003e32     Metastases Abdominal-Pelvic Organs\u003cbr\u003e33     Peritoneal Cavity and Gastrointestinal Tract\u003cbr\u003e34     Bone Metastases\u003cbr\u003e35     Cancer of Unknown Primary\u003cbr\u003e36     Imaging in Thyroid Cancer\u003cbr\u003e37     Melanoma\u003cbr\u003e38     Soft Tissue Sarcomas\u003cbr\u003e39     Interventional Imaging in the Oncologic Patient\u003cbr\u003e40     Complications in the Oncologic Patient: Chest\u003cbr\u003e41     Complications in the Oncologic Patient: Abdomen and Pelvis\u003cbr\u003e42     Pulmonary Embolic Disease and Cardiac Masses and Tumors\u003cbr\u003e43     Protocols for Imaging Studies in the Oncologic Patient\u003cbr\u003e44     Front Matter\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Saunders","offers":[{"title":"Default Title","offer_id":46648686149912,"sku":"9780323695381","price":132.78,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323695381_35c19cb9-e631-4773-a0aa-f08e76f2e576.jpg?v=1694990109"},{"product_id":"cancer-immunotherapy-immune-suppression-and-tumor-growth-hardback-9780123942968","title":"Cancer Immunotherapy; Immune Suppression and Tumor Growth (Hardback) 9780123942968","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer Immunotherapy\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eImmune Suppression and Tumor Growth\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eHighlights emerging new principles of immune suppression that drive cancer and offers radically new ideas about how therapy can be improved by attacking these principles.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eGeorge C. Prendergast (Edited by), Elizabeth M. Jaffee (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780123942968, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 29 July 2013\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e684 pages\u003cbr\u003e27.6 x 21.5 x 3.6 cm, 1.86 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"...an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease.\" --\u003cb\u003eAnticancer Research, January 2015\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"Prendergast… and Jaffee…supply basic, translational, and clinical cancer researchers in immunology, biology, and pharmacology with 34 chapters on immunotherapy in cancer treatments. They address new principles of immune suppression in cancer and recent thinking in how immunotherapeutic and chemotherapeutic agents might be combined to defeat mechanisms of tumoral immune suppression and reprogram the inflammatory microenvironment of tumor cells to enhance long-term outcomes.\" --\u003cb\u003eReference and Research Book News, December 2013\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eThere has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer, and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumor immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers with an indispensable overview of immune escape as a critical trait in cancer and how applying specific combinations of immunotherapy and chemotherapy to attack this trait may radically improve the treatment of advanced disease. \u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003ePart I:  Principles of Cancer Immunobiology\u003c\/b\u003eIntroductionCancer Immunoediting: From Immune Surveillance to Immune EscapeImmunosurveillance: Innate and Adaptive Anti-Tumor ImmunityCytokine Regulation of Immune Tolerance to TumorsImmunological Sculpting: Natural Killer Cell Receptors and LigandsImmune Escape:  Immunosuppressive Networks\u003cb\u003ePart II: Cancer Therapeutics\u003c\/b\u003eCytotoxic Chemotherapy in Clinical Treatment of CancerTargeted Therapeutics in Cancer TreatmentConcepts in Pharmacology and ToxicologyCancer Immunotherapy: Challenges and OpportunitiesCancer Vaccines\u003cb\u003ePart III:  Targets and Tactics to Improve Cancer Immunotherapy By Defeating Immune Suppression\u003c\/b\u003eImmunotherapy and Cancer Therapeutics: Why Partner?Immune Stimulatory Features of Classical ChemotherapyDendritic Cells and Co-Inhibitory MoleculesRegulatory T Cells in Tumor Immunity: Role of Toll-like Receptors Tumor-associated Macrophages in Cancer Growth and ProgressionTumor-associated Myeloid-derived Suppressor CellsProgrammed Death Ligand-1 and Galectin-1: Pieces in the Puzzle of Tumor Immune EscapeIDO in Immune Escape: Regulation and Therapeutic InhibitionArginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune ModulationSummary: Future Questions\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Immunology [\u003ca title=\"See our other books on Immunology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Immunology%20%5BMJCM%5D%22\"\u003eMJCM\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648690442520,"sku":"9780123942968","price":82.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780123942968.jpg?v=1694093361"},{"product_id":"handbook-of-cancer-treatment-related-symptoms-and-toxicities-paperback-9780323672412","title":"Handbook of Cancer Treatment-Related Symptoms and Toxicities (Paperback \/ softback) 9780323672412","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eHandbook of Cancer Treatment-Related Symptoms and Toxicities\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eConcise, targeted coverage of an essential aspect of optimal care for patients with cancer\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eVamsidhar Velcheti (Author), Salman R Punekar (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323672412\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 30 June 2021\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e352 pages\u003cbr\u003e22.9 x 15.2 x 2.3 cm, 0.34 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eEarly recognition and management of adverse effects of cancer treatments are essential for optimal care of patients with cancer, and drastically different approaches are required for different physiologic reactions. Handbook of Cancer Treatment-Related Symptoms and Toxicities is a focused, one-stop resource that enables clinicians to quickly find up-to-date, reliable information needed at the point of care. The high-yield approach prioritizes the most common toxicities associated with cancer treatment, and concise, templated chapters offer fast access to information needed in day-to-day practice.\u003cul\u003e \u003cli\u003ePresents a user-friendly overview of cancer treatment-related symptoms and toxicities management in a practical, easy-to-use format, allowing you to quickly find information in one convenient, concise resource. \u003c\/li\u003e \u003cli\u003eCovers systemic and radiation therapies, including chemotherapy, immunotherapy, targeted therapies, and radiation therapy, detailing symptoms of each toxicity to confirm your diagnosis. \u003c\/li\u003e \u003cli\u003eOverviews pharmacologic and non-pharmacologic approaches to symptom management. \u003c\/li\u003e \u003cli\u003eOffers recommendations for mitigating toxicities in high-risk patients. \u003c\/li\u003e \u003cli\u003eDiscusses key topics such as management of infusion reactions, when the need for biopsy is warranted, and the unique challenges posed by novel immunotherapies. \u003c\/li\u003e \u003cli\u003eEnhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003ePart 1. Cytotoxic Chemotherapy\u003c\/p\u003e \u003cp\u003e1. Mechanism of Chemotherapy in Cancer Treatment\u003c\/p\u003e \u003cp\u003e2. Neutropenic Complications of Chemotherapy\u003c\/p\u003e \u003cp\u003e3. Chemotherapy Induced Anemia\u003c\/p\u003e \u003cp\u003e4. Cancer Treatment Related Thrombocytopenia\u003c\/p\u003e \u003cp\u003e5. Oral Mucositis\u003c\/p\u003e \u003cp\u003e6. Gastrointestinal Complications of Chemotherapy\u003c\/p\u003e \u003cp\u003e7. Neurological Complications\u003c\/p\u003e \u003cp\u003e8. Pulmonary Toxicities of Cytotoxic Chemotherapy\u003c\/p\u003e \u003cp\u003e9. Dermatological Complications of Chemotherapy\u003c\/p\u003e \u003cp\u003e10. Cardiotoxicities of Chemotherapy\u003c\/p\u003e \u003cp\u003e11. Management of Cancer Treatment Infusion Reactions\u003c\/p\u003e \u003cp\u003ePart 2. Targeted Therapies\u003c\/p\u003e \u003cp\u003e12. Mechanism of Targeted Therapies in Cancer Treatment\u003c\/p\u003e \u003cp\u003e13. Gastrointestinal Complications\u003c\/p\u003e \u003cp\u003e14. Pulmonary Toxicities of Molecular Targeted Therapies\u003c\/p\u003e \u003cp\u003e15. Dermatologic Toxicities\u003c\/p\u003e \u003cp\u003e16. Cardiotoxicities\u003c\/p\u003e \u003cp\u003ePart 3. Immunotherapies\u003c\/p\u003e \u003cp\u003e17. Mechanism of Immune-Related Adverse Events\u003c\/p\u003e \u003cp\u003e18. Endocrine Toxicities\u003c\/p\u003e \u003cp\u003e19. Gastrointestinal Toxicities\u003c\/p\u003e \u003cp\u003e20. Neurological Complications of Immunotherapy\u003c\/p\u003e \u003cp\u003e21. Pulmonary Toxicities\u003c\/p\u003e \u003cp\u003e22. Dermatological Complications\u003c\/p\u003e \u003cp\u003e23. Immunotherapy-Induced Cardiotoxicities\u003c\/p\u003e \u003cp\u003e24. Rheumatological Complications\u003c\/p\u003e \u003cp\u003ePart 4. Radiation Therapy\u003c\/p\u003e \u003cp\u003e25. Mechanisms of Radiation-Related Toxicities\u003c\/p\u003e \u003cp\u003e26. Radiation-Induced Mucositis and Esophagitis\u003c\/p\u003e \u003cp\u003e27. Radiation Therapy Related Dermatologic Toxicities\u003c\/p\u003e \u003cp\u003e28. Pulmonary Toxicity from Radiation Therapy\u003c\/p\u003e \u003cp\u003e29. Radiation-Induced Cardiotoxicities\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648691949848,"sku":"9780323672412","price":62.39,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323672412_e529a056-5d80-4bf2-9739-eb1a0d0479bb.jpg?v=1694990052"},{"product_id":"the-human-body-linking-structure-and-function-paperback-9780128042540","title":"The Human Body; Linking Structure and Function (Paperback) 9780128042540","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eThe Human Body\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eLinking Structure and Function\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eA comprehensive volume covering the assemblage and operation of the human body and its function\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eBruce M. Carlson (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128042540, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 26 October 2018\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e436 pages\u003cbr\u003e27.6 x 21.5 x 2.7 cm, 1.2 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eThe Human Body: Linking Structure and Function\u003c\/i\u003e provides knowledge on the human body's unique structure and how it works. Each chapter is designed to be easily understood, making the reading interesting and approachable. Organized by organ system, this succinct publication presents the functional relevance of developmental studies and integrates anatomical function with structure.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. Cells – Fundamental Units of Life2. Tissues – Cells Working Together3. Skin4. The Skeleton5. The Muscular System6. The Nervous System7. Special Senses – Vision and Hearing8. The Lymphoid System and Immunity9. The Endocrine System10. The Circulatory System11. The Respiratory System12. The Digestive System13. The Urinary System14. The Reproductive System\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Cellular biology [\u003ca title=\"See our other books on Cellular biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Cellular%20biology%20%5Bcytology%5D%20%5BPSF%5D%22\"\u003ecytology PSF\u003c\/a\u003e], Molecular biology [\u003ca title=\"See our other books on Molecular biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Molecular%20biology%20%5BPSD%5D%22\"\u003ePSD\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Clinical \u0026amp; internal medicine [\u003ca title=\"See our other books on Clinical \u0026amp; internal medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Clinical%20\u0026amp;%20internal%20medicine%20%5BMJ%5D%22\"\u003eMJ\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648712200472,"sku":"9780128042540","price":81.59,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128042540.jpg?v=1694093502"},{"product_id":"proton-therapy-indications-techniques-and-outcomes-hardback-9780323733496","title":"Proton Therapy; Indications, Techniques and Outcomes (Hardback) 9780323733496","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eProton Therapy\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eIndications, Techniques and Outcomes\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eExpert knowledge and guidance in proton therapy from the global leader in the field\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eSteven J Frank (Author), X. Ronald Zhu (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323733496\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 6 July 2020\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e272 pages\u003cbr\u003e22.9 x 15.1 x 2.2 cm, 0.54 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003e\"The book will be very useful to its intended audience: current and potential users of proton therapy.\"\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e-Neil Kanth Taunk, MD, MS (University of Pennsylvania School of Medicine) \u003cb\u003eDoody's Review Service\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eAs proton therapy treatment centers become smaller and more cost-effective, education and training for today’s multi-disciplinary oncology teams are more important than ever before. This state-of-the-art reference \u003cb\u003ebrings you fully up to date with all aspects of proton therapy\u003c\/b\u003e, with \u003cb\u003eguidance you can trust from MD Anderson Cancer Center\u003c\/b\u003e, the largest and most experienced proton therapy center in the world. Led by Drs. Steven J. Frank and X. Ronald Zhu, \u003ci\u003eProton Therapy\u003c\/i\u003e provides a unique opportunity to benefit from the unsurpassed knowledge and expertise of an esteemed team of leaders in the field\u003ci\u003e.\u003c\/i\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cb\u003e \u003cli\u003eCovers all cancers for which proton therapy is used most often\u003c\/li\u003e\u003c\/b\u003e, including prostate, head and neck, pediatrics, central nervous system, gastrointestinal, sarcomas, lungs, breast, lymphomas, and gynecologic cancers.  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eProvides \u003cb\u003eup-to-date information\u003c\/b\u003e on radiobiology, treatment planning and quality assurance, indications for proton therapy, management approaches, and outcomes after proton therapy by disease site.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDiscusses \u003cb\u003etechnologic advances\u003c\/b\u003e such as spot scanning and treatment planning systems for the management of solid tumors; radiobiology of proton therapy, including DNA damage and repair mechanisms and acute and late effects on normal tissues; and multifield optimized intensity-modulated proton therapy (MFO-IMPT) for optimizing the distribution of linear energy transfer (LET) of proton beams within target volumes and away from critical normal structures.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes a \u003cb\u003especial section on head and neck cases\u003c\/b\u003e in the e-book that photographically illustrates the full cycle of proton therapy care.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eEnhanced\u003c\/li\u003e\u003c\/b\u003e \u003cb\u003eeBook version included with purchase. \u003c\/b\u003eYour enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cb\u003eSECTION 1:  INTRODUCTION\u003cbr\u003e\u003c\/b\u003e1. Principles of Radiobiology\u003cbr\u003e2. Principles of Proton Beam Therapy\u003cbr\u003e\u003cb\u003eSECTION 2:  PHYSICS AND TREATMENT PLANNING\u003c\/b\u003e\u003cbr\u003e3. Clinical Commissioning of Pencil Beam Scanning for Intensity-Modulated Proton Therapy\u003cbr\u003e4. Immobilization and Simulation\u003cbr\u003e5. Principles of Intensity-Modulated Proton Therapy Treatment Planning\u003cbr\u003e6. Physics Quality Assurance\u003cbr\u003e7. Intensity-Modulated Proton Therapy Patient Treatments\u003cbr\u003e\u003cb\u003eSECTION 3:  DISEASE SITES\u003c\/b\u003e\u003cbr\u003e8. Proton Radiotherapy for Breast Cancer\u003cbr\u003e9. Adult Central Nervous System Tumors\u003cbr\u003e10. Gastrointestinal\u003cbr\u003e11. Proton Therapy for Gynecologic Malignancies\u003cbr\u003e12. Proton Therapy for Prostate Cancer\u003cbr\u003e13. Head and Neck\u003cbr\u003e14. Proton Therapy for Hematologic Malignancies\u003cbr\u003e15. Pediatric Considerations for Proton Therapy\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648714985752,"sku":"9780323733496","price":114.37,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323733496_4e5e2f3d-187b-48c6-857b-a0e402f1992d.jpg?v=1694990179"},{"product_id":"hoffman-and-abeloffs-hematology-oncology-review-paperback-9780323429757","title":"Hoffman and Abeloff's Hematology-Oncology Review (Paperback) 9780323429757","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eHoffman and Abeloff's Hematology-Oncology Review\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003ePrepare for hematology and oncology exams with one convenient, reliable resource\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eClaudine Isaacs (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323429757\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 24 November 2017\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e400 pages, 300 illustrations (300 in full color)\u003cbr\u003e27.6 x 21.6 x 2.5 cm, 0.79 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eFor those preparing for \u003cb\u003ecertification or recertification in hematology or oncology\u003c\/b\u003e, \u003ci\u003eHoffman and Abeloff's Hematology-Oncology Review\u003c\/i\u003e is a\u003cb\u003e single-volume source of authoritative, up-to-date exam preparation\u003c\/b\u003e. This unique question and answer review helps you \u003cb\u003esucceed on today’s board exams\u003c\/b\u003e with more than 1,000 board-style questions, answers, and rationales; comprehensive coverage of essential exam topics, and online practice tests.\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eIncludes \u003cb\u003e1,000+ board-style questions\u003c\/b\u003e with answers and rationales explaining both correct and incorrect answers.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eFeatures \u003cb\u003ethree online practice tests per specialty that follow the ABIM exams blueprint\u003c\/b\u003e, ensuring that complex content is delivered in easily digestible segments for more efficient review.\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers a broad range of topics compiled by experts in hematology and oncology, including cancer biology and genomics, immunotherapy, hematologic malignancies, solid tumor malignancies, non-malignant hematology, and supportive care.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eUniquely designed as both a\u003cb\u003e standalone review and a study companion\u003c\/b\u003e to \u003ci\u003eAbeloff’s Clinical Oncology\u003c\/i\u003e and \u003ci\u003eHematology: Basic Principles and Practice\u003c\/i\u003e.\u003c\/li\u003e \u003cb\u003e  \u003c\/b\u003e\u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eExpert Consult™ eBook version included with purchase. This \u003cb\u003eenhanced eBook experience\u003c\/b\u003e allows you to search all of the text, figures, and references from the book on a variety of devices.\u003c\/li\u003e \u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eIsaacs: Hoffman and Abeloff's Hematology-Oncology Review\u003c\/p\u003e  \u003ci\u003e \u003c\/i\u003e\u003cp\u003e1. Cancer biology and Genomics\u003c\/p\u003e \u003cp\u003e2. Tumor Immunology\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e \u003cp\u003e3. Anti-Cancer Therapies \u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e SECTION 1: Chemotherapy\u003c\/p\u003e \u003cp\u003eSECTION 2: Immunotherapy, antibodies, vaccines and pathway inhibitors\u003c\/p\u003e \u003cp\u003e4. Clinical Trial Design and Ethics\u003c\/p\u003e \u003cp\u003e5. Hereditary Cancer Syndromes\u003c\/p\u003e\n\u003cb\u003e\u003cu\u003e \u003c\/u\u003e\u003c\/b\u003e\u003cp\u003eHEMATOLOGIC MALIGNANCIES\u003c\/p\u003e \u003cp\u003e6. Acute Myeloid Leukemia and Myelodysplastic Syndrome\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7. Myeloproliferative Disorders\u003c\/p\u003e \u003cp\u003e8. Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and other Chronic Lymphoproliferative Disorders\u003c\/p\u003e \u003cp\u003e9: Hodgkin lymphoma\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10. Non-Hodgkin Lymphoma\u003c\/p\u003e \u003cp\u003e11. Multiple myeloma and other plasma cell dyscrasias\u003c\/p\u003e \u003cp\u003e12. T cell and NK cell neoplasms and other lymphoid malignancies\u003c\/p\u003e \u003cp\u003e13. Hematopoeietic Cell Transplantation\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cb\u003e\u003cu\u003e \u003c\/u\u003e\u003c\/b\u003e\u003cp\u003eSOLID TUMOR MALIGNANCIES\u003c\/p\u003e \u003cp\u003e14. Breast cancer\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ea: Early Stage Breast Cancer\u003c\/p\u003e \u003cp\u003eb: Metastatic breast cancer\u003c\/p\u003e \u003cp\u003ee. Premalignant breast conditions and \u003ci\u003ein situ\u003c\/i\u003e disease \u003c\/p\u003e \u003cp\u003e15. Lung Cancer\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003ea: Non-small cell lung cancer\u003ci\u003e \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eb: Small cell lung cancer\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16. Other Thoracic Malignancies\u003c\/p\u003e \u003cp\u003ea: Mesothelioma\u003c\/p\u003e \u003cp\u003eb: Thymoma and thymic cancer\u003c\/p\u003e \u003cp\u003e17. Head and Neck cancer \u003c\/p\u003e \u003cp\u003e18 : Esophageal Cancer\u003c\/p\u003e \u003cp\u003e19: Gastric cancer\u003c\/p\u003e \u003cp\u003e20: Pancreatic cancer\u003c\/p\u003e \u003cp\u003e21: Colorectal cancer and Anal Cancer\u003c\/p\u003e \u003cp\u003e22: Hepatobiliary cancer\u003c\/p\u003e \u003cp\u003e23: Neuroendocrine, small bowel and appendiceal malignancies\u003c\/p\u003e \u003cp\u003e24. Prostate cancer \u003c\/p\u003e \u003cp\u003e25. Bladder and other urothelial cancers\u003c\/p\u003e \u003cp\u003e26. Renal Carcinomas\u003c\/p\u003e \u003cp\u003e27. Germ cell tumors\u003c\/p\u003e \u003cp\u003e28. Gynecological Malignancies\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003col\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eOvarian Cancer and Fallopian Tube Cancer \u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCancer of the Cervix, Uterus, Vagina, Vulva and Gestational Choriocarcinoma \u003c\/li\u003e \u003c\/ol\u003e \u003cp\u003e29. Melanoma and other skin cancers \u003c\/p\u003e \u003cp\u003e30. Bone and soft tissue sarcoma\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31.Cancer of unknown primary site\u003c\/p\u003e\n\u003ci\u003e \u003c\/i\u003e\u003cp\u003e32. . Malignancies of the Central Nervous System\u003c\/p\u003e \u003cp\u003ea. Primary\u003c\/p\u003e \u003cp\u003eb. Metastatic\u003c\/p\u003e\n\u003cb\u003e\u003cu\u003e \u003c\/u\u003e\u003c\/b\u003e\u003cp\u003eNONMALIGNANT HEMATOLOGIC CONDITIONS\u003c\/p\u003e \u003cp\u003e33. Coagulation\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34. Hematopoietic System  \u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1: Hematopoietic System Disorders RBC or iron\u003c\/p\u003e \u003cp\u003e35. Transfusion Medicine\u003ci\u003e  \u003c\/i\u003e\u003c\/p\u003e \u003cb\u003e\u003cu\u003e \u003c\/u\u003e\u003c\/b\u003e\u003cp\u003eSURVIVORSHIP AND END OF LIFE CARE\u003c\/p\u003e \u003cp\u003eChapter 36. Supportive Care \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Haematology [\u003ca title=\"See our other books on Haematology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Haematology%20%5BMJF%5D%22\"\u003eMJF\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648835277080,"sku":"9780323429757","price":61.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323429757.jpg?v=1694094503"},{"product_id":"cancer-immunotherapy-hardback-9780120224890","title":"Cancer Immunotherapy (Hardback) 9780120224890","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer Immunotherapy\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eJames Allison (Author), Glen Dranoff (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780120224890, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 19 May 2006\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e400 pages, Illustrated\u003cbr\u003e22.9 x 15.1 x 2.6 cm, 0.77 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003ePRAISE FOR THE SERIES:\u003cbr\u003e\"...among the most active volumes in the libraries of our universities and institutions.\" \u003cb\u003e--SCIENCE\u003cbr\u003e\u003c\/b\u003e\u003cbr\u003e\"A provocative and scholarly review of research.\"\u003cb\u003e --JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION\u003c\/b\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eFor some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been  tumor-specific antigens.  \u003cbr\u003e\u003cbr\u003eThis  thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eEngineered cellular vaccines\u003cbr\u003eBlockade of T cell checkpoints.\u003cbr\u003eSerex in the identification of target antigens\u003cbr\u003eNew approaches to tumor immunotherapy\u003cbr\u003eMelanoma antigens\u003cbr\u003eAntibodies and chimeric molecules\u003cbr\u003eTumor Immunosurveillance\u003cbr\u003eDendritic Cells\u003cbr\u003eStrategies for Tumor Vaccination\u003cbr\u003eDNA vaccines\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Biophysics [\u003ca title=\"See our other books on Biophysics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Biophysics%20%5BPHVN%5D%22\"\u003ePHVN\u003c\/a\u003e], Immunology [\u003ca title=\"See our other books on Immunology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Immunology%20%5BMJCM%5D%22\"\u003eMJCM\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Public health \u0026amp; preventive medicine [\u003ca title=\"See our other books on Public health \u0026amp; preventive medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Public%20health%20\u0026amp;%20preventive%20medicine%20%5BMBN%5D%22\"\u003eMBN\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648847106328,"sku":"9780120224890","price":138.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780120224890.jpg?v=1695006551"},{"product_id":"cancer-drug-design-and-discovery-hardback-9780123965219","title":"Cancer Drug Design and Discovery (Hardback) 9780123965219","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer Drug Design and Discovery\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThe second edition of this authoritative reference features the latest on the design and development of new anticancer small molecules, including topics such as the identification of molecular targets, cancer genomics, personalized medicine and more.\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eStephen Neidle (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780123965219\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 5 December 2013\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e640 pages, 50 illustrations\u003cbr\u003e23.4 x 19 x 3.5 cm, 1.55 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"…offers unique information on the discovery and design of new anticancer agents, covering recent notable successes resulting from the human genome and cancer genomics projects…an excellent reference for translational researchers interested in cancer biology and medicine as well as students in pharmacy, pharmacology, or medicinal and biological chemistry…\" --\u003cb\u003eAnticancer Research 34, 2014\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The second edition of this book walks readers through the myriad cancer drugs and their molecular targets, with a special emphasis on past, present, and future drug design efforts... the book examines both drugs currently in the clinic and those merely on the drawing board…This comprehensive update of the 2008 edition will serve student or experienced cancer researchers well as a reference on anticancer drug development.\" Rating: 4 Stars --\u003cb\u003eDoody.com, March 21, 2014\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"Specialists in cancer and pharmaceuticals, most in academic settings, look at basic principles of cancer drugs, methodology, drugs in the clinic, new agents, and the reality of cancer drugs in the clinic…They do include many case studies, and some chapters provide questions for classroom use.\" --\u003cb\u003eProtoView.com, February 2014\u003c\/b\u003e \u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eCancer Drug Design and Discovery, Second Edition\u003c\/i\u003e is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under development. By highlighting some of the general principles involved in taking molecules through basic science to clinical development, this book offers a complete and authoritative reference on the design and discovery of anticancer drugs for translational scientists and clinicians involved in cancer research.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eIntroduction - Stephen Neidle\u003c\/p\u003e \u003cp\u003eForeword - Hilary Calvert\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I. Basic Principles and methodology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eModern cancer drug discovery: integrating targets, technologies and treatments — Paul Workman and Ian Collins\u003c\/p\u003e \u003cp\u003ePharmacogenomics and personalised medicines in cancer treatment — Wei-Peng Yong, Ross Soo and Federico Innocenti\u003c\/p\u003e \u003cp\u003eStructural biology and anticancer drug design — Puja Pathuri, David Norton, Henriette Willems, Dominic Tisi and Harren Jhoti\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II. Drugs in the laboratory and clinic\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eTemozolomide: from cytotoxic to molecularly-targeted agent — Malcolm Stevens\u003c\/p\u003e \u003cp\u003eTemozolomide: patents and the perils of invention — Malcolm Stevens\u003c\/p\u003e \u003cp\u003eA new generation of cell-targeted drugs for cancer treatment — Paola B. Arimondo, Nicolas Guilbaud and Christian Bailly\u003c\/p\u003e \u003cp\u003eInhibition of DNA repair as a therapeutic target — Stephany Veuger and Nicola J Curtin Inhibitors of tumour angiogenesis — Adrian L. Harris and Daniele G Generali\u003c\/p\u003e \u003cp\u003eThe Renaissance of CYP17 Inhibitors for the Treatment of Prostate Cancer — Qingzhong Hu and Rolf W. Hartmann\u003c\/p\u003e \u003cp\u003eApoptosis in Cancer: Mechanisms, Deregulation and Therapeutic Targeting — Zahid H Siddik\u003c\/p\u003e \u003cp\u003eTargeting the MDM2-p53 protein-protein interaction: design, discovery and development of novel anticancer agents — Ian R Hardcastle\u003c\/p\u003e \u003cp\u003eTargeting altered metabolism – emerging cancer therapeutic strategy — Minsuh Seo, Robert Blake Crochet and Yong-Hwan Lee\u003c\/p\u003e \u003cp\u003eInhibitors of the Phosphatidylinositol 3-kinase (PI3K) Pathway — William A Denny and Gordon W. Rewcastle\u003c\/p\u003e \u003cp\u003eAntibody-drug conjugates delivering DNA cytotoxics — John A Hartley\u003c\/p\u003e \u003cp\u003eInhibition of telomerase: promise, progress and potential pitfalls — Christopher G. Tomlinson, Scott B. Cohen and Tracy M. Bryan\u003c\/p\u003e \u003cp\u003eTargeting B-RAF: the discovery and development of B-RAF inhibitors — Phillip A Harris\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III. The reality of cancer drugs in the clinic\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFailure Modes in Anticancer Drug Discovery and Development — Richard A. Walgren and Christopher. A. Slapak\u003c\/p\u003e \u003cp\u003eAnticancer drug registration and regulation: current challenges and possible solutions — David Taylor, Erling Donnelly and Silvia Chioato\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pharmacology [\u003ca title=\"See our other books on Pharmacology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pharmacology%20%5BMMG%5D%22\"\u003eMMG\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648849072408,"sku":"9780123965219","price":89.19,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780123965219_6975ffa4-1f49-4254-8cf9-1f36c8ccb43c.jpg?v=1694352184"},{"product_id":"sarcoma-2022-and-beyond-an-issue-of-surgical-oncology-clinics-of-north-america-hardback-9780323849302","title":"Sarcoma 2022 and Beyond, An Issue of Surgical Oncology Clinics of North America (Hardback) 9780323849302","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eSarcoma 2022 and Beyond, An Issue of Surgical Oncology Clinics of North America\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eTimely, relevant discussions on sarcoma\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eChandrajit P. Raut (Edited by), Alessandro Gronchi (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323849302, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 20 June 2022\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e240 pages\u003cbr\u003e28 x 19 x 2.1 cm, 0.57 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eIn this issue of Surgical Oncology Clinics, guest editors Drs. Chandrajit P. Raut and Alessandro Gronchi bring their considerable expertise to the topic of Sarcoma. Top experts in the field provide articles on management of common types of sarcoma, as well as drug trials, WHO updates, and clinical trials.\u003cul\u003e \u003cli\u003e  \u003cp\u003eContains 15 relevant, practice-oriented topics including relevant trials update in sarcomas and GIST: what surgeons should know; management of retroperitoneal\/mesenteric liposarcoma; management of solitary fibrous tumors; management of skin sarcomas (AS, LMS, DFSP, AFX); management of leiomyosarcoma; and more. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003eProvides in-depth clinical reviews on sarcoma, offering actionable insights for clinical practice. \u003c\/p\u003e\n\u003c\/li\u003e \u003cli\u003e  \u003cp\u003ePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. \u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eWHO Pathology: Highlights of the 2020 Sarcoma Update\u003cbr\u003eRelevant Trials Update in Sarcomas and Gastrointestinal Stromal Tumors: What Surgeons Should Know\u003cbr\u003eNew Drug Approvals for Sarcoma in the Last 5 Years\u003cbr\u003eImmunotherapy in Sarcoma: Where Do Things Stand?\u003cbr\u003eRetroperitoneal and Mesenteric Liposarcomas\u003cbr\u003eManagement of Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma\u003cbr\u003eGastrointestinal Stromal Tumor: New Insights for a Multimodal Approach\u003cbr\u003eManagement of Desmoid Tumors\u003cbr\u003eToward Better Understanding and Management of Solitary Fibrous Tumor\u003cbr\u003eManagement of Vascular Sarcoma\u003cbr\u003eManagement of Skin Sarcomas\u003cbr\u003eLeiomyosarcoma: Current Clinical Management and Future Horizons\u003cbr\u003eManagement of Synovial Sarcoma and Myxoid Liposarcoma\u003cbr\u003eThe Cancer Genome Atlas: Impact and Future Directions in Sarcoma\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648860180760,"sku":"9780323849302","price":77.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323849302.jpg?v=1694992185"},{"product_id":"imaging-in-dermatology-paperback-9780128028384","title":"Imaging in Dermatology (Paperback) 9780128028384","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eImaging in Dermatology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThis comprehensive book provides essential information for the use of technologies in analyzing, monitoring, diagnosing, and treating skin disorders, including coverage of a large number of topics in dermatological imaging, the use of lasers in dermatology studies, and the implications of using these technologies in research\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eMichael R. Hamblin (Edited by), Pinar Avci (Edited by), Gaurav K Gupta (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128028384, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 11 August 2016\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e560 pages\u003cbr\u003e27.6 x 21.5 x 3.5 cm, 1.54 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eImaging in Dermatology\u003c\/i\u003e covers a large number of topics in dermatological imaging, the use of lasers in dermatology studies, and the implications of using these technologies in research. Written by the experts working in these exciting fields, the book explicitly addresses not only current applications of nanotechnology, but also discusses future trends of these ever-growing and rapidly changing fields, providing clinicians and researchers with a clear understanding of the advantages and challenges of laser and imaging technologies in skin medicine today, along with the cellular and molecular effects of these technologies.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. Introduction Michael R. Hamblin, Pinar Avci and Gaurav K. Gupta\u003c\/p\u003e \u003cp\u003e2. The role of clinical photography in dermatology Alexis Sidoroff\u003c\/p\u003e \u003cp\u003e3. Dermoscopy Aimilios Lallas, Zoe Apalla, Elizabeth Lazaridou, and Demetrios Ioannides\u003c\/p\u003e \u003cp\u003e4. Trichoscopy: The dermatologist’s third eye Uday Khopkar and Nilam Jain\u003c\/p\u003e \u003cp\u003e5. Dermatoscopic correlates of nail apparatus disease Sara Leite de Azevedo Campos and André Jacinto Garcez de Lencastre\u003c\/p\u003e \u003cp\u003e6. Optical Coherence Tomography for Skin Cancer and Actinic Keratosis Lotte Themstrup, and Gregor B.E. Jemec\u003c\/p\u003e \u003cp\u003e7. Optical Coherence Tomography (OCT) Imaging of Skin Scarring and Fibrosis Andrew Mamalis, Derek Ho and Jared Jagdeo\u003c\/p\u003e \u003cp\u003e8. Polarization Speckles and Skin Applications Tim K. Lee, Lioudmila Tchvialeva, Igor Markhvida, Haishan Zeng, Alexander Doronin, Igor Meglinski and David I. McLean\u003c\/p\u003e \u003cp\u003e9. New Developments in Fluorescence Diagnostics Juraj Hegyi and V. Hegyi\u003c\/p\u003e \u003cp\u003e10. Ex vivo fluorescence microscopy: clinical applications in dermatology and surgical pathology Caterina Longo, Stefano Gardini, Simonetta Piana, Fabio Castagnetti, Giuseppe Argenziano, Giovanni Pellacani and Moira Ragazzi\u003c\/p\u003e \u003cp\u003e11. Coherent Raman Scattering Micros-copy in Dermatological Imaging Hequn Wang and Conor L. Evans\u003c\/p\u003e \u003cp\u003e12. Rapid real-time Raman spectroscopy and imaging-guided confocal Raman spectroscopy for in vivo skin evaluation and diagnosis Jianhua Zhao, Harvey Lui, David I. McLean and Haishan Zeng\u003c\/p\u003e \u003cp\u003e13. Surface Enhanced Raman Spectroscopy for Intradermal Measurements Keren Chen, Yihong Ong, Clement Yuen and Quan Liu\u003c\/p\u003e \u003cp\u003e14. Broadband Coherent Anti-Stokes Raman Scattering Charles H. Camp Jr.\u003c\/p\u003e \u003cp\u003e15. In Vivo Reflectance Confocal Microscopy in Dermatology Ivette Alarcon, Caterina Longo and Salvador González\u003c\/p\u003e \u003cp\u003e16. Hyperspectral and Multispectral Imaging in Dermatology Fartash Vasefi, Nicholas MacKinnon and Daniel L. Farkas\u003c\/p\u003e \u003cp\u003e17. Diffuse Reflectance Spectroscopy and Imaging Austin J. Moy and James W. Tunnell\u003c\/p\u003e \u003cp\u003e18. Spectral Imaging in Dermatology Derek Ho, Ekaterina Kraeva, Jared Jagdeo, and Richard M Levenson\u003c\/p\u003e \u003cp\u003e19. Applications of Multi-Photon Microscopy in Dermatology Peter T. C. So, Elijah Yew and Christopher Rowlands\u003c\/p\u003e \u003cp\u003e20. Non-linear microscopy in clinical dermatology Riccardo Cicchi, Dimitrios Kapsokalyvas, and Francesco Saverio Pavone\u003c\/p\u003e \u003cp\u003e21. Non-invasive topical in vivo imaging of skin: confocal reflectance microscopy and polarized light imaging Steven L. Jacques\u003c\/p\u003e \u003cp\u003e22. Polarization Optical Imaging of Skin Pathology and Ageing Anna N. Yaroslavsky, Xin Feng and Victor A. Neel\u003c\/p\u003e \u003cp\u003e23. Mechanical characterization of skin using surface acoustic waves Chunhui Li, Guangying Guan, Ruikang Wang and Zhihong Huang\u003c\/p\u003e \u003cp\u003e24. Photoacoustic tomography in the Diagnosis of Melanoma Yong Zhou and Lihong V. Wang\u003c\/p\u003e \u003cp\u003e25. Ultrasound Imaging in Dermatology Ximena Wortsman\u003c\/p\u003e \u003cp\u003e26. Optoacoustic Imaging of Skin Mathias Schwarz, Juan Aguirre, Murad Omar and Vasilis Ntziachristos\u003c\/p\u003e \u003cp\u003e27. Use of Total Body Photograph and Serial Digital Dermoscopy in Dermatology Brian W. Petersen and H. William Higgins II\u003c\/p\u003e \u003cp\u003e28. Functional MRI Advances to Reveal the Hidden Networks behind the Cerebral Processing of Itch Alexandru D. P. Papoiu\u003c\/p\u003e \u003cp\u003e29. Magnetic Resonance Microscopy of Skin Katharina Eva Göbel 30. The Role of Magnetic Resonance Imaging in the Management of Anogenital Hidradenitis Suppurativa Olwen Westerland, Geoff Charles-Edwards, Vicky Goh and Nyreen Griffin\u003c\/p\u003e \u003cp\u003e31. Thermal imaging in dermatology, a review of current technologies and applications Mathias Bonmarin and Frédérique-Anne Le Gal\u003c\/p\u003e \u003cp\u003e32. The Role of PET\/CT in Cutaneous Melanoma Austin C. Bourgeois, Alexander S Pasiak and Yong C. Bradley\u003c\/p\u003e \u003cp\u003e33. Molecular imaging of Merkel Cell Carcinoma Volkan Beylergil, Julio Arevalo Perez, Joseph R. Osborne\u003c\/p\u003e \u003cp\u003e34. Imaging in Merkel cell carcinoma Lorenz Kadletz, Stefan F. Nemec, and Bobam M. Erovic\u003c\/p\u003e \u003cp\u003e35. Images of Cutaneous Lymphoma Alavi Abass, Tom Werner, Sara Fardin and Saeid Gholami\u003c\/p\u003e \u003cp\u003e36. Imaging Cutaneous Squamous Cell Carcinoma of the Head and Neck Geoffrey C. Casazza and Marcus M. Monroe\u003c\/p\u003e \u003cp\u003e37. Imaging patterns of metastatic melanoma Benjamin Peters and Filip M. Vanhoenacker\u003c\/p\u003e \u003cp\u003e38. From Image to Information:  Image Processing in Dermatology and Cutaneous Biology Marty O. Visscher, Shoná A. Burkes, R. Randall Wickett, Kenneth P. Eaton \u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Molecular biology [\u003ca title=\"See our other books on Molecular biology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Molecular%20biology%20%5BPSD%5D%22\"\u003ePSD\u003c\/a\u003e], Genetics [\u003ca title=\"See our other books on Genetics\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Genetics%20%5Bnon-medical%5D%20%5BPSAK%5D%22\"\u003enon-medical PSAK\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648861720856,"sku":"9780128028384","price":99.75,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128028384.jpg?v=1694094659"},{"product_id":"cancer-oxidative-stress-and-dietary-antioxidants-hardback-9780128195475","title":"Cancer; Oxidative Stress and Dietary Antioxidants (Hardback) 9780128195475","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancer\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eOxidative Stress and Dietary Antioxidants\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eA comprehensive discussion of the pros and cons of dietary antioxidants and their use for cancer treatment in the development of new drugs\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eVictor R Preedy (Edited by), Vinood B. Patel (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128195475, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 15 January 2021\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e596 pages\u003cbr\u003e27.6 x 21.5 x 3.3 cm, 1.9 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\"This book is a valuable resource for cancer researchers, oncologists, nutritionists and other members of the biomedical field who are interested in enhancing treatment outcome, improving the quality of life of patients, and developing new treatments in the fight against cancer.\" \u003cb\u003e--Anticancer Research\u003c\/b\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eCancer: Oxidative Stress and Dietary Antioxidants, Second Edition,\u003c\/i\u003e covers the science of oxidative stress in cancer and the potentially therapeutic usage of natural antioxidants in the diet or food matrix. The processes within the science of oxidative stress are described in concert with other processes, such as apoptosis, cell signaling, and receptor-mediated responses. This approach recognizes that diseases are often multifactorial and that oxidative stress is a single component. Other sections cover new organ site tumors—skin and liver cancer, the role of polymorphisms, cytochrome p450s, COX gene, fatty acids, apoptosis, T cells and mitochondria, prevention\/protection with anthocyanins, esculetin, nanoparticles, and more.\u003c\/p\u003e  \u003cp\u003eThis book is a valuable resource for cancer researchers, oncologists, nutritionists and other members of the biomedical field who are interested in enhancing treatment outcome, improving the quality of life of patients, and developing new treatments in the fight against cancer.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eSection 1 Oxidative Stress and Cancer\u003c\/b\u003e1. Paraoxonases, Oxidative stress and Breast cancer2. Oxidative stress and prostate cancer3. Oxidative stress in lung cancer4. Endogenous antioxidants in the prognosis and treatment of lung cancer5. Oxidative stress in stomach cancer6. Oxidative stress and oral cavity cancer7. Oxidative stress, Epigenetics and Bladder Cancer8. Linking oxidative stress and ovarian cancers9. Oxidative stress in viral carcinogenesis10. Polymorphisms, antioxidant genes and cancer11. Interlinking high fat diets, oxidative stress, heart and carcinogenesis12. Maternal nutrition, antioxidant defenses and tumor-bearing offspring13. Inflammation and oxidatively induced DNA damage: A synergy leading to cancer development14. Ferroptosis, Free radicals and cancer15. Nrf2, YAP antioxidant potential and cancer16. Cancer, NF kappa B,and oxidative stress-dependent phenotypes17. 8-hydroxydeoxyguanosine and diabetic cancer patients\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2. Antioxidants and Cancer\u003c\/b\u003e18. Molecular Approaches Toward Targeted Cancer Therapy with Some Food Plant Products: On the Role of Antioxidants and Immune Microenvironment19. Prostate Cancer and food-based antioxidants in India as plausible therapeutics20. Linking non-enzymatic antioxidants in the diet and colorectal cancer21. Fruit and vegetables juices and breast cancer22. N-3 fatty acids and oxidative stress in cancer23. Statins, cancer and oxidative stress24. Role of anthocyanins in oxidative stress and the prevention of cancer in the digestive system25. Caffeic Acid targets metabolism of cervical squamous cell carcinoma26. Caffeic acid, oxidative balance and melanoma cancer cells27. Oxidative stress and cancer: Antioxidative role of Ayurvedic plants28. Polyphenol chlorogenic acid, antioxidant profile and breast cancer29. Cinnamomum cassia, apoptosis, transcription 3 inactivation and reactive oxygen species in cancer studies30. Cocoa and anti- oxidative stress actions in colonic cancer31. Croton gratissimus, cancer and antioxidant activities32. Curcumin, oxidative stress and breast cancer33. Curcumin analogs, oxidative stress and prostate cancer34. Fern extract, oxidative stress and skin cancer35. Lycium barbarum (Goji berry), human breast cancer and antioxidant profile36. Manuka honey, oxidative stress, 5-fluorouracil usage and colon cancer cells37. Piplartine (piperlongumine), oxidative stress and use in cancer38. Antioxidant pleurotus ostreatus (Jacq.) P. Kumm and lymphoid cancer cells39. Skin cancer, polyphenols and oxidative stress40. Pterostilbene and cancer chemoprevention41. Resveratrol, reactive oxygen species and mesothelioma42. Exercise, Selenium and Cancer Cells43. Silybum marianum, antioxidant activity and cancer patients44. Terminalia ferdinandiana Exell. Fruit extracts, antioxidant profile, proliferation and cancer45. Uncaria tomentosa: a promising source of therapeutic agent for prevention and treatment of oxidative stress and cancer46. Pharmacologic vitamin C and use in cancer47. Antioxidant vitamins and genetic polymorphisms in breast cancer48. Antioxidant vitamins in acute lymphoblastic leukemia\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3. Online Resources\u003c\/b\u003e49. Resources\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Life sciences: general issues [\u003ca title=\"See our other books on Life sciences: general issues\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Life%20sciences:%20general%20issues%20%5BPSA%5D%22\"\u003ePSA\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e], Dietetics \u0026amp; nutrition [\u003ca title=\"See our other books on Dietetics \u0026amp; nutrition\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Dietetics%20\u0026amp;%20nutrition%20%5BMBNH3%5D%22\"\u003eMBNH3\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648869781784,"sku":"9780128195475","price":154.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128195475.jpg?v=1694094701"},{"product_id":"bone-cancer-bone-sarcomas-and-bone-metastases-from-bench-to-bedside-hardback-9780128216668","title":"Bone Cancer; Bone Sarcomas and Bone Metastases - From Bench to Bedside (Hardback) 9780128216668","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eBone Cancer\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eBone Sarcomas and Bone Metastases - From Bench to Bedside\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003ePresents a global overview of the biological\/clinical aspects of bone cancers with enough detail to be understandable by a large audience\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eDominique Heymann (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128216668, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 22 September 2021\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1078 pages, 175 illustrations (120 in full color)\u003cbr\u003e27.6 x 21.6 x 5 cm, 3.04 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePraise for the Previous Editions: \u003c\/b\u003e\"...a comprehensive description of bone tumors from basic to clinical aspects by the most recent data available...specifically useful to medical students and scientists, health professionals, researchers and teachers working in the osteo-articular field.\" \u003cb\u003e--Anticancer Research\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e\"Reviewing the current advances in the progression and therapeutic approaches to bone cancer is an extremely challenging task. Bone cancer is not a single disease; rather, it is a field comprising a diverse and complex range of malignancies, from primary bone tumors of stromal cell origin, to hematopoietic malignancies and secondary metastatic bone disease. Dominique Heymann has assembled an exciting, comprehensive and up-to-date series of reviews contributed by experts in the basic and clinical aspects of bone research. In the past decade, our understanding of cancers involving bone has increased tremendously, underpinned by advances in the cellular, molecular and biochemical mechanisms of bone cell interactions in health and disease, together with advances in genetics, diagnostics, imaging and therapeutic strategies. All these aspects are covered in this timely volume, which will galvanize further cooperative efforts in the coming years between basic researchers, oncologists and pathologists towards understanding the causes of different bone cancers and translating this knowledge into the clinic.\" \u003cb\u003e--Agi E. Grigoriadis, PhD, Departments of Craniofacial Development and Orthodontics, King's College London, United Kingdom\u003c\/b\u003e \u003c\/p\u003e \u003cp\u003e\"Our understanding of bone biology and diseases has strikingly progressed in the last decade. In parallel, the processes that lead to various forms of cancer have been further unraveled and the mechanisms leading to metastatic spread further explored. In this book, Dr. Heymann has gathered some of the world experts on these subjects to explore the cutting edge where these fields merge in the context of bone cancer and metastasis, their pathophysiology, diagnosis and treatment. This encompassing book will undoubtedly meet the needs of residents and fellows as well as expert clinicians and scientists.\" \u003cb\u003e--Roland Baron, Professor, Harvard Medical School, Boston MA, USA\u003c\/b\u003e \u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eBone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside, Third Edition\u003c\/i\u003e comprehensively investigates key discoveries in the field of bone biology. New aspects of bone cancer biology are treated in new chapters covering exosomes, autophagy, and metabolism. These have led to the development of entirely new areas for investigation, such as therapies which combine surgery and biological approaches.  \u003c\/p\u003e  \u003cp\u003eThe Third Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with 40% new material. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials. \u003c\/p\u003e  \u003cp\u003eGiven the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases. This revision opens the door to myeloma with two short chapters dedicated to this bone-associated disease.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eEpidemiology of Bone Cancer\u003c\/p\u003e \u003cp\u003e1. Osteoarchaeology: lessons to learn from the past\u003c\/p\u003e \u003cp\u003e2. Epidemiology of primary bone tumors and economical aspects of bone metastases\u003c\/p\u003e \u003cp\u003eModels of Bone Cancers and Technical Aspects\u003c\/p\u003e \u003cp\u003eAnimal Models\u003c\/p\u003e \u003cp\u003e3. Animal models of bone sarcomas\u003c\/p\u003e \u003cp\u003e4. In vivo models used in studies of bone metastaes\u003c\/p\u003e \u003cp\u003e5. Zebrafish models for studying bone tumors\u003c\/p\u003e \u003cp\u003eMathematic models and machine learning\u003c\/p\u003e \u003cp\u003e6. Use of machine learning in bone cancers\u003c\/p\u003e \u003cp\u003e7. Artifical intelligence for bone cancer imaging\u003c\/p\u003e \u003cp\u003ePreparation of tissue samples: technical aspects\u003c\/p\u003e \u003cp\u003e8. Technical aspects: how do we best prepare bone samples for proper histological analysis?\u003c\/p\u003e \u003cp\u003eBone Microenvironment and Bone Cancer\u003c\/p\u003e \u003cp\u003eBone niche\u003c\/p\u003e \u003cp\u003e9. Bone niche and bone metastases \u003c\/p\u003e \u003cp\u003e10. Bone: a fertil soil for tumor development\u003c\/p\u003e \u003cp\u003e11. Osteomimicry: old concepts and new findings \u003c\/p\u003e \u003cp\u003eDialog between cancer cells and bone cells\u003c\/p\u003e \u003cp\u003e12. Role of mesenchymal stem cells in bone cancers, initiation, propagation and metastasis \u003c\/p\u003e \u003cp\u003e13. Technical approaches for studying the communications between osteocytes and cancer cells\u003c\/p\u003e \u003cp\u003e14. Osteocytes and bone cancers\u003c\/p\u003e \u003cp\u003e15. Immune functions of osteoclasts: new insights for bone cancers\u003c\/p\u003e \u003cp\u003e16. Immune infiltrate in bone sarcomas\u003c\/p\u003e \u003cp\u003e17. Macrophages and pathophysiology of bone cancers\u003c\/p\u003e \u003cp\u003eMediators of cell communications\u003c\/p\u003e \u003cp\u003e18. Growth factors, cytokines and pediatric malignant primary bones tumors\u003c\/p\u003e \u003cp\u003e19. The role of NFkB in bone cancer\u003c\/p\u003e \u003cp\u003e20. TGF-beta and bone cancers: a specific focus \u003c\/p\u003e \u003cp\u003e21. Extracellular vesicles, tumor growth and metastatic process\u003c\/p\u003e \u003cp\u003e22. Connexin43 and development of primary bone tumors : osteosarcoma and Ewing’s sarcoma\u003c\/p\u003e \u003cp\u003e23. The role of endocannabinoid system in bone cancer\u003c\/p\u003e \u003cp\u003eMetabolism\u003c\/p\u003e \u003cp\u003e24. Impact of the microenvironment acidosis on bone cancers \u003c\/p\u003e \u003cp\u003e25. Hypoxic niche and bone cancers\u003c\/p\u003e \u003cp\u003e26. Metabolism and bone cancers\u003c\/p\u003e \u003cp\u003eBone Tumor Heterogeneity, Plasticity and Biomarkers\u003c\/p\u003e \u003cp\u003eHeterogeneity and plasticity\u003c\/p\u003e \u003cp\u003e27. EMT process in bone metastasis\u003c\/p\u003e \u003cp\u003e28. Cancer stem cells and clonal evolution in bone sarcomas\u003c\/p\u003e \u003cp\u003e29. Dormancy in cancer bone metastasis\u003c\/p\u003e \u003cp\u003eBiomarkers\u003c\/p\u003e \u003cp\u003e30. Bone Remodelling Markers and Bone Cancer \u003c\/p\u003e \u003cp\u003e31. Epigenetic Heterogeneity in Primary Bone Cancers \u003c\/p\u003e \u003cp\u003e32. miRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors\u003c\/p\u003e \u003cp\u003e33. MicroRNAs and bone metastasis: how small RNAs regulate secondary tumour formation and progression in the skeleton\u003c\/p\u003e \u003cp\u003e34. Long-non coding RNA and bone sarcoma\u003c\/p\u003e \u003cp\u003e35. Liquid biopsy and circulating tumor cells in bone sarcomas: identification of new biomarkers and analysis of the tumor heterogeneity\u003c\/p\u003e \u003cp\u003e36. Disseminated tumor cells in bone marrow of cancer patients \u003c\/p\u003e \u003cp\u003eII. PRIMARY BONE TUMORS\u003c\/p\u003e \u003cp\u003eBiological aspects\u003c\/p\u003e \u003cp\u003e37. Cytogenetics of bone sarcomas \u003c\/p\u003e \u003cp\u003e38. Genetic aspects of primary bone tumors\u003c\/p\u003e \u003cp\u003e39. Markers of bone sarcomas\u003c\/p\u003e \u003cp\u003e40. Molecular pathology of osteosarcoma\u003c\/p\u003e \u003cp\u003e41. Genomic and proteomic profiling of osteosarcoma \u003c\/p\u003e \u003cp\u003e42. Ewing sarcoma family of tumors\u003c\/p\u003e \u003cp\u003e43. Molecular aspects of Ewing sarcomas \u003c\/p\u003e \u003cp\u003e44. Osteoclast-rich lesions: a clinical and molecular overview\u003c\/p\u003e \u003cp\u003e45. Biology of cartilage tumor family\u003c\/p\u003e \u003cp\u003eClinical aspects and Perspectives\u003c\/p\u003e \u003cp\u003eImaging\u003c\/p\u003e \u003cp\u003e46. Imaging of bone sarcomas \u003c\/p\u003e \u003cp\u003eTherapeutic approaches\u003c\/p\u003e \u003cp\u003e47. Current therapeutic approaches of bone sarcomas\u003c\/p\u003e \u003cp\u003e48. Surgical approaches of bone sarcomas: Margins and clinical impact \u003c\/p\u003e \u003cp\u003e49. Apoptosis and drug resistance in malignant bone tumors: impact on the clinical practices \u003c\/p\u003e \u003cp\u003e50. Chondrosarcoma of Bone: Diagnosis and Therapy \u003c\/p\u003e \u003cp\u003e51. Radiotherapy and Primary bone tumors\u003c\/p\u003e \u003cp\u003e52. New therapeutic advances of bone sarcomas\u003c\/p\u003e \u003cp\u003eIII. BONE METASTASES\u003c\/p\u003e \u003cp\u003eBiological aspects\u003c\/p\u003e \u003cp\u003e53. The histopathology of skeletal Metastases \u003c\/p\u003e \u003cp\u003e54. Indentification of new therapeutic targets of bone cancers by proteomic strategies \u003c\/p\u003e \u003cp\u003eClinical aspects and Perspectives\u003c\/p\u003e \u003cp\u003eImaging\u003c\/p\u003e \u003cp\u003e55. Interventional radiologic techniques in management of bone tumors \u003c\/p\u003e \u003cp\u003e56. Diagnosis of bone metastases in urological malignancies – an update\u003c\/p\u003e \u003cp\u003eBone pain\u003c\/p\u003e \u003cp\u003e57. Mechanisms and management of bone cancer pain \u003c\/p\u003e \u003cp\u003e58. Involvement of sympathic nerves in bone mestastasis\u003c\/p\u003e \u003cp\u003e59. Pain control with palliative radiotherapy in patients with bone metastases \u003c\/p\u003e \u003cp\u003e60. Palliative care of bone metastases\u003c\/p\u003e \u003cp\u003eTherapeutic approaches\u003c\/p\u003e \u003cp\u003e61. Radiotherapy of bone metastases\u003c\/p\u003e \u003cp\u003e62. Cellular and molecular actions of bisphosphonates: therapeutic interest in tumor-associated bone diseases\u003c\/p\u003e \u003cp\u003e63. Bone-Targeted agents and skeletal-related events in breast cancer patients with bone metastases\u003c\/p\u003e \u003cp\u003e64. Bone metastases – current status of bone-targeted treatments\u003c\/p\u003e \u003cp\u003e65. Therapies of bone metastases in castration-resistant prostate cancer\u003c\/p\u003e \u003cp\u003e66. Therapy with bone-targeting radiopharmaceuticals\u003c\/p\u003e \u003cp\u003e67. Therapeutic approaches of bone metastases associated with breast cancer\u003c\/p\u003e \u003cp\u003eMYELOMA: A BONE ASSOCIATED DISEASE\u003c\/p\u003e \u003cp\u003e68. Biological relationship between bone and myeloma cells\u003c\/p\u003e \u003cp\u003e69. Recent therapeutic approaches in myeloma\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Orthopaedics \u0026amp; fractures [\u003ca title=\"See our other books on Orthopaedics \u0026amp; fractures\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Orthopaedics%20\u0026amp;%20fractures%20%5BMNS%5D%22\"\u003eMNS\u003c\/a\u003e], Endocrinology [\u003ca title=\"See our other books on Endocrinology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Endocrinology%20%5BMJG%5D%22\"\u003eMJG\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648957272344,"sku":"9780128216668","price":195.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128216668.jpg?v=1694095702"},{"product_id":"drug-discovery-in-cancer-epigenetics-hardback-9780128022085","title":"Drug Discovery in Cancer Epigenetics (Hardback) 9780128022085","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eDrug Discovery in Cancer Epigenetics\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eProviding information on putative epigenetic targets, available drugs, tools for drug discovery, and routes for translation\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eGerda Egger (Edited by), Paola Arimondo (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128022085\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 5 February 2016\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e498 pages, c. 60 color\u003cbr\u003e23.4 x 19 x 3 cm, 1.2 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eDrug Discovery in Cancer Epigenetics\u003c\/i\u003e is a practical resource for scientists involved in the discovery, testing, and development of epigenetic cancer drugs. Epigenetic modifications can have significant implications for translational science as biomarkers for diagnosis, prognosis or therapy prediction. Most importantly, epigenetic modifications are reversible and epigenetic players are found mutated in different cancers; therefore, they provide attractive therapeutic targets. There has been great interest in developing and testing epigenetic drugs, which inhibit DNA methyltransferases, histone modifying enzymes or chromatin reader proteins. The first few drugs are already FDA approved and have made their way into clinical settings. This book provides a comprehensive summary of the epigenetic drugs currently available and aims to increase awareness in this area to foster more rapid translation of epigenetic drugs into the clinic.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003eI. Introduction \u003cbr\u003e1: Basic Epigenetic Mechanisms and Phenomena\u003cbr\u003e2: Cancer Epigenetics\u003cbr\u003eII. Methods and Tools for Epigenetic Drug Development\u003cbr\u003e3: Drug Discovery Methods\u003cbr\u003e4: Preclinical Cancer Models with the Potential to Predict Clinical Response\u003cbr\u003e5: Discovery of Biomarkers for Drug Development\u003cbr\u003e6: Networks and Consortia for Epigenetic Drug Discovery\u003cbr\u003eIII. Classes of Epigenetic Drugs\u003cbr\u003e7: DNA Methyltransferase Inhibitors\u003cbr\u003e8: Small Molecule Inhibitors of Histone Deacetylases and Acetyltransferases as Potential Therapeutics in Oncology\u003cbr\u003e9: Targeting histone methylation. The development of selective methyltransferase and demethylase inhibitors\u003cbr\u003e10: Bromodomains as Anti-Cancer Targets\u003cbr\u003e11: Epigenetic Readers Interpreting the Lysine Methylome – Biological Roles and Drug Discovery\u003cbr\u003e12: Non coding RNAs: Clinical and Therapeutic Applications\u003cbr\u003eIV. Clinical Implications of Epigenetic Therapy\u003cbr\u003e13: Clinical Applications of Epigenetic Drugs\u003cbr\u003e14: Efficacy of Combined Epigenetic Therapies\u003cbr\u003e15: Predicting and Monitoring Responses to Epigenetic Drugs\u003cbr\u003e16: Episensitization: A New Word for A New Concept\u003cbr\u003e17: The Emerging Potential for Epigenetic Therapeutics in Non-Cancer Disorders\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Pharmacology [\u003ca title=\"See our other books on Pharmacology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Pharmacology%20%5BMMG%5D%22\"\u003eMMG\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648972837144,"sku":"9780128022085","price":108.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128022085_12b6d15d-2947-4574-a205-f113d274ec2b.jpg?v=1694353090"},{"product_id":"vitamin-d-volume-two-hardback-9780123870346","title":"Vitamin D; Volume Two (Hardback) 9780123870346","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eVitamin D\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eVolume Two\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eNow available in two separate volumes, this third edition of \u003ci\u003eVitamin D\u003c\/i\u003e is packed with over 100 chapters covering such new topics as brain and thyroid cancer\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eDavid Feldman (Edited by), J. Wesley Pike (Edited by), John S. Adams (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780123870346\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 20 July 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1024 pages\u003cbr\u003e27.6 x 21.5 x 4.8 cm, 2.48 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cem\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\"In this brief review, it is impossible to cover all the nuances of vitamin D addressed in this book. Interested readers may want to peruse the book chapters to assess relevance to their personal interests. I regard this impressive text as a ‘‘must have’’ in the medical libraries of most hospitals. Clinicians and researchers with an interest in vitamin D may want their own personal copy for ready reference. I highly recommend it and congratulate the authors and editors in providing a much needed reference text on arguably one of the more important nutrients to our species.\" \u003cb\u003e--American Journal of Human Biology\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"In this remarkable compendium, the editors provide a fresh and comprehensive review of a multifaceted and sometimes controversial vitamin D. This third edition is not just an update, but a greatly expanded work organized to authoritatively cover the evidence for new roles of vitamin D in cardiovascular health, immunity, psychiatric disorders, and much more. In more than 100 chapters, experts span the history of vitamin D, update its molecular mechanism and chemistry, provide specifics of clinical use in disorders of the skeleton, and review progress in an array of diseases including diabetes, inflammatory bowel disease, multiple sclerosis, and psoriasis. In this edition one finds new information for a broad audience including internal medicine, nutrition, orthopedics, basic scientists, and teachers. How does one define optimal vitamin D status? How does vitamin D affect innate immunity? What are the epigenetic modifications of the vitamin D receptor that contribute to its function? Are there other natural ligands for the vitamin D receptor? These are a part of the new increased scope of \u003cb\u003eVitamin D, Third Edition\u003c\/b\u003e. If you are interested in vitamin D, you should have this book.\" \u003cb\u003e--Mark S. Nanes, MD, PhD, Professor of Medicine, Emory University, Atlanta, GA, USA\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The Third Edition of the classic text \u003cb\u003eVitamin D\u003c\/b\u003e is a superb summary of an important and topical issue. Its contributors are truly experts in the field and they have managed to comprehensively describe the biochemistry, pharmacology and effects of vitamin D as well as to eloquently weave in the relevant biology of bone, muscle, immunology and other relevant tissues. The 105 readable chapters offer a complete and well balanced mix of basic and clinical topics that provides an opportunity to understand the full breadth of vitamin D action. Each section represents an excellent summary of up-to-date information and, as a whole, this text offers an outstanding resource that will appeal to a broad spectrum of readers – from students to established clinicians and investigators.\" \u003cb\u003e--Eric Orwoll, MD, Department of Medicine, Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, OR, USA\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\"The Third Edition of \u003cb\u003eVitamin D\u003c\/b\u003e is well written, comprehensive and balanced. Several of the new chapters, such as Epigenetic Modifications and Wnt\/ß-Catenin Signaling, have strayed away from the \"traditional\" vitamin D but the authors have put these topics very clearly into perspective in ways that will be valuable to those studying vitamin D action. The overall list of authors for this book is a virtual '\"who's who\" of vitamin D research, and the coverage of the topic is appropriately broad, including those matters in nutrition and epidemiology that have been the subject of much interest in recent years.\" \u003cb\u003e--T. Jack Martin, AO MD DSC FRACP FRCPA FAA FRS, John Holt Fellow, Emeritus Professor of Medicine, Bone, Joint \u0026amp; Cancer Unit, St Vincent's Institute, Victoria, Australia\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eThe\u003cb\u003e Third Edition\u003c\/b\u003e of this classic compendium,\u003cb\u003e Vitamin D,\u003c\/b\u003e is the most comprehensive, authoritative reference available in the field. In two volumes and over 100 chapters, the editors and authors have marshaled all currently available data on the basic mechanisms, normal physiology and effects on disease of Vitamin D; they have laid out for the reader up-to-date and expert information on the role of vitamin D in health and many disorders. With new chapters on multiple cancers, this complete reference work is essential for anyone working in endocrinology, osteology, bone biology, or cancer research.\u003c\/p\u003e\n\u003cb\u003e  \u003c\/b\u003e\u003cp\u003eVolume One chapters cover the chemistry and metabolism of vitamin D, role in mineralization, other target organs, and general physiological effects. \u003cb\u003eVolume Two\u003c\/b\u003e is more clinically oriented addressing deficiency problems (including diagnosis, interactions in the endocrine system, and involvement in malignancies). \u003cb\u003eVolumes One and Two are now sold separately in print. Volume One ISBN: 9780123870353; Volume Two ISBN: 9780123870346.\u003c\/b\u003e\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eVOLUME ONE\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eSECTION I: CHEMISTRY, METABOLISM, CIRCULATION \u003c\/p\u003e \u003cp\u003e1 Historical Overview of Vitamin D\u003c\/p\u003e \u003cp\u003eHector F. Deluca\u003c\/p\u003e \u003cp\u003e2 Photobiology of Vitamin D \u003c\/p\u003e \u003cp\u003eMichael F. Holick\u003c\/p\u003e \u003cp\u003e3 The Activating Enzymes of Vitamin D Metabolism (25- and 1a-Hydroxylases)\u003c\/p\u003e \u003cp\u003eGlenville Jones and David E. Prosser\u003c\/p\u003e \u003cp\u003e4 CYP24A1: Structure, Function, and Physiological Role\u003c\/p\u003e \u003cp\u003eRene St. Arnaud\u003c\/p\u003e \u003cp\u003e5 The Vitamin D Binding Protein: DBP\u003c\/p\u003e \u003cp\u003eRoger Bouillon \u003c\/p\u003e \u003cp\u003e6 Industrial Aspects of Vitamin D \u003c\/p\u003e \u003cp\u003eArnold L. Hirsch\u003c\/p\u003e \u003cp\u003eSECTION II: MECHANISMS OF ACTION\u003c\/p\u003e \u003cp\u003e7 VDR \u003c\/p\u003e \u003cp\u003eJ. Wesley Pike\u003c\/p\u003e \u003cp\u003e8 Nuclear Vitamin D Receptor: Natural Ligands, Molecular Structure-Function, and Transcriptional Control of Vital Genes \u003c\/p\u003e \u003cp\u003eMark R. Haussler, Carol A. Haussler, Jui-Cheng Hsieh, Peter W. Jurutka, and G. Kerr Whitfield\u003c\/p\u003e \u003cp\u003e9 Structural Basis for Ligand Activity in VDR\u003c\/p\u003e \u003cp\u003eDino Moras and Natacha Rochel\u003c\/p\u003e \u003cp\u003e10 Coregulators of VDR-mediated Gene Expression \u003c\/p\u003e \u003cp\u003ePaul McDonald and Diane R. Dowd\u003c\/p\u003e \u003cp\u003e11 Target Genes of Vitamin D: Spatio-temporal Interaction of Chromatin, VDR and Response Elements \u003c\/p\u003e \u003cp\u003eCarsten Carlberg\u003c\/p\u003e \u003cp\u003e12 Epigenetic Modifications in Vitamin D Receptor Mediated Transrepression\u003c\/p\u003e \u003cp\u003eShigeaki Kato, Alexander Kouzmenko, Fumiaki Ohtake, and Ryoji Fujiki\u003c\/p\u003e \u003cp\u003e13 Vitamin D and Wnt\/ß-Catenin Signaling\u003c\/p\u003e \u003cp\u003eAlbert Munoz, José Manuel González-Sancho, and María Jesús Larriba\u003c\/p\u003e \u003cp\u003e14 Vitamin D Response Element Binding Protein \u003c\/p\u003e \u003cp\u003eJohn S. Adams, Thomas S. Lisse, Hong Chen, Mark S. Nanes, and Martin Hewison\u003c\/p\u003e \u003cp\u003e15 Vitamin D Sterol\/VDR Conformational Dynamics and Nongenomic Actions\u003c\/p\u003e \u003cp\u003eAnthony W. Norman and Mathew T. Mizwicki\u003c\/p\u003e \u003cp\u003eSECTION III: MINERAL AND BONE HOMEOSTASIS \u003c\/p\u003e \u003cp\u003e16 Development of the Skeleton\u003c\/p\u003e \u003cp\u003eJane B. Lian, Gary S. Stein, Martin Montecino, Janet L. Stein, Andre J. van Wijnen\u003c\/p\u003e \u003cp\u003e17 Vitamin D Regulation of Osteoblast Function\u003c\/p\u003e \u003cp\u003eRenny Franchesci and Yan Li\u003c\/p\u003e \u003cp\u003e18 Osteoclasts\u003c\/p\u003e \u003cp\u003eF. Patrick Ross\u003c\/p\u003e \u003cp\u003e19 Molecular Mechanisms for Regulation of Intestinal Calcium and Phosphate Absorption by Vitamin D\u003c\/p\u003e \u003cp\u003eJames Fleet and Ryan D. Schoch\u003c\/p\u003e \u003cp\u003e20 The Calbindins: Calbindin-D28K and Calbindin-D9K and the Epithelial Calcium Channels TRPV5 and TRPV6 \u003c\/p\u003e \u003cp\u003eSylvia Christakos, Leila Mady, and Puneet Dhawan\u003c\/p\u003e \u003cp\u003e21 Mineralization\u003c\/p\u003e \u003cp\u003eAdele Boskey and Eve Donnelly\u003c\/p\u003e \u003cp\u003e22 VITAMIN D Regulation of Type I Collagen Expression in Bone \u003c\/p\u003e \u003cp\u003eBarbara Kream and Alexander Lichtler\u003c\/p\u003e \u003cp\u003e23 Target Genes: Bone Proteins \u003c\/p\u003e \u003cp\u003eHoward Morris, Paul H. Anderson, Gerald J. Atkins, and David M. Findlay\u003c\/p\u003e \u003cp\u003e24 Vitamin D and the Calcium-Sensing Receptor \u003c\/p\u003e \u003cp\u003eEdward M. Brown\u003c\/p\u003e \u003cp\u003e25 Effects of 1,25-Dihydroxyvitamin D3 on Voltage-Sensitive Calcium Channels in Osteoblast Differentiation and Morphology \u003c\/p\u003e \u003cp\u003eMary Farach-Carson and William R. Thompson\u003c\/p\u003e \u003cp\u003eSECTION IV: TARGETS\u003c\/p\u003e \u003cp\u003e26 Vitamin D and the Kidney\u003c\/p\u003e \u003cp\u003eRajiv Kumar and Peter Tebben\u003c\/p\u003e \u003cp\u003e27 Vitamin D and the Parathyroids \u003c\/p\u003e \u003cp\u003eJustin Silver and Tally Neveh-Many\u003c\/p\u003e \u003cp\u003e28 Cartilage \u003c\/p\u003e \u003cp\u003eBarbara D. Boyan, Maryam Doroudi and Zvi Schwartz\u003c\/p\u003e \u003cp\u003e29 Vitamin D and Oral Heath \u003c\/p\u003e \u003cp\u003eAriane Berdal, Muriel Molla, Vianney Descroix\u003c\/p\u003e \u003cp\u003e30 The Role of Vitamin D and its Receptor in Skin and Hair Follicle Biology\u003c\/p\u003e \u003cp\u003eMarie B. Demay\u003c\/p\u003e \u003cp\u003e31 Vitamin D and the Cardiovascular System\u003c\/p\u003e \u003cp\u003eDavid Gardner, Songcang Chen, Denis Glenn, and Wei Ni\u003c\/p\u003e \u003cp\u003e32 Vitamin D: A Neurosteroid Affecting Brain Development and Function; Implications for Neurological and Psychiatric Disorders\u003c\/p\u003e \u003cp\u003eJohn McGrath, Darryl Eyles, and Thomas Burne\u003c\/p\u003e \u003cp\u003e33 Contributions of Genetically Modified Mouse Models to Understanding the Physiology and Pathophysiology of the 25-hydroxyvitamin D-1-alpha Hydroxylase Enzyme [1a(OH)ase] and the Vitamin D Receptor (VDR) \u003c\/p\u003e \u003cp\u003eDavid Goltzman, Geoffrey N. Hendy, and Richard Kremer\u003c\/p\u003e \u003cp\u003eSECTION V: HUMAN PHYSIOLOGY\u003c\/p\u003e \u003cp\u003e34 Vitamin D: Role in the Calcium and Phosphorus Economies\u003c\/p\u003e \u003cp\u003eRobert P. Heaney\u003c\/p\u003e \u003cp\u003e35 Fetus, Neonate and Infant\u003c\/p\u003e \u003cp\u003eChris Kovacs\u003c\/p\u003e \u003cp\u003e36 Vitamin D Deficiency and Calcium Absorption During Childhood \u003c\/p\u003e \u003cp\u003eSteven A. Abrams\u003c\/p\u003e \u003cp\u003e37 Adolescence and Acquisition of Peak Bone Mass\u003c\/p\u003e \u003cp\u003eConnie Weaver, Rick Lewis, and Emma Liang\u003c\/p\u003e \u003cp\u003e38 Vitamin D Metabolism in Pregnancy and Lactation \u003c\/p\u003e \u003cp\u003eBonny Specker, Natalie W. Thiex, and Heidi J. Kalkwarf \u003c\/p\u003e \u003cp\u003e39 Vitamin D: Relevance in Reproductive Biology and Pathophysiological Implications in Reproductive Dysfunction\u003c\/p\u003e \u003cp\u003eHugh S. Taylor and Lubna Pal\u003c\/p\u003e \u003cp\u003e40 Vitamin D and the Renin-Angiotensin System \u003c\/p\u003e \u003cp\u003eYan Chun Li\u003c\/p\u003e \u003cp\u003e41 Parathyroid Hormone, Parathyroid Hormone-Related Protein and Calcitonin\u003c\/p\u003e \u003cp\u003eJohn J. Wysolmerski and Elizabeth Holt\u003c\/p\u003e \u003cp\u003e42 FGF23\/Klotho New Regulators of Vitamin D Metabolism \u003c\/p\u003e \u003cp\u003eL. Darryl Quarles and Valentin David\u003c\/p\u003e \u003cp\u003e43 The Role of the Vitamin D Receptor in Bile Acid Homeostasis\u003c\/p\u003e \u003cp\u003eDavid J. Mangelsdorf, Daniel R. Schmidt, Steven A. Kliewer\u003c\/p\u003e \u003cp\u003e44 Vitamin D and Fat\u003c\/p\u003e \u003cp\u003eClifford J. Rosen and Francisco J. A. de Paula\u003c\/p\u003e \u003cp\u003e45 Extra-renal 1a-hydroxylase \u003c\/p\u003e \u003cp\u003eMartin Hewison and John S. Adams\u003c\/p\u003e \u003cp\u003eSection VI: Diagnosis and Management \u003c\/p\u003e \u003cp\u003e46 Approach to the Patient \u003c\/p\u003e \u003cp\u003eMichael P. Whyte\u003c\/p\u003e \u003cp\u003e47 Detection of Vitamin D and Its Major Metabolites\u003c\/p\u003e \u003cp\u003eBruce W. Hollis\u003c\/p\u003e \u003cp\u003e48 Bone Histomorphometry\u003c\/p\u003e \u003cp\u003eJuliet E. Compston and Linda Skingle\u003c\/p\u003e \u003cp\u003e49 Radiology \u003c\/p\u003e \u003cp\u003eJudith E. Adams\u003c\/p\u003e \u003cp\u003e50 High-Resolution Imagine Techniques for Bone Quality Assessment\u003c\/p\u003e \u003cp\u003eSharmila Majumdar, Andrew J. Burghardt, and Roland Krug\u003c\/p\u003e \u003cp\u003e51 The Role of Vitamin D in Orthopaedic Surgery\u003c\/p\u003e \u003cp\u003eJoseph M. Lane, Aasis Unnanuntana, and Brian J. Rebolledo\u003c\/p\u003e \u003cp\u003eSECTION VII: NUTRITION, SUNLIGHT, GENETICS, AND VITAMIN D DEFICIENCY\u003c\/p\u003e \u003cp\u003e52 Worldwide Vitamin D Status\u003c\/p\u003e \u003cp\u003ePaul Lips and Natasja van Schoor\u003c\/p\u003e \u003cp\u003e53 Sunlight, Vitamin D and Prostate Cancer Epidemiology \u003c\/p\u003e \u003cp\u003eGary G. Schwartz\u003c\/p\u003e \u003cp\u003e54 Nutrition and lifestyle effects on vitamin D status \u003c\/p\u003e \u003cp\u003eSusan J. Whiting and Mona S. Calvo\u003c\/p\u003e \u003cp\u003e55 Bone Loss, Vitamin D and Bariatric Surgery: Nutrition, Obesity and Bariatric Surgery \u003c\/p\u003e \u003cp\u003eLenore Arab and Ian Yip\u003c\/p\u003e \u003cp\u003e56 Genes and Risk of Disease\u003c\/p\u003e \u003cp\u003eAndré G. Uitterlinden\u003c\/p\u003e \u003cp\u003e57 The Pharmacology of Vitamin D \u003c\/p\u003e \u003cp\u003eReinhold Vieth\u003c\/p\u003e \u003cp\u003e58 How to Define Optimal Vitamin D Status?\u003c\/p\u003e \u003cp\u003eRoger Bouillon \u003c\/p\u003e \u003cb\u003e \u003c\/b\u003e\u003cp\u003eVOLUME TWO\u003c\/p\u003e \u003cp\u003eSECTION VIII: DISORDERS\u003c\/p\u003e \u003cp\u003e59 The Hypocalcemic Disorders: Differential Diagnosis and Therapeutic Use of Vitamin D\u003c\/p\u003e \u003cp\u003eThomas O. Carpenter and Karl L. Insogna\u003c\/p\u003e \u003cp\u003e60 Vitamin D Deficiency and Nutritional Rickets in Children\u003c\/p\u003e \u003cp\u003eJohn M. Pettifor\u003c\/p\u003e \u003cp\u003e61 Vitamin D and Osteoporosis\u003c\/p\u003e \u003cp\u003ePeter R. Ebeling and John A. Eisman\u003c\/p\u003e \u003cp\u003e62 Relevance of Vitamin D Deficiency in Adult Fracture and Fall Prevention \u003c\/p\u003e \u003cp\u003eHeike Bischoff-Ferrari and Bess Dawson-Hughes\u003c\/p\u003e \u003cp\u003e63 Clinical Disorders of Phosphate Homeostasis\u003c\/p\u003e \u003cp\u003eMarc K. Drezner and Karen E. Hansen\u003c\/p\u003e \u003cp\u003e64 Pseudo-vitamin D Deficiency \u003c\/p\u003e \u003cp\u003eFrancis H. Glorieux, Thomas Edouard, and René St-Arnaud\u003c\/p\u003e \u003cp\u003e65 Hereditary 1,25-Dihydroxyvitamin D Resistant Rickets\u003c\/p\u003e \u003cp\u003ePeter J. Malloy, David Feldman, and Dov Tiosano\u003c\/p\u003e \u003cp\u003e66 Glucocorticoids and Vitamin D \u003c\/p\u003e \u003cp\u003ePhilip Sambrook\u003c\/p\u003e \u003cp\u003e67 Drug and Hormone Effects on Vitamin D Metabolism\u003c\/p\u003e \u003cp\u003eSol Epstein and Barrie M. Weinstein\u003c\/p\u003e \u003cp\u003e68 Vitamin D and Organ Transplantation\u003c\/p\u003e \u003cp\u003eElizabeth Shane and Emily M. Stein\u003c\/p\u003e \u003cp\u003e69 Vitamin D and Bone Mineral Metabolism in Hepatogastrointestinal Diseases  Daniel Bikle\u003c\/p\u003e \u003cp\u003e70 Vitamin D and Renal Disease \u003c\/p\u003e \u003cp\u003eAdriana S. Dusso and Eduardo Slatopolsky\u003c\/p\u003e \u003cp\u003e71 Idiopathic Hypercalciuria and Nephrolithiasis\u003c\/p\u003e \u003cp\u003eMurray J. Favus and Fredric L. Coe\u003c\/p\u003e \u003cp\u003e72 Hypercalcemia Due to Vitamin D Toxicity\u003c\/p\u003e \u003cp\u003eJohn P. Bilezikian, Natalie E. Cusano, and Susan Thys-Jacobs\u003c\/p\u003e \u003cp\u003e73 Vitamin D: Cardiovascular Effects and Vascular Calcification \u003c\/p\u003e \u003cp\u003eDwight A. Towler\u003c\/p\u003e \u003cp\u003eSECTION IX: ANALOGS\u003c\/p\u003e \u003cp\u003e74 New Analogs\u003c\/p\u003e \u003cp\u003eHector DeLuca and Lori A. Plum\u003c\/p\u003e \u003cp\u003e75 Mechanisms for the Selective Actions of Vitamin D Analogs\u003c\/p\u003e \u003cp\u003eAlex J. Brown \u003c\/p\u003e \u003cp\u003e76 Analogs of Calcitriol \u003c\/p\u003e \u003cp\u003eAnnemieke Verstuyf, Pierre De Clercq, Roger Bouillon, Lieve Verlinden, Guy Eelen, and Maurits Vandewalle\u003c\/p\u003e \u003cp\u003e77 Analogs and Fx Prevention\u003c\/p\u003e \u003cp\u003eNoboru Kubodera and Fumiaki Takahashi\u003c\/p\u003e \u003cp\u003e78 Non-Secosteroidal Ligands and Modulators\u003c\/p\u003e \u003cp\u003eKeith R. Stayrook, Yanfei L. Ma, Matthew W. Carson, and Jeffrey A. Dodge\u003c\/p\u003e \u003cp\u003e79 The bile acid derivatives lithocholic acid acetate and lithocholic acid propionate are functionally selective vitamin D receptor ligands \u003c\/p\u003e \u003cp\u003eMakoto Makishima and Sachiko Yamada\u003c\/p\u003e \u003cp\u003e80 CYP24A1 Regulation in Health and Disease\u003c\/p\u003e \u003cp\u003eMartin Petkovich, Tina Epps, and Christian Helvig\u003c\/p\u003e \u003cp\u003e81 Calcitriol and Analogs in the Treatment of Chronic Kidney Disease\u003c\/p\u003e \u003cp\u003eRavi Thadhani and Ishir Bhan\u003c\/p\u003e \u003cp\u003eSECTION X: CANCER\u003c\/p\u003e \u003cp\u003e82 The Epidemiology of Vitamin D and Cancer Risk\u003c\/p\u003e \u003cp\u003eEdward Giovannucci\u003c\/p\u003e \u003cp\u003e83 Vitamin D: Cancer and Differentiation \u003c\/p\u003e \u003cp\u003eJohannes P. T. M. van Leeuwen, Alberto Munoz, Marjolein van Driel, and David Feldman\u003c\/p\u003e \u003cp\u003e84 Vitamin D Effects on Differentiation and Cell Cycle\u003c\/p\u003e \u003cp\u003eGeorge P. Studzinski, Elzbieta Gocek, and Michael Danilenko\u003c\/p\u003e \u003cp\u003e85 Vitamin D Actions in Mammary Gland and Breast Cancer \u003c\/p\u003e \u003cp\u003eJoellen Welsh\u003c\/p\u003e \u003cp\u003e86 Vitamin D and Prostate Cancer\u003c\/p\u003e \u003cp\u003eDavid Feldman and Aruna V. Krishnan\u003c\/p\u003e \u003cp\u003e87 The VITAMIN D System and Colorectal Cancer Prevention\u003c\/p\u003e \u003cp\u003eHeide S. Cross\u003c\/p\u003e \u003cp\u003e88 Hematological Malignancy\u003c\/p\u003e \u003cp\u003eH. Phillip Koeffler and Ryoko Okamoto\u003c\/p\u003e \u003cp\u003e89 Vitamin D and Skin Cancer \u003c\/p\u003e \u003cp\u003eJean Y. Tang and Ervin H. Epstein\u003c\/p\u003e \u003cp\u003e90 The Anti-Tumor Effects of Vitamin D in Other Cancers\u003c\/p\u003e \u003cp\u003eDonald Trump and Candace Johnson\u003c\/p\u003e \u003cp\u003eSECTION XI: IMMUNITY, INFLAMMATION, AND DISEASE \u003c\/p\u003e \u003cp\u003e91 Vitamin D and Innate Immunity\u003c\/p\u003e \u003cp\u003eJohn H. White\u003c\/p\u003e \u003cp\u003e92 Control of Adaptive Immunity by Vitamin D Receptor Agonists\u003c\/p\u003e \u003cp\u003eLuciano Adorini\u003c\/p\u003e \u003cp\u003e93 The role of vitamin D in innate immunity: Antimicrobial Activity, Oxidative Stress and Barrier Function\u003c\/p\u003e \u003cp\u003ePhilip T. Liu\u003c\/p\u003e \u003cp\u003e94 Vitamin D and Diabetes\u003c\/p\u003e \u003cp\u003eChantal Mathieu, Conny Gysemans, and Hannelie Korf\u003c\/p\u003e \u003cp\u003e95 Vitamin D and Multiple Sclerosis\u003c\/p\u003e \u003cp\u003eColleen E. Hayes, Faye E. Nashold, Justin A. Spanier, Corwin D. Nelson, and Christopher G. Mayne\u003c\/p\u003e \u003cp\u003e96 Vitamin D and Inflammatory Bowel Disease \u003c\/p\u003e \u003cp\u003eMargherita Cantorna and Danny Bruce\u003c\/p\u003e \u003cp\u003e97 Psoriasis and other Skin Diseases\u003c\/p\u003e \u003cp\u003eJörg Reichrath and Michael F. Holick\u003c\/p\u003e \u003cp\u003eSECTION XII: THERAPEUTIC APPLICATIONS AND NEW ADVANCES \u003c\/p\u003e \u003cp\u003e98 The Role of Vitamin D in Type 2 Diabetes and Hypertension\u003c\/p\u003e \u003cp\u003eBess Dawson-Hughes and Anastassios G. Pittas\u003c\/p\u003e \u003cp\u003e99 Vitamin D Receptor Agonists in the Treatment of Benign Prostatic Hyperplasia \u003c\/p\u003e \u003cp\u003eMario Maggi, Annamaria Morelli, and Luciano Adorini\u003c\/p\u003e \u003cp\u003e100 Sunlight protection by Vitamin D Compounds\u003c\/p\u003e \u003cp\u003eRebecca S. Mason, Katie M. Dixon, Vanessa Sequiera, and Clare Gordon-Thomas\u003c\/p\u003e \u003cp\u003e101 The Role of Vitamin D in Osteoarthritis and Rheumatic Disease\u003c\/p\u003e \u003cp\u003eTimothy M. McAlindon and M. Kyla Shea\u003c\/p\u003e \u003cp\u003e102 Vitamin D and cardiovascular Disease \u003c\/p\u003e \u003cp\u003eHarald Dobnig and Harald Sourij\u003c\/p\u003e \u003cp\u003e103 Vitamin D, Childhood Wheezing, Asthma, and Chronic Obstructive Pulmonary Disease\u003c\/p\u003e \u003cp\u003eCarlos A. Camargo, Jonathan Mansbach, and Adit Ginde\u003c\/p\u003e \u003cp\u003e104 Vitamin D and Skeletal Muscle Function \u003c\/p\u003e \u003cp\u003eRobert U. Simpson and Lisa Ceglia\u003c\/p\u003e \u003cp\u003e105 VITAL \u003c\/p\u003e \u003cp\u003eJoAnn E. Manson\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Orthopaedics \u0026amp; fractures [\u003ca title=\"See our other books on Orthopaedics \u0026amp; fractures\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Orthopaedics%20\u0026amp;%20fractures%20%5BMNS%5D%22\"\u003eMNS\u003c\/a\u003e], Endocrinology [\u003ca title=\"See our other books on Endocrinology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Endocrinology%20%5BMJG%5D%22\"\u003eMJG\u003c\/a\u003e], Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648979325208,"sku":"9780123870346","price":121.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780123870346.jpg?v=1695014141"},{"product_id":"cancers-in-the-urban-environment-how-malignant-diseases-are-caused-and-distributed-among-the-diverse-people-and-neighborhoods-of-a-major-global-metropolis-paperback-9780128117453","title":"Cancers in the Urban Environment; How Malignant Diseases Are Caused and Distributed among the Diverse People and Neighborhoods of a Major Global Metropolis (Paperback) 9780128117453","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eCancers in the Urban Environment\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eHow Malignant Diseases Are Caused and Distributed among the Diverse People and Neighborhoods of a Major Global Metropolis\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eThe largest compendium of cancer descriptive epidemiology available\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eThomas M. Mack (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128117453\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 2 December 2020\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e1148 pages\u003cbr\u003e27.6 x 21.5 x 6.8 cm, 2.99 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eCancers in the Urban Environment: How Malignant Diseases Are Caused and Distributed among the Diverse People and Neighborhoods of a Major Global Metropolis, Second Edition, \u003c\/i\u003eprovides a detailed description of the occurrence of common forms of cancer in the ethnically, socially and environmentally complex milieu of a modern urban complex. The location is Los Angeles County, and the patterns of 72 different malignancies are described according to race, age, sex, social class calendar time (since 1972) and most notably, individual neighborhood, using detailed maps of high risk. This second edition uses twice as many cases and more demographic diversity.\u003c\/p\u003e  \u003cp\u003ePhysicians and scientific investigators in California and elsewhere can use the material provided to counsel patients and evaluate the consistency of any specific pattern of occurrence with each specific causal hypothesis. A detailed appendix describes the source of data, provides the basis for the choices made in the production of the volume, and gives a perspective on the search for \"clusters\" of malignancy.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e1. What Cancers Are2. Environmental and Other Causes of Cancer3. Resources Used to Detect Local Increases in Risk4. Methods Used to Detect Local Increases in Risk5. Errors Due to Chance6. Comparison Between \"Apples\" and \"Oranges\"7. Failure to Detect Local Increases in Risk8. Investigating a Lead9. Guide to the Figures10. Interpretation11. Scientific and Technical Notes12. Oropharyngeal Carcinoma13. Salivary Gland Malignancies14. Squamous Carcinoma of the Esophagus\/Gastric Cardia15. Adenocarcinoma of the Esophagus\/Gastric Cardia16. Adenocarcinoma of the (Lower) Stomach17. Carcinoma of the Small Intestine18. Colon Carcinoma, Total (Both Upper and Sigmoid)19. Carcinoma of the Upper Colon20. Carcinoma of the Sigmoid Colon21. Carcinoma of the Rectum22. Hepatocellular Carcinoma23. Cholangiocarcinoma24. Gallbladder Carcinoma25. Biliary Tract Carcinoma26. Pancreas Carcinoma27. Carcinoma of the Nose\/Sinuses28. Carcinoma of the Larynx29. Lung and Bronchus Carcinoma, Total (All Types)30. Squamous Cell Carcinoma of the Lung and Bronchus31. Large Cell carcinoma of the Lung and Bronchus32. Small Cell Carcinoma of the Lung and Bronchus33. Adenocarcinoma of the Lung and Bronchus34. Bronchioloalveolar Carcinoma of the Lung and Bronchus35. Undifferentiated Carcinoma of the Lung and Bronchus36. Carcinoma of the Lung and Bronchus, Not Otherwise Classified37. Mesothelioma38. Soft Tissue Sarcoma39. Angiosarcoma40. Kaposi Sarcoma41. Osteosarcoma42. Ewing's Sarcoma43. Malignant Chordoma44. Malignant Melanoma45. Breast Carcinoma46. Squamous Cervix Carcinoma (Invasive)47. Endometrial (Uterine Corpus) Carcinoma48. Epithelial Carcinoma of the Ovary49. Germ Cell Malignancies50. Prostate Carcinoma51. Anogenital Adenocarcinoma52. Anogenital Squamous Carcinoma53. Mixed Cell Genital Tumors54. Transitional Cell (Non-Squamous) Bladder Carcinoma55. Squamous Bladder Carcinoma56. Renal Cell Carcinoma57. Wilms Tumor (Nephroblastoma)58. Retinoblastoma59. Brain Malignancies (Gliomas)60. Spinal Cord Malignancies61. Neurolemoma (Nerve Sheath Malignancy)62. Neuroblastoma63. Malignant Meningioma64. Papillary Carcinoma of the Thyroid65. Follicular Carcinoma of the Thyroid66. Other Carcinoma of the Thyroid67. Pituitary Carcinoma68. Multiple Endocrine Neoplasia69. Carcinoma of the Thymus70. Mixed Cellularity Hodgkin Lymphoma71. Nodular Sclerosis Hodgkin Lymphoma72. Other Hodgkin Lymphoma73. All Non-Hodgkin Lymphomas (All Non-Hodgkin Lymphoma Types)74. Follicular Non-Hodgkin Lymphoma75. Diffuse Large B-Cell Non-Hodgkin Lymphoma76. Diffuse Small Lymphocytic or Plasmacytic B-Cell Non-Hodgkin Lymphoma77. Diffuse Mixed B-Cell Non-Hodgkin Lymphoma78. High-Grade Non-Hodgkin Lymphoma79. T-Cell Non-Hodgkin Lymphoma80. Maltoma Non-Hodgkin Lymphoma81. Other Non-Hodgkin Lymphoma82. Central Nervous System Non-Hodgkin Lymphomas (All Non-Hodgkin Lymphoma Types)83. Stomach Non-Hodgkin Lymphomas (All Non-Hodgkin Lymphoma Types)84. Other Gastrointestinal Non-Hodgkin Lymphomas (All Non-Hodgkin Lymphoma Types)85. Lymph Node\/Other Organ Non-Hodgkin Lymphomas (All Non-Hodgkin Lymphoma Types)86. Multiple Myeloma87. Acute Lymphoblastic Leukemia88. Chronic Lymphocytic Leukemia89. Hairy Cell Leukemia90. Acute Non-Lymphocytic Leukemia91. Chronic Myelocytic Leukemia92. Other Leukemias93. All Malignancies of Infants\/Toddlers94. All Malignancies of Older Children95. All Malignancies of Young Adults96. All Malignancies of Older Adults97. All Malignancies98. Overall Summary\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Freshly Printed Books","offers":[{"title":"Default Title","offer_id":46648983486744,"sku":"9780128117453","price":120.79,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128117453.jpg?v=1694095852"},{"product_id":"thyroid-cancer-and-nuclear-accidents-long-term-aftereffects-of-chernobyl-and-fukushima-paperback-9780128127681","title":"Thyroid Cancer and Nuclear Accidents; Long-Term Aftereffects of Chernobyl and Fukushima (Paperback) 9780128127681","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eThyroid Cancer and Nuclear Accidents\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eLong-Term Aftereffects of Chernobyl and Fukushima\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003e\u003cp\u003eExplores the lessons learned about thyroid cancer risk and prevention based on two major nuclear power plant accidents\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eShunichi Yamashita (Edited by), Geraldine Thomas (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780128127681, Elsevier Science\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 31 March 2017\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e246 pages\u003cbr\u003e22.9 x 15.1 x 1.7 cm, 0.41 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003ci\u003eThyroid Cancer and Nuclear Accidents: Long-Term Aftereffects of Chernobyl and Fukushima\u003c\/i\u003e discusses the radiobiological effects of the release of radioiodine from two nuclear power plant accidents and appropriate interpretation of the results of thyroid ultrasound examination. The book pulls together expert opinion on radiation related thyroid cancer in an understandable manner, even for non thyroidologists.\u003c\/p\u003e  \u003cp\u003eThe book explains what has been learned from both accidents in relation to prevention of thyroid cancer following nuclear power plant accidents. The book encompasses topics such as risk estimations of thyroid cancer following nuclear accidents and clinical aspects after those specific situations. Additionally, it discusses in detail the reports from Fukushima related to thyroid cancer in the population. This book is a valuable resource for oncologists and biomedical researchers with interest in nuclear accidents and cancer cases.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003ePart I: Overview: Keynote Lectures\u003c\/b\u003e1. Thirty Years After Chernobyl—Overview of the Risks of Thyroid Cancer, Based Upon the UNSCEAR Scientific Reports (2008–2012)2. Thirty Years After the Chernobyl Nuclear Power Plant Accident: Contribution From Japan—“Confirming the Increase of Childhood Thyroid Cancer?3. From Chernobyl to Fukushima and Beyond—A Focus on Thyroid Cancer4. Reassessing the Capability to Attribute Pediatric Thyroid Cancer to Radiation Exposure: The FHMS Experience\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: Chernobyl + 30\u003c\/b\u003e5. Post-Chernobyl Pediatric Papillary Thyroid Carcinoma in Belarus: Histopathological Features, Treatment Strategy, and Long-Term Outcome6. Clinical Aspects of Pediatric Thyroid Cancer and Follow-Up of Patients in Belarus Following the Chernobyl Accident7. Long-Term Analysis of the Incidence and Histopathology of Thyroid Cancer in Ukraine in Adult Patients Who Were Children and Adolescents at the Time of the Chernobyl Accident8. Thyroid Cancer Risk in Ukraine Following the Chernobyl Accident (The Ukrainian–American Cohort Thyroid Study)9. Results of the Thyroid Cancer Epidemiological Survey in Russia Following the Chernobyl Accident10. Influence of Radiation Exposure and Ultrasound Screening on the Clinical Behavior of Papillary Thyroid Carcinoma in Young Patients11. Results of Treatment in Children and Adolescents With Differentiated Thyroid Carcinoma Not Exposed and Exposed to Radiation From the Chernobyl Accident12. Somatic Genomics of Childhood Thyroid Cancer\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Fukushima + 5\u003c\/b\u003e13. A Review of Studies on Thyroid Dose Estimation After the Fukushima Accident14. Five-Year Interim Report of Thyroid Ultrasound Examinations in the Fukushima Health Management Survey15. The Features of Childhood and Adolescent Thyroid Cancer After the Fukushima Nuclear Power Plant Accident16. Psychosocial Impact of the Thyroid Examination of the Fukushima Health Management Survey17. Thyroid Cancer Screening and Overdiagnosis in Korea18. Management of Papillary Thyroid Carcinoma in Japan\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV: International Report\u003c\/b\u003e19. UNSCEAR Activities Related to the 2011 Fukushima-Daiichi Nuclear Power Station Accident20. The Radiological Consequences of the Fukushima Dai’ichi NPP Accident: Estimates From the Group of Experts Convened by the International Atomic Energy Agency\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Oncology [\u003ca title=\"See our other books on Oncology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Oncology%20%5BMJCL%5D%22\"\u003eMJCL\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Academic Press","offers":[{"title":"Default Title","offer_id":46648991023384,"sku":"9780128127681","price":56.89,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780128127681.jpg?v=1694095901"}],"url":"https:\/\/freshlyprintedbooks.co.uk\/collections\/oncology.oembed?page=15","provider":"Freshly Printed Books","version":"1.0","type":"link"}